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ABSTRACT 
Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV) belong to the viral subfamily 
Alphaherpesvirinae, and are important neurotropic human pathogens. HSV and VZV fuse their envelope 
with the membrane of the host cell, a process termed cell entry, accomplished by a conserved trio of viral 
glycoproteins (gB, gH and gL). Host cell receptors mediate viral entry, i.e. nectin1 is recognized by the 
viral tropism factor gD in HSV, while the host receptor is still elusive in VZV. Integrins are widely 
distributed adhesion membrane proteins, and give critical contribution to the entry of most human 
Herpesviruses. αvβ6 or αvβ8 integrins are interchangeable receptors for HSV gH/gL, and they could 
synchronize fusion exerted by gB with the virion endocytosis they mediate. αvβ6 or αvβ8 integrins 
modify the glycoprotein machinery of HSV, but the modification they induce on gH/gL heterodimer was 
never investigated. The results presented here argue in favor of an integrin dependent mechanism which  
involves the conserved glycoprotein apparatus of HSV and seems to be essential to HSV entry. This 
mechanism, which also depends on the presence of gB and nectin1-bound gD,  entails the dissociation 
of gL from gH/gL heterodimer, and its release in the media of culture cells upon binding of αvβ6 or αvβ8 
integrins receptors. Recent findings disclose both the resemblance between HSV and VZV gH/gL 
heterodimer structures and the role of integrins of the alpha V family as receptors for VZV entry, a role 
probably shared with Myelin Associated Glycoprotein (MAG). However, while MAG function in fusion 
was associated with VZV gB, it was not clarified which glycoprotein(s) was(were) involved in integrin-
mediated VZV entry. Data presented here argue in favor of integrin direct binding with a part of the 
conserved VZV entry machinery, while VZV fusion seems to be the result of more complex interactions. 
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1 INTRODUCTION 
 
1.1.1 Brief introduction to Herpesviruses 
 
The Herpesviridae family includes viruses from reptiles, birds and mammals, which all share a similar 
architecture of the virion.1 The Human species hosts nine herpesviruses: herpes simplex virus 1 (HSV-
1, HHV-1), herpes simplex virus 2 (HSV-2, HHV-2), varicella-zoster virus (VZV, HHV-3), Epstein-
Barr virus (EBV, HHV-4), human cytomegalovirus (HCMV, HHV-5), Human herpesviruses 6A, 6B, 
and 7 (HHV-6A, HHV-6B, HHV-7), and Kaposi’s sarcoma–associated herpesvirus (KSHV or HHV-8). 
Epidemiology varies among viruses, as infection might result in a specific disease. Herpesviruses have 
a double strand DNA genome, the replication cycle is characterized by a nuclear viral gene 
transcription, a nuclear viral DNA synthesis and a nuclear assembly of the viral nucleocapsid. Another 
shared feature among herpesviruses is latency, that allows a lifelong persistence of the virus in specific 
tissues inside the host. Herpesviruses produce viral progeny through lytic infection, namely, the 
destruction of the host cell. Herpesviruses could infect different kinds of hosts, i.e. HSV has the 
capability to infect also murine cells. Another important hallmark is the duration of their replicative 
cycle, with important implication for in vitro studies. Common to all herpesviruses is the ability to 
encode a variable set of enzymes, which allows the virus to speed up its own nucleic acid metabolism 
once inside a susceptible and permissive host. This way, the virus favors its replication at the expense 
of that of the host cell. Examples include: DNA polymerase, DNA helicase, DNA primase and 
thymidine kinase, thymidylate synthetase, dUTPase, ribonucleotide reductase. 
 
1.1.2 Brief History of HSV and VZV 
 
Hippocrates was the first to ever document herpesviruses lesions, in 400 BCE. They were referred to as 
herpes, because of their ability to crawl inside the skin.2 
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In the 18th century, Bateman described herpes as a “restricted group of localized vesicles with a short, 
self-limiting course”, while in 1768 Herberden operated distinctions among varicella and smallpox, 
whose etiology was previously thought to be the same. In 1863, Von Barensprung identified a 
correspondence between dermatomes and rash distribution of Zoster. The 19th and 20th centuries were 
characterized by the first experiments on viral transmission involving human volunteers. 
In particular, in 1873, Vidal showed that herpes simplex was caused by an infectious agent, inasmuch it 
could be passed between humans. In 1892, Von Bokay demonstrated the common infectious etiology 
between Zoster and Varicella by means of inoculating children with Zoster derived essudates.3 In 1924, 
Gruter showed that the isolated HSV agent could be experimentally transmitted among rabbits. Garland 
and Hope Simpson proposed that Zoster originated when latent Varicella reactivated.4,5 
Concurrently, in the 1930s, Burnett and William described the lifelong persistency of HSV and 
observed its reactivation during stress conditions. Importantly, these reactivations happened only in 
individuals with HSV neutralizing antibodies, as suggested by Andrews and Carmichael. In 1953, 
Weller replicated the same hallmarks of VZV infection in tissue culture by using both Varicella and 
Zoster starting material.6 
In the 1970s, it was demonstrated that a human fetus could be seriously threatened by encephalitis 
induced by genital herpes. For this purpose, antiviral Vidarabine was used to prevent replication of 
HSV-2. Eliot et al. subsequently discovered Acyclovir, whose derivatives are still administered 
nowadays to control herpesvirus infections. In 1974, Takahashi developed the first vaccine against a 
herpesvirus, starting from VZV Oka parental strain, making Varicella and Zoster preventable 
diseases.7,8 In 1986, Davison and Scott completed the DNA sequencing of VZV genome (strain 
Dumas), the smallest genome among that of herpesviruses.9 
 
1.1.3 Herpesvirus Classification 
 
In the 1970s, before the advent of DNA sequencing, known herpesviruses were classified as 
Herpesviridae by the International Committee on the Taxonomy of Viruses (ICTV). Whitin this family, 
three subfamilies were identified, resuming species-specific biological characteristics: 
Alphaherpesvirinae, Betaherpesvirinae, and Gammaherpesvirinae.10 In particular, alphaherpesviruses 
are characterized by a short life cycle and are thus easily and rapidly spread in culture. 
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Alphaherpesviruses establish latency in the sensoria ganglia of the host and destroy infected cells very 
quickly. Genomic data analysis and the comparison of gene distribution provide the basis for a deeper 
organization of the virus subfamily into genera, i.e. both HSV-1 and HSV-2 belongs to the genus 
Simplexvirus. VZV belong to the genus Varicellovirus, together with Pseudorabies Virus (PrV), which, 
in turn, affect swine. HSV-1, HSV-2, VZV and PrV belong to the alphaherpesivirinae subfamily.  
HCMV belongs to Betaherpesviridae and is characterized by a long life cycle which is performed in a 
restricted number of host cells. In vitro culture of HCMV requires more time to proceed and host cells 
are peculiarly modified in their structure, exhibiting dilatation referred to as cytomegalia. 
Betaherpesviruses establish latency in secretory glands, lymphoreticular cells and kidneys. Other 
human betaherpesviruses are Roseolovirus (HHV-6, HHV-7). Gammaherpesviruses are divided into 
genera Lymphocryptovirus (EBV) and Rhadinovirus (KSHV). They infect prevalently T or B cells, i.e. 
EBV infects only human cells from limphoid tissues, where it also establishes its latency. The 
availability of specific receptors alone is not sufficient to explain the possibility to infect a wide range 
of hosts.  
It was recently demonstrated that degenerated primers for viral hallmark genes (as DNA polimerase) 
could be annealed by a polimerase chain reaction (PCR) technique onto genomic samples from 
mollusks to mice. This result discloses an unexpectedly wide spread during evolution of 
herpesviruses.11 Viral DNA polimerase gene was conserved during evolution as it performed an 
essential function in the viral infection cycle.  
 
1.1.4 Epidemiology of HSV 
 
Only an infected human transmits HSV to susceptible humans, and no animal vector has ever been 
recognized for HSV. HSV is distributed in the worldwide population without distinction between 
developed and less developed countries; HSV infection is observed with no seasonal influence.12 50% 
of the human population could have been infected by HSV; HSV is life long infection, as the virus 
became latent inside neurons of the infected individual. This mechanism raises the possibility for 
subsequent reactivations and consequent spreading in the rest of the population. HSV causes very little 
fatality cases, most of them are recorded after severe infection of newborns. On the contrary, when 
HSV infects children (termed primary infection, often located in the mouth or ocular area), symptoms 
are usually subclinical or absent. Infection requires infectious agent penetration through abraded skin or 
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mucosa. The encounter with axonal termini of sensory neurons leads to retrograde transportation of the 
capsid to the neuron nucleus, where virus latency is established.13 
HSV becomes latent inside the sensoria ganglia of the host, where it is maintained as an episomal DNA 
until various environmental stimuli -connected with psychophysical stress or absorption of UV 
radiations- induce its reactivation. After a limited lytic cycle, which allows to maintain a reserve of 
viral genome in infected ganglia, reactivated HSV undergoes anterograde transportation to the 
innervated skin site (that usually corresponds to the site of primary infection) originating typical fever 
blisters. The recurrent cold sore are sites of active replication, functional for virus spreading among 
susceptible individuals and the lesion produced might affect skin sites near the original one.13 
HSV incubation period is commonly 4 days long but it could last up to 12 days. During the incubation 
period, the DNA of the virus is detectable by PCR assays. HSV-1 symptomatology includes 
oropharyngeal disease which could last for up to 3 weeks. Symptoms involve ulcerations on the lips 
(typical of recurrent infection) and in the gingival mucosa (the typical site of primary infection). 
HSV-2 symptomatology includes genital macules, vesicles and ulcers, that are productive sites of 
infection; vaginal delivery in these conditions allows spreading to the newborn, with encephalitis or 
disseminated infection as possible complications. In immunodeficient individuals, HSV might cause 
severe infection, leading to progressive diseases of the respiratory and gastrointestinal tracts. 
In the cases where HSV infection may lead to complications, i.e. aseptic meningitis, the prodrug 
acyclovir must be administered intravenously; otherwise, topical or oral administration is used to 
mitigate symptoms of infection, while it remains not possible to eradicate the latent form of the virus. 
 
1.1.5 Epidemiology of VZV 
 
Only an infected human transmits VZV to susceptible human and no animal vector has ever been 
recognized. VZV tropism includes T cells, epithelial cells and neuron cells, but dissemination to other 
organs as lung, liver or the central nervous system might happen when viremia and viral replication 
escape the control of the adaptive immune response.14 
Varicella is the clinical manifestation of the VZV primary infection, which is presumed to start with 
inhalation of the airborne virus, because VZV might spread by means of respiratory droplets.15 Among 
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susceptible individuals, VZV infections may originate also from the inoculation of mucosal epithelium 
with vaccine strain preparation or vesicular fluids from VZV skin lesions. 
Initial VZV replication involves the respiratory mucosa; primary infection causes varicella and occur 
after 10 to 21 days of incubation. During this period, VZV infects host T cells and it spreads 
throughout the body into the skin. The incubation period is prolonged, inasmuch VZV skin infection is 
counteracted by epithelial innate barriers, i.e. epithelial IFN constitutive expression.16 From the 
respiratory mucosa, VZV might gain access to the tonsils, where the virus spreads to T cells with skin 
homing markers. 17 In 10 to 21 days these cells disseminate in the skin, where VZV creates a site of 
productive replication, termed varicella vesicles, that allow spreading in the rest of the population by 
contact or by airborne transportation via desquamation.  
48 h before the onset of varicella, the individuals are contagious, and prodromal symptoms include 
fever up to 40°C and headache, while lethargy and anorexia appear after the erythematous macules 
(rash). VZV associated rash evolves rapidly into skin vesicular lesions, with intense itching. 
Subsequently, these lesions start to form crusts. The number of lesions may range from 10 to 2000 
units, initially distributed throughout the face or the trunk. As T cell associated VZV is transported 
throughout the blood torrent, VZV can easily reach the liver or other target organs, whose infection 
typically causes complications in susceptible individuals. To establish latency, VZV might reach 
sensoria ganglia both by centripetal migration from axons termini of sensory neurons, or directly by 
hematogenous trasportation. 
The prevalence of VZV in the human population was determined by means of autopsy studies up to 
94%, and up to 99% by means of IgG antibodies detection in the population living in temperate climate 
zone.18,19 In tropical regions, VZV has a less wide distribution, as only half of the individuals under 24 
had developed varicella.20,21 
Reactivation of latent VZV follows undetermined factors, progressively reaching a 50% risk in people 
older than 85, and may originate Zoster. Zoster is a vesicular rash with dermatomal distribution, whose 
manifestation is due to the loosening of innate and adaptive immunity.22 Zoster is associated with pain, 
referred to as post herpetic neuralgia (PHN), since the VZV reactivation phenomenon induces neuronal 
damages, with inflammation, necrosis and consequent neuritis, myelitis and degeneration.23,24 The 
onset of complications associated with VZV depends prevalently on the immune state of the host, and 
may facilitate bacterial infections in children, varicella pneumonia in adults and the already mentioned 
neurologic syndromes in the elderly.25-27 
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VZV prevalently establishes latency in sensoria ganglia from T3 to L2 of the trunk and, as it infects 
neurons but also their satellite cells, it may expand to other neurons inside the ganglion, contributing to 
PHN.28,29 T cells are important to terminate initial varicella viremia; in immunodeficient individuals, 
VZV reactivation might lead to a generalized Zoster. Generalized Zoster does not have a dermatomal 
distribution; the atypical pattern results from direct reinfection of circulating T cells, which had 
encountered the reactivating ganglia, originating another varicella like viremia.30 
Memory B cell pool is maintained active in the individual to prevent subsequent reinfection upon 
repeated environmental contacts with the pathogen. VZV replication is neutralized by means of 
circulating IgG antibodies, while memory T cells hamper VZV reactivation.31,32 Immune response 
mediated by T cells could be monitored at skin level by analysis of delayed type hypersensitivity 
(DTH) response to VZV antigens, indicating if one individual is subjected to VZV reactivation due to 
waning immunity.33  
Zoster and varicella persist for 1-2 weeks, while PHN may precede or follow Zoster manifestation by 
months, or even occur without skin manifestation; in this latter case, the chronic radicular pain 
produced was termed zoster sine herpete. VZV adverse symptoms, as well as those generated by severe 
HSV infections, are controlled by administration of the prodrug Acyclovir, which results especially 
important to terminate VZV associated viremia in immunocompromised individuals.34 
VZV vaccine is a mixture of different live attenuated virion particles derived from Oka strain, that was 
obtained by VZV propagation in guinea pig and human fibroblast; it is typically administered to 
children at 17000 plaque forming units (pfu) per dose.7,35 Genome variability between the parental and 
vaccine Oka strains affects prevalently 63 sites, whose main target is the gene regulator open reading 
frame (ORF) 62.36 Interestingly, only 5% of vaccinated children develop varicella, and the vaccine Oka 
strain retains the ability to infect other individuals.37 VZV vaccine induces long term (up to 10 years) 
specific cellular immunity against the wild type VZV strains, and vaccination of elderly individuals 
was associated with diminished PHN onsets. Two vaccine administrations are required to gain high 
VZV seroconversion rate.39,40  
Both varicella and zoster skin lesions are site of productive infection yielding cell-free virions in vivo, 
while in vitro VZV remains associated with culture cell membranes, and cell free virions have a 
particle to infectivity ratio of 40,000:1, instead of 60:1 typical of HSV-2.40 Cell-free VZV virions, 
derived in vivo from keratinocytes, have higher titers as compared to that harvested in vitro. VZV can 
infect also Schwann cells and astrocytes in vitro.41,42 
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As VZV vaccine has proved to be safe, it is now tempting to convey foreign antigens from other 
pathogens for vaccination purpose, so as to allow engineering of a multiplex vaccination platform.43 
 
1.2.1 Herpes Virion Structure 
 
 
Figure A. Rendering of the HSV-1 virion by cryoelectron tomography. (H) Envelope surface (blue, 
membrane) with spikes (yellow, glycoproteins). Spliced view of the HSV virion: capsid (light blue), with its 
thread-like surface structures; tegument (orange), which is asymmetrically arranged, envelope (blue and yellow). 
pp, proximal pole; dp, distal pole. Images are adapted from ref 60. 
 
The genetic material of the herpesviruses resides in the virion core as a molecule of dsDNA which 
ranges from 124 to 295 kilo base pairs (kbp) in length throughout the family. Virion capsid is made of 
161 capsomers; these latter form an icosahedron of 100 nm in diameter. The core and the capsid form 
the nucleocapsid. The genetic material is released in the host cell or inserted during virion assembly 
through a unique portal structure, which is found in the assembled capsid. The nucleocapsid is 
absorbed into a proteinaceous material, termed tegument, which appears to be amorphous and 
asymmetrical. The tegument is bordered by a lipid bilayer, decorated with integral viral proteins. The 
lipid bilayer is termed envelope. 
The mature virion diameter ranges between 120 to 260 nm and depends prevalently on the thickness of 
the tegument layer (figure A).44 As estimated by Sodium dodecyl sulphate poliacrilamide gel 
electrophoresis (SDS-PAGE) or proteomic analyses, the Herpes virion contains up to 7 viral proteins in 
the nucleocapid, up to 20 viral proteins in the tegument and up to 19 viral proteins in the envelope.46-48 
The Herpes virion encases about 10000 protein units, some viral proteins were not addressed to any 
virion compartment. The copy number of proteins of viral origin is variable from 1 to 1000 units. The 
envelope glycoprotein B is present on Herpes virion in 800 copies on average. The herpes virion also 
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encases proteins of host origin, with structural or catalytic function, but without an obvious 
significance for virus infection. The Herpes virion also carries mRNAs into the host cell, both from 
viral and host origin, whose transcription might be inherent to infection.49,50 
 
The Core 
 
Herpes virion core encases the genetic material as a single molecule of dsDNA, which is tightly packed 
and presents a toroidal shape, and whose negative charges are neutralized by means of spermine and no 
histones.51-53 As the volume occupied by the buffered DNA molecule perfectly fits the capsid capacity, 
ATP is required to perform core filling. Pressure facilitates the subsequent ejection of the genetic 
material during host infection.54 
 
The Capsid 
 
The herpes virion capsid presents threefold symmetry and is made of 161 capsomers. 150 hexons form 
the faces, whose longitudinal section is 9.5 × 12.5 nm, 11 pentons form the edges and DNA portal. The 
four constituent proteins are evolutionarily conserved.55,56 Three forms of capsid coexist inside infected 
cells: A form is the capsid devoid of the core, B capsid is capsid without DNA, still depending on a 
mounting scaffold, and C capsid is the mature capsid without scaffold, already filled with viral DNA.57 
Conserved capsid proteins are distributed as follows: 
 major capsid protein (MCP), 6 copies per hexon, 5 copies per penton and 955 copies per capsid; 
 monomer and dimer proteins of the triplex (one triplex is formed by 1 TRI1 and 2 TRI2), 320 
triplex per capsid; 
 capsomere-interacting protein (SCP) 
 
MCP protein folding showed resemblance to that of tailed DNA bacteriophages capsid proteins, 
implying a common ancestry between these classes.58 At the end of a vertical axis of the capsid, 12 
copies of the portal protein (PORT) form the capsid portal, which is crossed by dsDNA during 
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packaging or after infection in the opposite direction. The capsid portal is occluded by the portal 
capping protein (PCP), only associated with type C capsids. 
In HSV VP5 (UL19), VP26 (UL35), VP23 (UL18), and VP19C (UL38) form the capsid, whose faces 
are made of layered lattices of polymerized capsid proteins; these layers are concentric, to allow the 
passage of the DNA molecule.59 In the HSV virion, the nucleocapsid occupies 30% of the total virion 
volume and is found in an eccentric position. The nucleocapsid is indeed tethered to the so termed 
proximal pole of the envelope, while the distal pole stands 30 nm apart, separated by a thick tegument 
layer.60 
In VZV, structural studies were impeded by difficulties in harvesting cell free virus at high titer in 
culture. Moreover, virion harvested in culture lacked the capsid dense core associated with DNA 
filling, which is in accordance with the typical low infectivity of cultured VZV.61 In VZV the capsid is 
formed by ORFs 20, 21, 23, 33, 40, and 41, as inferred by analogy among other herpesviruses 
homologs. 
 
The Tegument 
 
The tegument is a proteinaceous structure included between the nucleocapsid and the envelope, 
showing a fibrous appearance upon negative staining.62,63 The thickness of the tegument around the 
nucleocapsid is not constant and is controlled by the virus.64 In fact, the 20 viral proteins that form the 
tegument show polarity, as the tegument is an ordered structure. Specific interaction of tegument 
proteins with nucleocapsid proteins is documented.65,66 In particular, the inner tegument contacts the 
nucleocapsid and the outer tegument contacts integral proteins of the viral envelope. The polarity of the 
tegument is acquired neatly during virion maturation. In fact, the virion sequentially crosses the 
cytoplasmic compartment, characterized by the presence of a particular selection of viral and host 
proteins.67 These proteins, once inside the newly infected host, represent a stock of ready-to-use 
enzymatic tools that help conquering the host by inhibiting host innate immunity or blocking host 
protein synthesis. 
Notable proteins included in the tegument of HSV virion are virion host shut-off (VHS) protein 
(UL41), virion transactivator protein VP16 (UL48) and VP1-2 (UL36), which is a very large protein. 
VZV includes three different transactivators in its tegument, namely ORFs 4, 62, and 63. VZV 
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tegument also includes proteins identified by genes ORF 9, ORF 10, ORF 11 and ORF 12 (that 
represent a conserved gene cluster) and two kinases encoded by ORF 47 and ORF 66.68-71 To 
determinate whether a protein derives from the tegument, infection should be carried out in the 
presence of cycloheximide and then actinomycin D.72 
 
The Envelope 
 
The envelope is the lipid bilayer derived from host cellular membrane that surrounds the nucleocapsid 
and the tegument, it presents a trilaminar appearance when investigated through an electron 
microscope.73 The fact that herpes virions are encircled by lipids and that the envelope is essential for 
infection, implies that herpes virions are sensitive to detergents. The virus hijacks the biosynthetic 
pathway and modifies the host cell membranes with the insertion of viral membrane glycoproteins, 
which are subsequently acquired during virion maturation, when the nucleocapsid packaging is 
complete. Viral glycoproteins are essential both to perform egress from host membrane compartments 
and to infect another cell, i.e. to accomplish fusion and cell entry. The importance of glycoproteins is 
attested by their conspicuous presence on the virion envelope surface. For example, HSV expresses 11 
different envelope glycoproteins (gB, gC, gD, gE, gG, gH, gI, gJ, gK, gL and gM), with up to 1000 
individual copy number per virion, while only four glycoproteins are essential to mediate the entry of 
susceptible cells. 
In HSV, glycoprotein spikes increase the virion diameter up to 225 nm locally, while the average 
diameter measures 186 nm. Glycoprotein spikes do not follow a homogeneous distribution, but are 
organized forming a dense cluster at the distal pole. 
The VZV envelope membrane, contrary to what happens with HSV, does not have a single source, as it 
includes markers from the endoplasmic reticulum (ER) membrane, from cytoplasmic vesicles, and 
from the surface of host cell.75 
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The Genome 
 
The Herpes virion dsDNA is linear, but it circularizes upon release from the nucleocapsid to the 
nucleus of an infected cell. In the herpesviradae family, genome length is comprised between 124 kbp 
and 295 kbp, while genome variability among cultured viruses of the same species may account for up 
to 10kbp additional variability. This additional variability is due to repeated passaging in cell culture 
and often results in genome modification, like gene duplication, gene deletion and copy number variant 
at reiterated sequence level. In vitro virus fitness does not necessarily overlap with the one required for 
an efficient in vivo infection. Strains with a high number of cell passages present mutations that 
eliminate needless gene expression to allow a better spread. For example, HCMV strain used for in 
vitro cultivation carries the deletion of an array including 19 genes. Besides, mutations in a restricted 
group of genes in HCMV clinical isolates allow for an efficient spread in culture cells.75,76 
In the herpesviradae family, the total G+C content in the genome is comprised between 31% and 77%, 
while the G+C content varies inside the same genome, typically leading to a higher G+C content in 
genome repeated terminal ends. Repeated terminal ends in herpesviruses genomes are generally 100bp 
long. In VZV, the right terminal end is repeated and inverted inside the genome, but not inside the left 
terminal end. The biological behavior of inverted repeats allows for inversion and gene expansion of 
the part of the genome they limit. In herpesviruses, allow the small part, termed S,  of the genome to 
switch with the large part of the genome, termed L. The switching of the S part and the L part of the 
VZV genome leads to the recovery of two equimolar species of genome from purified VZV virion.77 In 
HSV, the inverted terminal repeats surround both the L part and the S part of the genome, leading to 
the recovery of four equimolar species of genome from purified HSV virion.78 There are no relations 
between L and S termini sequences. 
HSV genome is complex and characterized by two unique sequences, referred to as long (UL) and short 
(US), surrounded both by inverted repeats, termed a, b and c, and by direct repeats, termed aL and aS. 
UL is comprised between repeats ab and b’a’, while US is comprised between repeats a’c and c’a; the 
number of repeats varies at both UL termini, namely at the L-S junction and at the left UL termini. 
Hence HSV genome could be represented by the following array: aL an b – UL - bʹ aʹm cʹ - US – c a aS. 
HSV genome has three origins of replication: one, termed oriL, resides is in the UL sequence, while the 
others, oriS, are located in the US flanking regions. HSV genome is 152,261 bp long, with a G+C 
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content of 68%.79,80 VZV genome is 124,784 bp with 46% of G+C content, with an unpaired cytosine 
at its left end and an unpaired guanine at the right end that allow circularization.81 
In VZV there are two genome regions, termed short terminal repeat (TRS) and short inverted repeat 
(IRS), that account for genome isomerization, namely the US termini orientation switching. These 
repeats encode a series of three conserved duplicated genes (ORF 62/71, ORF 63/70 or ORF 64/69).82 
VZV genome encases five small repeated regions, termed R1, R2, R3, R4 and R5, whose length varies 
depending on the number of repetitions of the same short sequence. Intergenic regions between ORFs 
60 and 61, 61 and 62, and 62 and 63 originate non coding transcripts in VZV.83 Terminal ends of 
herpesvirus genomes contain pac sequence, which serves both for dsDNA packaging inside the capsid 
and for cleavage of the concatemeric genomes, generated by rolling circle DNA replication.84 
 
1.3.1 Characteristics of Herpes Genes  
 
A typical herpes gene presents cis-acting regulatory sequences comprised between 50bp and 200bp 
upstream the TATA box, while the transcription start site is comprised between 20bp and 25bp 
downstream. Translation takes place after a non-translated leader sequence extended for 30bp to 300bp 
upstream the ORF. The ORF terminates before the non translated trailer sequence, that is 10 to 30 bp 
long, and a regular polyadenylation signal, which can be shared by co-terminal transcripts. Both HSV 
and VZV made use of GU rich sequences GTCTGTGT and TGGTGGTA after polyadenilation sites, 
that are important for termination of transcription.85 The obvious requirement for genome space 
economy and the strong selective pressure, typical of viruses, generated aberrant genes. For example, 
the expression of this genes depends on a degenerated TATA box, i.e. HSV-1 gamma 34.5. Other 
examples are HSV UL26 and UL26.5 genes that originate proteins with different functions but are 
translated from the same mRNA (from different starting codons).86,87 Genes whose promoters reside 
after the TATA box and promoters shared by head-to-tail genes were also described.88 HSV genome 
contains overlapping genes (gamma 34.5 and ORF P and O), with antisense coding ORFs.89 In general, 
viral transcripts are not subjected to splicing, and their expression depends only on host RNA 
polymerase II transcription and subsequent mRNA polyadenilation. At most, 10% of herpes transcripts 
are spliced. To accomplish the sequential expression program typical of herpesviruses (further detailed 
below), a spliced isoform needs to be transcribed from more than one promoter, increasing genome 
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space requirements.90 Herpesviruses codify also for miRNA and non coding mRNA, i.e. the HSV 
Latency Associated Transcript (LATs).91 
In herpesviruses, the number of genes is comprised between 70 (VZV) and 200 (HCMV). These data 
were inferred by herpesviral mutants, transcriptional mapping and in silico analysis. HSV encodes for 
at least 84 proteins, while 90 genes are transcribed including non coding RNA, miRNAs or mRNAs, 
that originate more than one protein (UL3, UL26).92 The gene numbers should be underestimated as 
compared to the total amount of herpesvirus expressed genes: detection techniques skip very short 
ORFs, alternatively spliced mRNA or translationally frameshifted proteins. Large portions of VZV and 
HSV genome are colinear and proteins exhibit similar regions; 56 of the 62 genes in the VZV UL 
region and all the 4 genes in the VZV US region are homolog to those encoded by HSV. VZV ORFs 1, 
2, 13, 32, 57, and S/L have no homolog in HSV and are not essential for VZV replication in cell 
culture, while ORF 13 has a KSHV homolog.93-97 
 
1.3.2 Gene Functions in Herpesviruses 
 
To determine the functionality of various herpesvirus genes experimental systems were employed. 
However, these experimental systems lack the essential protein determinants proper of the host cell. To 
overcome biases originated by restricted systems, the whole herpes genome could be modified by 
recombineering technology, i.e. ablating one gene at time, by means of the bacterial artificial 
chromosome (BAC) system. The mutant genome is subsequently reconstituted directly into its natural 
host by DNA transfection. Promoter and gene dissection in the VZV genome was established by Arvin 
et al. They employed VZV recombinants for in vivo infection of human tissues (T cells, fibroblast or 
neurons) xenografted in SCID mice.98-102 Herpes gene products have multiple functions, which could 
be triggered by their subcellular location, by a specific post-translational modification or by the 
presence or absence of a specific host or viral interactor. For example, HSV ICP0 works as a specific 
transactivator of viral genes in the nucleus, but it subsequently localizes in the host cytoplasm, to 
interact with specific proteins.103,104 
To investigate interactions between viral and host proteins, analysis in the context of infection is 
required as reference. In fact, inside the infected host, viral proteins exert their natural influence on 
themselves, and encounter all their natural host targets, together with their post translational modifiers. 
50% of the proteins encoded by HSV is dispensable during cell culture infection, but not for viral 
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replication or reactivation from latency in animal models. To establish a latent infection, all the viral 
encoded genes are dispensable one at time. Not dispensable genes for herpesvirus infection in cell 
culture are termed essential genes, with notable intermediate cases as, i.e. HSV ICP0. ICP0 is an 
essential gene, but its expression is dispensable during infection in cell culture at high multiplicity of 
infection (MOI). 
 
1.3.3 Interferences with the Host Cell 
 
Proteins encoded by herpesviruses allow for the conquest of the host; they firstly promote host cell 
entry, then contribute to develop the cascade of protein expression ,which finally leads to the hijacking 
of biosynthesis machineries and to the production of a new viral progeny. In particular, viral protein 
expression operates in regulation of viral gene expression, as well as in the nucleid acids metabolism, 
in the formation of the virion capsid or to counteract host cell defenses. Alphaherpesviruses share a 
conserved array of homolog regulatory genes, namely ICP0, ICP4 and ICP27, which serve to 
transactivate viral genetic material, following an established pattern of protein expression. Examples of 
proteins involved in managing host homeostasis are conserved in alphaherpesviruses. 
VZV ORF 10 forms a ternary complex with host Oct1 and HCF on TAATGARAT sequences to allow 
transcription of VZV ORF 62. VZV ORF 10 is the tegumental homolog of HSV VP16 and 
complements HSV VP16 mutants, but it is not essential for VZV infection.105-107 VZV ORF 36, viral 
thymidine kinase (TK), is not essential for VZV replication and, if compared to that of HSV, has a 
prevalent deoxycytidine activity.108 VZV ORF 18 and ORF 19 are homolog to HSV ribonucleotide 
reductase, respectively to the small and large subunits, that are insensitive to concentration of 
deoxyribonucleotides.109 VZV ORF 47 and ORF 66 are tegument serine threonine kinases; VZV ORF 
66 shares homology in its catalytic domain with HSV US3.110 VZV ORF 17 is the homolog of HSV 
UL41 viral host shutoff (VHS), a RNAse that degrades host mRNAs in the cytosol, but has lower 
activity than its HSV counterpart.111 
Modifications in cell homeostasis upon herpesvirus infection include shutting off host anabolic 
reactions to facilitate the onset of viral biosynthesis, i.e. seizure of protein synthesis machinery to build 
capsids or activation of DNA replication in these host cells, whose cell cycle is arrested in G0 state. 
Moreover, modifications in the cell exerted by some herpesviruses are known also to promote the 
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immortalization of the host cell. Herpesviruses have genetically invested in proteins whose main 
function is to react to the host cell innate defenses and host immunity, in order to pursue viral survival 
in an hostile environment.112-114 For example, herpesviruses block apoptosis or induction of interferons 
at cellular level, while in the host organism they could interfere with antigen presentation, sequester 
antibodies (gE/gI, HSV) or even mimic immuno modulator proteins (IL10, HCMV). These viral 
strategies delay the development of an immune or cellular response in the host. Herpesviruses take 
advantage of this delay to efficiently infect the host and to shortly establish life-long latency. The fact 
that herpesviruses are hardly lethal testifies that they establish fine interactions with their hosts (i.e. 
latency), in order to gain the maximum spreading capability inside the host population. In particular, 
alphaherpesviruses are different from other herpesviruses, because they sequester and modify cellular 
proteins instead of expressing cellular orthologs, whose aim is to mislead the host. In the case of HSV, 
the host protein phosphatase 1 α is sequestered by the viral protein gamma 34.5. 
Herpes DNA resides in the cell nucleus of infected cells as an episome, and its transcription depends on 
its state of chromatinization, namely if promoters are accessible to RNA polymerase II. The state of 
chromatinization depends on the cells, which sequester viral DNA in PML bodies to prevent viral 
transcription; to counteract this function, HSV encodes the ICP0 transactivator, whose manifold 
functions include an E3 Ubiquitin ligase activity specifically directed to PML (see below). 
Promyelocytic Leukemia Protein Nuclear Bodies (PML-NBS), termed also ND10 bodies, are 
upregulated by IFNs and exert a cytoprotective function in the host, sequestering aberrant proteins or 
newly assembled viral nucleocapsids.115 HSV ICP0 targets PML for degradation to prevent restriction 
of gene expression, while VZV ORF61, the ICP0 homolog, employs small ubiquitin like modifier 
(SUMO) to disperse PML-NBS.116 
In the case of HSV, the onset of lytic infection encompasses a sequential derepression of specific 
heterochromatinized alpha genes that, in turn, favor the transcription of beta genes, while in the case of 
reactivation from latency, the genome derepression process seems to be not specific.117 
All herpesviruses encase a group of 41 evolutionarily conserved genes, termed core genes, that are 
found into six blocks. These gene blocks show conserved order and polarity, but are distributed in 
manifold combinations of order and polarity among herpes genomes.118,119 The pattern of these 
conserved gene blocks is similar at subfamily level (i.e. between alphaherpesviruses), while gene 
sequence conservation is generally poor. Inside alphaherpesviruses, evolutionarily conserved genes are 
the tropism factor gD (except for VZV), the tegument trans inducing factor (alpha-TIF) -which induces 
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transcription of immediate early genes-, and the transcriptional regulator ICP4. The origin binding 
protein (OBP) is conserved only in alpha and partly in beta families of herpesviruses.120 OBP function 
is to allow aggregation of the viral replication machinery around its binding site on viral DNA. During 
evolution, herpesviruses acquired at least one gene from host source, that is thymidylate synthase in the 
case of alphaherpesviruses, while KSHV inherited 12 host genes, with obvious implications for 
oncogenicity in this latter case.121,122 To acquire genes, retroviruses should coinfect an herpervirus host; 
indeed, acquired genes are encoded by what resembles a single ORFs cDNA. Acquired genes localize 
in the genomes termini or between blocks of conserved genes. Herpesviruses might acquire these 
pieces of host DNA after speciation, namely by independent retrotrasposition events. In the case of 
KSHV, the viral encoded type D cyclin gene had undergone modifications in contrast to the one 
encoded by the host, being constitutively activated and promoting transformation of the infected 
cells.123 
 
1.4.1 Biological cycle of Herpesviruses: Initiation of Infection  
 
The biological cycle of Herpesviruses starts with initiation of infection and continues either with lytic 
replication or with latency. In those cells, where the virus is already latent, it can only proceed in lytic 
infection. These processes are influenced only by the virus and depend on the availability of specific 
factors inside the host cell. Initiation of infection is, for the virus, the period between the encounter 
with viral cognate receptor on the host cell surface and the onset of viral transcription. Virion envelope 
glycoproteins orchestrate the cell entry, sequentially interacting with each other and with host surface 
receptors. Initial tethering is provided by gC and gB binding to host heparan sulphate (HS) moieties. 
HS is a glycosaminoglycan related to heparin, a sulfated polymer of both disaccharides glucuronic acid 
(GlcA) and N-acetylglucosamine (GlcNAc), that is present on the membrane surface of mammal cells. 
Heparan sulphate increases HSV infectivity in a reversible and non-essential manner, as acidic 
detached virions maintain their infectivity. The state of the art of the alphaherpesvirus cell entry is 
described in detail in the dedicated section. Briefly, the conserved herpesvirus glycoprotein trio is 
composed by gB, which provides first attachment, and gH/gL, which activates gB to exert its fusogenic 
capabilities. Host cellular receptors respond to virion binding. Namely, they could promote endocytosis 
(i.e. integrins) or trigger molecular pathways, which alter the host cellular homeostasis (i.e. TLRs). The 
host cytoskeleton represents the first barrier for the viral capsid, preventing viral transition to the 
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nuclear pore. Cytoplasm macromolecular density constitutes a second barrier to viral capsid diffusion. 
Nucleocapsids tether themselves to dynein microtubular motor with centripetal direction to translocate 
near the nucleus. Once in proximity of the nuclear pore, intrinsic pressure and ATP consumption drive 
the ejection of nucleocapsid genetic material inside the nucleus.54 The genome becomes immediately 
chromatinized inside the nucleus; at this level, the availability of host factors lets the virus enter the 
lytic or latency cycle.124 Tegument proteins released in the cytoplasm contribute to the host defense 
blockade and activation of immediate early genes. 
 
1.4.2 HSV Lytic Replication 
 
Lytic replication consists in the synthesis of viral DNA, DNA encapsidation and virion envelopment; 
namely, the production of viral infectious particles, exhaustion and destruction of the host cell. Lytic 
replication encompasses a cascade expression of viral genes, synthesis of viral DNA, assembly of viral 
capsids and egress. HSV induces compartmentalization of existing host cellular districts.  
Herpesvirus protein expression follows a precisely timed program, made of immediate early (alpha), 
early (beta) and late (gamma) genes, which is necessarily synchronized with viral DNA replication. In 
particular, alpha genes require no viral protein synthesis once inside the host, beta genes require no 
DNA synthesis to be expressed while gamma genes expression depends on DNA synthesis. In 
particular, gamma 1 (leaky-late) gene transcription increases proportionally to viral DNA synthesis 
while gamma 2 (true-late) genes totally depends on viral DNA synthesis for transcription. 
Transcription, genome replication and capsid assembly take place in separate zones inside the nucleus. 
Immediate early genes encode for regulatory proteins, capable of activating transcription of early 
genes, shuttling their RNA to the host cytoplasm, altering the cell cycle and the chromatin structure. 
Early genes encode for viral DNA synthesis machinery, namely the genes that constitute the replicative 
fork, and enzymes that enrich the host nucleotide pool, as i.e. tymidilate synthase (HSV). Late genes 
encode for capsid, tegument and envelope proteins. 
HSV alpha genes are generally transcribed from near the termini of the genome, while ICP0 and ICP4 
immediate early genes are encoded into genome inverted repeats (thus are present in more than one 
copy). The tegument protein VP16 (alpha TIF) promotes gene transcription in the nucleus and it is 
detectable between 2 and 4 h post infection. The role of VP16 in the host nucleus is to promote the 
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onset of transcription from immediate early promoters, characterized by the GnTAATGArTTC 
response element. VP16 interacts with octamer binding protein 1 (Oct1) and host cell factor (HCF1). 
The ternary complex VP16/Oct1/HCF1 recruits lysine specific demethylase 1 (LSD1), which is part of 
the CoREST/REST complex, to modify the epigenetic state of the viral genome, thus allowing ensuing 
of the viral transcription.125 
In HSV there are six immediate early proteins, US1.5 and those termed infected cell protein (ICP) 0, 
ICP4, ICP22, ICP27, ICP47. These alpha proteins regulate their own expression, promote transcription 
of beta genes and could be important to drive the transition between beta and gamma gene expression. 
In particular, alpha proteins provide inhibition of various host cell functions, i.e., transcription, mRNA 
splicing, mRNA transportation, protein synthesis and immune response. ICP34.5 is located in the 
repeated UL termini, while the other beta and gamma genes are located throughout the HSV genome. 
The Alpha protein ICP4 is required for HSV beta gene expression, and these genes present an onset of 
4 to 8 h post infection. Beta genes encode for enzymes involved in the nucleic acid metabolism, 
important for genome replication and nucleotide pool maintenance. Beta genes are divided into two 
groups: genes which belong to the first group, as ICP8, UL29, ICP6 and UL39, are transcribed together 
with alpha genes. Beta genes belonging to the second group, as UL23 (the viral tymidine kinase), are 
transcribed later (these include UL30, UL42, UL52, UL9, UL8 and UL5). Alpha and beta genes allow 
transcription of gamma genes, which in turn require genome synthesis for expression; late gamma 
genes instead repress transcription of alpha and beta genes. Gamma genes encode structural proteins, 
i.e. the constituents of the capsid or the tegument; examples are ICP5, gB, gD, ICP34.5 and UL44, gC, 
UL41, UL36, UL38 and UL11. 
 
1.4.3 VZV Lytic Replication 
 
VZV accomplishes its replicative cycle and could be detected into the extracellular matrix at 12 h post 
infection in vitro, while mature enveloped virions are formerly detectable at 9 h post infection. VZV  in 
vitro and in vivo replication in skin fibroblasts leads to the formation of syncytia, namely 
multinucleated cells that result from the fusion of multiple cells. Syncytia formation is not essential for 
infection. Syncytia induced by VZV infection appear at 9 h post infection in melanoma cell culture; 
within 48 h the cell fusion involves 75% of the cell monolayer, while after 60 h syncytia detach from 
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the growing surface.126 VZV gB/gH/gL are essential for syncytia formation, a process that also depends 
on a functional gE/gI heterodimer in vivo, and requires gE N-terminus.127-129 Syncytia show enlarged 
nuclei with a modified structure, with marginated chromatin and abnormal nucleoli. VZV deals with 
the formation of syncytia by setting up “viral highways” on the host cell membrane, that involve 
filopodia, used by the cell associated virion to circulate efficiently towards other susceptible cells, 
increasing the overall spread.130-132 
Upon entry in the host cell, VZV tegument proteins reach the cytoplasm, where they exert modulatory 
roles on the host (ORF 10) and they subvert protein synthesis machinery (ORF 47 and ORF 66 
kinases). VZV tegument proteins might enter into the nucleus together with the viral DNA, so as to 
activate a specific transcriptional program (ORFs 4, 62 and 63).68,69 In particular, ORF 62 activates the 
transcription of its own gene IE 62 and of the most other viral genes, including ORF 61, which is not a 
tegument protein.126 The transcriptional cascade in VZV was not further established because of the 
difficulties in synchronizing the infection, due to the low titer of cell free VZV virions harvested from 
in vitro replication . 
VZV ORF 28 (DNA polymerase) and VZV ORF 29 (ssDNA binding protein) are transcribed from a 
bidirectional promoter with shared regulatory elements; these elements are transactivated by VZV IE62 
interaction with host transcription factors as upstream stimulatory factor (USF).133-135 Also, VZV ORFs 
62 and 63 transcription is mediated by a bidirectional promoter.136 
VZV promoters are influenced by host transcription factors as Sp1, USF and activating transcription 
factor (ATF).  These cellular proteins interact with viral modulatory genes as ORF 61, ORF 62, ORF  
63 and IE4. ORF 62 is the VZV transactivator required for DNA replication. The HSV homolog is 
ICP4; ICP4 HSV mutant can be complemented by VZV ORF 62 although only ICP4 can induce DNA 
bending.137-139 VZV ORF 61 is expressed upon VZV entry and immediately localizes into infected cell 
nuclei; VZV ORF61 is the homolog of HSV ICP0. Both HSV ICP0 and VZV ORF 61 carry a RING 
finger domain to exert transactivation and dispersion of promyelocytic leukemia (PML) nuclear 
bodies.140-143 VZV IE4 homolog in HSV is ICP27, but their functions do not overlap as VZV IE4 
cannot complement an HSV1 mutant. Both HSV ICP27 and VZV IE4 carry putative ZINC finger 
domain to exert transactivation function, which in turn is dependent on dimerization. VZV IE4 can 
shuttle mRNA and its transactivating activity is modulated by ORF 61.144-146 VZV IE63 localizes 
during infection in the nucleus where it colocalizes with IE62, and it is the homolog of HSV ICP22 
(HSV US1.5 and US1 genes). IE63 binds to RNA polymerase II and to antisilencing protein 1.147,148 
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1.4.4 Genome Replication in Herpesviruses 
 
Herpesviruses genome replication must be correctly timed with capsid assembly and rely on cis acting 
elements interspersed in the viral genome and on trans acting factors. The aim of trans acting factors is 
managing genome synthesis from a single viral template. Herpesviruses constantly manage nucleotide 
pools inside host cells, to provide substrate for their genome synthesis, typically by enhancing 
pyrimidine biosynthesis.149 Other examples of host metabolism modifications include the introduction 
by HCMV of tricarboxylic acid (TCA) cycle shunts, whose aim is to provide a sufficient amount of 
reserve lipids for subsequent infection stages.149-151 The genome of any herpesvirus has at least one cis 
acting site, termed oriLyt, employed for aggregation of the DNA replication machinery. 
Alphaherpesviruses use an origin binding protein (OBP), which provides modification to the DNA 
structure to allow nucleation of the other proteins involved in the replicative fork assembly. All the 
viral fork components belong to core genes and are thus evolutionarily conserved, they consist of a six 
gene array including a viral DNA polymerase (POL),  a DNA polymerase processivity subunit (PPS), a 
single stranded DNA binding protein (SSB) and the helicase primase complex (HP1, HP2, and HP3). 
Herpesviruses genome replication is based on the rolling circle, that facilitates synchronization of 
continuous genome production by DNA replication with continuous capsid assembly and filling. As 
nucleocapsid is devoid of nucleosomes, the genome replication process should include mechanisms to 
prevent chromatinization.124 
 
1.4.5 Genome Replication of HSV 
 
Beta proteins are involved in replicating the viral DNA and their aggregation to the viral genome 
rapidly follows their translocation in the host nucleus. Beta proteins are also involved in pre-replicative 
sites formation, whose function is to provide a complete subset of enzymes to support DNA replication, 
as coactivators, corepressors histones and related modifying enzymes.125 
HSV replication starts after alpha and beta gene expression and in particular with the migration of UL9 
into the nucleus, together with early proteins. UL9 binds to oriL and oriS sequence in the viral genome 
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and unwinds the dsDNA. UL9 aggregates also the single strand DNA binding protein ICP8, whose 
presence finally recruits the complete HSV replication machinery on DNA replication forks. Genes 
involved in HSV DNA replication are encoded by UL5, UL8, UL52, UL30 and UL42. Initial theta 
replication switches to the rolling circle, that continuously forms concatemeric genomes. These head to 
tail linked genomes need to be cleaved into monomers, deprived of histones and packaged into the 
capsid. 
 
1.4.6 Genome Replication of VZV 
 
VZV DNA replication starts at 4h post infection, when ssDNA binding protein ORF29 and IE62 
aggregate onto VZV DNA126 VZV DNA polymerase is encoded by ORF28 while ORF16 is the VZV 
polimerase processivity factor.9 VZV genome has no Ori sequence similar to HSV OriL, and contains 
duplicate OriS in the IRS and TRS.152 VZV ORF51 is the Ori binding protein, homolog to HSV UL9; 
both bind to CGC triplet in the Oris sequence.153 VZV ORF29 is the homolog of HSV ICP8, though it 
cannot substitute for HSV ICP8; VZV ORF29 exerts negative regulation on DNA replication by 
binding to Oris.154  
 
1.4.7 Capsid Assembly in Herpesviruses 
 
The translation of herpesvirus mRNA takes place inside defined areas of the host cell, i.e. viral 
glycoproteins ought to be translated in ribosomes associated with the endoplasmic reticulum (ER) and 
with trafficking from the ER to the Golgi cisternae, and finally decorate the trans Golgi network 
membranes. Other examples are capsid proteins, that need to be transported through nuclear pores to 
reach the capsid assembly location in the nucleus, while tegument proteins should be translated or 
routed to cytoplasm areas where maturating capsid would traverse. Capsid assembly takes advantage of 
viral encoded scaffold proteins, whose aim is to catalyze capsid formation and thus are not retained at 
the end of the process. Insertion of newly-synthetized viral DNA inside the capsids is an energy 
demanding process.155 Ancillary proteins, contributing to the capsid assembly process are synthetized 
as a single precursor polyprotein (prePR) that contains an assembly protein precursor (pAP) and the 
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assembly protease (PR), which excises itself and contributes to maturation of the assembly protein 
(AP). Viral DNA fills the capsid until a sensing mechanism induce the cleavage of the genome in 
correspondence with the conserved pac sequence in genome termini. The sensing mechanism is 
provided by the portal capping protein (PCP) and other components of the portal like PORT, the 
terminases TER1 and TER2 and the TER binding protein (TERbp). 
In HSV, VP5 is the major capsid protein, VP23 and VP26 form the triplex, pre VP22 is the scaffolding 
protein, and VP19C contributes to the process. Empty capsid is assembled onto a scaffolding protein 
that is removed simultaneously with genome insertion and cleavage. The intranuclear capsid measures 
125 nm in diameter, which is not compatible for passage in an intact nuclear pore. VZV ORF40 is the 
major capsid protein, it is homolog to HSV UL19 and detectable in infected cell nuclei. VZV ORF 33 
gene encode the precursor of a serine protease which is necessary for maturation of the gene product of 
ORF 33.5, the VZV scaffold protein; ORF33.5 sequence is included into ORF 33 gene.156,157 
 
1.4.8 Egress of Herpesviruses 
 
Three hypothesis are available to explain filled capsid nuclear egress. The luminal transport hypothesis 
envisions that the capsid is enveloped in the nuclear inner membrane and proceeds throughout host 
cellular membrane compartments, finally reaching the cell surface.158-160 The luminal transport 
hypothesis collides with the fact that the nuclear inner membrane has a different composition in 
integral proteins as compared to virion mature envelope, and that viral tegument proteins are available 
prevalently only in the host cytoplasm. Another postulated mechanism best explains the acquirement of 
a stratified tegument and was termed envelopment-de-envelopement model. This latter envisions that 
nucleocapsid reaches the cytoplasm naked and then proceeds towards the cell membrane, sequentially 
acquiring soluble tegument proteins, which reside in the cytoplasm. In particular, this model suggests 
the envelopment of the capsid at the inner nuclear membrane and its subsequent de-envelopment at the 
outer nuclear membrane to reach cytoplasm. Another hypothesis implies a direct release from an 
enlarged nuclear pore or a destroyed nuclear membrane.161 Nevertheless, the envelopment-de-
envelopement model is the only model supported by ultrastructural data and genetic or biochemical 
proofs. The envelopment-de-envelopement model states that, inside the nucleus, nuclear egress 
membrane protein (NEMP) and nuclear egress lamina protein (NELP) are associated to the 
nucleocapsid, constituting a nuclear tegument. NEMP and NELP contribute, together with host kinases, 
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to the disaggregation of the nuclear lamina that fence the inner nuclear membrane, which, in the 
meanwhile, has received a limited subset of viral glycoproteins (presumably consisting in gB,gH/gL). 
Budding virion in intermembrane nuclear space thus acquires both an immature tegument and an 
immature envelope, but it carries functional NEMP and NELP, whose presence is restricted to virions 
budding from the inner nuclear membrane. Finally, these immature virions fuse their temporary 
(primary or nuclear) envelope with outer nuclear membrane to gain access to the host cell cytoplasm. 
Once inside the cytoplasm, non-enveloped nucleocapsids with a nascent tegument layer harvest other 
viral tegument proteins and mRNAs, and are finally targeted, via tethering to microtubules motors, to a 
cell membrane for release. In particular, target membrane belongs to an exit organelle, decorated with 
patches of viral encoded membrane proteins. Nascent virions bud into the organelle to gain their 
secondary envelopment and to gain access to the host cell exterior (virion release).160 The interaction of 
tegument proteins with cytoplasmic tails of viral membrane proteins, distributed on target organelles 
surface, might be necessary to proceed with budding into the organelle. Budding organelles share the 
common feature of being targeted to the host cell membrane to release their content. The budding 
organelle is Trans Golgi Network (TGN) for HSV and the recycling endosomes for HCMV while 
HHV-6A buds into multivesicular bodies. In contrast, in vitro modeling of VZV egress is incomplete as 
VZV replication in vivo seems to differ from the one tested in cell culture. Principal VZV proteins 
involved in egress are ORF24 and ORF27, with similar functions to HSV UL31 and UL34. In general, 
glycoproteins are inserted into TGN membranes, with an inverted topology; this organization might 
recall tegument proteins from the cytoplasm, that finally tether the capsid for budding. VZV virions 
remain usually surrounded by vacuoles in the cell cytoplasm. 
 
1.4.9 Latency  
 
Latency is a mechanism typical of all the herpesviruses already discovered that allows for a lifelong 
persistence in particular tissues of the host which, in turn, might experience no protein expression until 
reactivation happens (i.e. HSV). 
Herpes genome circularizes during latency, and expression in the host cell is restricted to a limited set 
of viral genes until reactivation takes place. During latency no herpesvirus progeny is produced, in 
contrast to other viral mechanisms like chronical, persistent or abortive infections. Reactivation from 
latency awaits a weakness period of the host immunological defenses, since in the immune host an 
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incoming lytic replication typically ends shortly, counteracted by an immune response onset. During 
HSV latency, epigenetic factors control latency associated transcription, and suppression of lytic 
infection inducing factors.124 The host tissue where latent infection is established varies among 
herpesviruses; HSV resides in  neurons of the dorsal root ganglia, while EBV resides in B 
lymphocytes. As the latent infection is a lifelong one, it might happen that the same herpervirus carry 
out both lytic and latent infection in the same host. In contrast, after the clearance of primary VZV or 
HSV infection, all the infected cells of the entire host present only latent infection. When herpesviruses 
manifest their pathological effect on an individual, due to the lytic replication, the virus remains latent 
in another host district to allow for subsequent reactivations.  
VZV, in contrast to HSV, may access sensoria ganglia during primary infection by hematogenous route 
in addition to centripetal axonal transportation; molecular mechanisms of VZV latency are not well 
established yet.  
During latency, HSV maintains its genome inside the neuron nucleus as a chromatinized and repressed 
episome, with no detectable viral protein expression and no VP16 transactivation. HSV encodes the 
latency associated transcripts (LATs) gene in its UL termini; the processing of this gene transcript 
originates a series of microRNAs that contribute to latency maintenance. In particular, LAT low copy 
transcript, termed minor LAT, is 8.3 kb long and is subjected to splicing, generating major LATs of 
1,5kb or 2kb that accumulate inside the nucleus.162 
 
1.5.1 α-herpesviruses entry summary 
 
Herpesviruses use a wide range of host surface molecules to determine their tropism, that is the attitude 
to preferentially target specific hosts, which is typically improved in its accuracy by means of a 
sequential exploitation of different receptors on the same cells.163 This is possible because 
herpesviruses evolved an exclusive multipartite entry apparatus, which is composed by a conserved 
glycoproteins trio, glycoprotein B (gB) and gH/gL, and which eventually include additional species-
specific tropism factors proteins or domains.164,165 Glycoproteins activation follows an interprotein 
signalling cascade prevalently among their ectodomains, that encase functions allowing entry into host 
cell. Fusion’s functions are unevenly distributed among the entry glycoproteins, whose 
multifunctionality is conserved accross the herpesviruses family.164 
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At the beginning of infection, Herpesviruses generally establish aspecific tethering to host cell 
membrane by gB and gC that bind to heparan sulphate moieties. Aspecific membrane binding serves to 
concentrate virions to the host cell surface where entry receptors could be found.164 gC is not essential 
in vitro, as is not the gB tethering activity, while in vivo HSV virion without gC suffers of an impaired 
binding.166,167 Heparan sulphate and syndecans are involved in the HSV virion surfing phenomenon, 
since HSV virions drive the formation of filopodia before gD encounters its receptors.168,169 The second 
step in infection is performed by the species-specific tropism factor, a viral membrane protein acquired 
throughout evolution, which allows the targeting of specific tissues. In α-herpesviruses, this passage is 
accomplished by gD binding to nectins, in the case of Herpes Simplex Virus (HSV), and Pseudorabies 
Virus (PrV, of swine origin) while in the case of Varicella Zoster Virus (VZV) the tropism factor is still 
elusive. HSV uses also Herpes Virus Entry Mediator (HVEM) to enter host cells. The third event in 
infection is the choice of a pathway of entry, which was recently elucidated in HSV; this step is not 
influenced by virion composition but is only dictated by the expression of specific routing factors on 
the membrane of host cells, i.e. integrins. Options for herpesviruses pathway of entry include the fusion 
of the virion envelope with plasma membrane or with endosome membrane.170,171 In particular, fusion 
with the endosome membrane involves neutral or acidic endosomes, or macropinocytosis.172-174 
Integrins usually interact with gH/gL (HSV, HCMV, EBV) but also with gB (KSHV), and are widely 
used by Herpesviruses implying conserved functions. Integrins may be recruited as receptors or 
coreceptors either to trigger endocytosis or to better define tropism or even to exploit activation of 
integrin’s downstream effectors. Finally, the fourth event is the merging of both virion and host cell 
membrane, referred to as fusion, which is undoubtedly an exclusively gB-driven process in HSV and in 
a gammaherpesvirus, Epstein-Barr Virus (EBV).164,175 Integrins bind HSV gH/gL, promoting virion 
endocytosis.176 gH/gL might limit the step rate fusion driven by gB to synchronize membrane fusion 
with endocytosis, which is a structured process.176 Hence, HSV gH/gL are thought to act as an 
intermediate in the stepwise process that leads to fusion, while in PrV gH seems to act as a co-fusogen 
with gB.164,176-180 PrV gH has a conserved mobile element, termed flap, which masks an important 
hydrophobic surface in the gH membrane proximal region; the flap could contribute to membrane 
destabilization when dislocated by a disulfide exchange in flap structural cysteines.178 
Herpesviruses spread among different susceptible hosts and their success during evolution could be 
ultimately due to their promiscuous use of an adaptable protein like gH/gL. gH/gL seems to be the 
smart hub where a combination of signals (molecular interactions) converge and are fairly processed 
(eventually at a slow rate) to accurately trigger gB to execute fusion. gB is instead the conserved 
fusogen across the family. gB structure might be under evolutionary pressure prevalently to perform 
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fusion, but not to allow tropism expansion.177 The evolution of herpesviruses might have invested in 
separating the functions needed for entry in different glycoproteins to gain the best result in terms of 
spreading and targeting efficiency. HSV is a well-fitting example, as function separation here reaches 
an higher level, with a distinct role for gD, as a tropism factor, and gH/gL as the regulator of gB 
fusogenic activity.180 
 
1.5.2 Overview of HSV fusion 
 
The current model for HSV glycoproteins activation cascade, which culminates in fusion and host cell 
entry, envisions that the tropism factor gD binds Herpes Virus Entry Mediator (HVEM) or nectin1. 
These receptors dislocate the so called profusion domain in gD, allowing fusion triggering and 
execution, functions subsequently exerted respectively by gH/gL and gB.181 In particular, gH/gL 
conformation is supposed to change in order to trigger fusion via gB, which is the structurally 
conserved fusion executor.164,179,182-185 The step accomplished by gD is species specific and is the best 
established part of HSV entry mechanism while subsequent steps involving HSV gH/gL and gB are 
still elusive. In fact all human herpesviruses employ tropism factors different from HSV gD, while their 
core fusion machinery, formed by gB and gH/gL, strikingly resembles the same.  gB and gH/gL should 
have evolved both to perform similar fusion functions and to respond to different host receptors, 
depending on the type of herpesvirus. 
In HSV, it was demonstrated that if gD is present and bound to one of its receptors, gH/gL interacts 
with gB only.186,187  Neutralizing MAbs were used to investigate the time course of the interaction 
cascade among HSV glycoproteins. In particular, MAbs that block gH/gL interaction with gB, as for 
example LP11, also block fusion.188-193 Few MAbs to gB, targeting gB fusion loops or whose epitopes 
reside in gB N-terminus, blocked only fusion without blocking gH/gL interaction with gB.194,195 These 
results support the view that HSV gH/gL would not function in fusion but instead will serve as an 
upregulator of gB fusion activity. This implies a sequential recruitment and activation of the HSV 
membrane glycoproteins.180  
To further establish the role of gH/gL as a fusion positive regulator of gB, in trans fusion was 
demonstrated, proving that gH/gL does not act as a co-fusogen in Cyto Megalo Virus (CMV), a β-
herpesvirus.196 In fact, the combination of glycoprotein expression in a co-seeding approach 
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demonstrates that gH/gL does not have to be in the same membrane of gB to carry out fusion via gB. 
Cell-cell fusion in trans (yet at a lower level than in cis) was observed also in HSV using receptor-
positive cells transiently expressing gH/gL, co-seeded with receptor negative cells expressing gD and 
gB87. Fusion was measured also if cells positive for HSV receptor expressing gH/gL were challenged 
with soluble gD and mixed to gB bearing receptor negative cells. On the contrary, no fusion was 
observed if receptor positive cells expressing HSV gB were incubated with soluble gD and co-seeded 
with receptor negative gH/gL bearing cells. This demonstrates that HSV gB is the only glycoprotein 
that must be inserted into a membrane to induce HSV membrane fusion mediated by gB, gH/gL and 
gD.197 
Complexes of gB-gH/gL were isolated from lysates of cells infected with HSV or cells expressing HSV 
glycoproteins.181,198 Interaction between gD and gH/gL is not stable, if a gD-gH/gL complex is 
stabilized it does not allow gB mediated fusion unless it is further dissociated.186 If gD and gH/gL C-
terminal tails were fused with splitted EYFP to gain a gD-gH/gL stable complex, fusion is hampered 
when gB and a host receptor become present together.187 Another parameter further affecting HSV 
fusion/entry is the sequential engagement of cellular receptors by gB and gH/gL. In particular, 
investigations are needed to identify changes in conformation happening to activated HSV gH/gL upon 
integrin binding. These modifications in gH/gL allow interaction of activated gH/gL with gB, 
triggering membrane fusion. 
 
1.5.3 HSV gD and its Host receptors 
 
  
Figure B. Protein structure of HSV gD ectodomain.  On the left HSV gD is oriented to enlight its IgV 
shaped core. On the right gD is depicted in rainbow colours and oriented to enlight the proximity between 
its N-(blue) and C-(red) terminus. Crystal structurea are from PDB (4MYV). 
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HSV gD has three different disulfide bonds in its structure and 3 glycosylation sites. The unbound gD 
has 21 N-terminal flexible residues and the transmembrane region (TMR) is located at amino acid 
position 341 – 361.199 gD encompasses a V-like immunoglobulin (IgV) core which acts as a scaffold 
for N- and C-terminal extensions (figure B).199 . A soluble form of gD, or a full length gD transiently 
expressed in cells permissive for HSV, blocked HSV entry. This phenomenon, termed “restriction”, is 
typical of receptor proteins, and implies that gD is the HSV glycoprotein which binds host entry 
receptor.  
 
 
Figure C. Protein structure of Herpes Virus Entry Mediator (HVEM). HVEM ectodomain is depicted in 
rainbow colours. HVEM can mediate the entry of HSV via gD. Crystal structure is from PDB (4FHQ). 
 
One of the established host receptors for HSV gD is Herpes Virus Entry Mediator  (HVEM), a Tumor 
Necrosis Factor Receptor (TNFR)-like molecule, typically expressed by immune cells (as 
lymphocytes), originally known as TNFRSF14 (figure C).179 HSV cannot infect T cells in vivo, but it 
may modify their response to infection via HVEM to gain a better spread. Indeed, gD binds HVEM in 
the same site for B and T Lymphocyte Attenuator (BTLA), a ligand shown to reduce HVEM surface 
expression. Another established function of gD is to prevent host monocytic cell apoptosis by 
interfering with FAS receptor activity in an HVEM dependent manner. The structure of the first 285 of 
394 residues of gD bound to HVEM show site-specific protein interactions.200 The gD N- terminus is 
not structured when gD is unbound, but if gD binds to HVEM, the gD N-terminus becomes stable with 
an hairpin-shape.199-201 The gD/HVEM hairpin accommodates Tyr23 of HVEM in a pocket, and is bent 
at position 21 of gD. gD even forms an intermolecular β-sheet with two cysteine rich domains (CRD) 
of HVEM.201,202 
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Figure D. Protein structure of a nectin1 dimer. Nectin1 dimer is depicted in rainbow colours. 
Immunoglobulin-like modular structures proper of the nectin1 ectodomain are noticeable. nectin1 can mediate 
the entry of HSV via gD. Crystal structure is from PDB (4FMF). 
 
The principal receptor for HSV is nectin1, as shown by means of MAbs alternatively directed to 
nectin1 or HVEM.203 Nectin1 is a membrane protein belonging to the immunoglobulin superfamily, 
which is expressed in neurons and epithelia.204 Nectins contribute to form adherens junction. 
Mutagenesis and epitope mapping show that nectin1 contacts HSV gD via its distal V-domain, which 
encompasses Ig-like structure (figure D).204-206  The  binding of this nectin1 domain to gD leads to the 
same affinity of the full nectin1 ectodomain (figure E).207 Epitope mapping also shows that nectin1 
binds gD to a different site in respect to HVEM. To confirm these data, the mutant gD (A3C-Y38C) 
was engineered in a way to form a hairpin at gD N-terminus with a disulfide bond.208-210  the N-
terminus flexible domain of gD (A3C-Y38C) mutant is blocked; this mutation avoids binding to 
HVEM, but not nectin1.209 Other mutations in gD 285t ectodomain, which affect only Nectin binding, 
excluded the existence of a common conformational change in gD exerted by HVEM or nectin1. It was 
shown that gD accommodates nectin1 Phe129 into a pocket of its IgV-like core.211,212 
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Figure E. Ectodomain of a nectin1 monomer (yellow) is depicted while interacting with HSV gD 
(red). Nectin1 contacts HSV gD by only the terminal part of its ectopic domain. Crystal structures are 
from PDB (4MYW). 
 
Crystal structure of unbound gD, until amino acid 306, shows that residues Pro 291 and Trp 291 in gD 
C-terminal domain are inserted in a pocket made of N-terminal residue and gD Ig-like core.199 gD306t 
has a lower affinity for its receptors, arguing that residues between 285 and 306 hinder binding to 
HVEM or nectin1, accomplishing gD auto inhibition.205,213,214 It was already known that gD C- and N-
terminals were close to each other, before binding to receptors, as proven by MAb AP7 conformational 
epitope (figure B).215,216 After receptor binding, the C-terminal gD domain is dislodged form the N-
terminal. For example, upon nectin1 binding to gD, Phe129 of nectin1 inserts inside gD pocket and 
dislodges the gD C-terminal, probably because it has a higher affinity; a similar dislocation might 
happen when gD binds HVEM. Mutation of nectin1 Phe129 to Leu or Ala prevents binding to gD, 
while mutation of gD Trp294 enhance gD affinity for its receptors but prevents fusion triggering.217,218 
Finally, another region can be found in gD ectodomain (termed profusion domain), which is important 
in driving fusion and virus entry, rather than receptor recognition.219 Soluble mutant form of gD, 
carrying ablated cytoplasmic tail and this particular domain, were capable of rescuing gD-/- virion 
infectivity.219-221 Also gD260t has a higher affinity for receptor in respect to gD306t, but gD285t 
exhibits the highest affinity for receptors (10−8M).205,213,214 
These differences in receptors affinity could be explained as follows: to interact with its receptor, 
gD306t needs to dislodge the C-terminal residues (269-307), which are partially absent in gD285t.
222 In 
this section, C-terminal domain is referred to as the C-terminal part of gD ectodomain, as the real gD 
C-terminal domain leans inside the virion. Crystal structure of the gD dimer shows that 269-306 C-
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terminal residues wrap around the core of the gD monomer, reaching its N-terminal region (1-22), 
which forms the flexible stretch. As it happens for residues 1-22, also residues 260-268 are not totally 
solved due to their intrinsic mobility, constituting a flexible hinge. In order to better understand gD C-
terminal region, a soluble mutant gD306t307Cys was engineered. In this gD mutant, the C-terminal is 
locked by an intermolecular disuphide bond that allows the formation of a gD dimer.199 As gD C-
terminal hampers binding of its receptors, also the locked C-terminal in gD306t307Cys mutant cannot 
bind any receptor. The hiding of gD binding sites to its receptors may aid the virus in saving its 
fusogenic potential inside the host, until the correct receptor is recognized. The gD mutant in K190C-
A277C is neither functional in cell-cell fusion, nor in gD -/- virion rescue, but it still bind receptors.223 
Features of this latter gD mutant imply that the ability of gD to trigger fusion is separable from its 
receptor interacting function. This aspect of HSV gD tropism factor allowed the creation of a 
retargeting strategy for oncolytics purpose. MAb MC2 mimics mutant gD (K190C-A277C) in the fact 
that it is a neutralizing MAb, which blocks infection, but it still allows (and even increases) interaction 
of gD with its receptors.224 
gD has four Functional Regions (FR) identified by generation of linker insertion mutants and targeted 
by neutralizing MAbs. FR1, residues 27-43, is at the N-terminus of gD and it is involved in HVEM 
induced hairpin. FR2, residues 125-161 and FR3, residues 225-246, correspond to the  gD Ig-like core. 
FR4, residues 277-310, contains the pro fusion domain. FR1 and FR3 of gD elicit also neutralizing 
MAb, which prevent binding of gD with its receptors.216,225,226 FR4 spans gD C-terminal and bears 
some epitope targeted by non-neutralizing MAbs, which promote gD C-terminal dislocation, increasing 
affinity for receptors. The region between FR3 and FR4 is targeted by MC2 MAb (epitope 234-250), 
and it is thought to contain residues capable of triggering fusion via gH/gL or gB.224 Again, by 
exploiting HSV gD mutation it was possible to define a gH/gL interacting region on gD, located 
between residues 260-310 (the profusion domain), while both 240-260 and 304-305 of HSV gD were 
demonstrated to interact with gB.164,181 Finally, gD residues 7–32 are required to promote gD activation 
by the host receptor 3-O-sulphated heparan sulphate, whose role in HSV infection seems to be marginal 
in respect to nectin1 or HVEM.226-228 
gD mechanism of action is interesting in oncolytic-HSV (o-HSV). In fact, the finely tuned model 
described so far seems to be less strict in defining structural requirement for fusion triggering and 
targeted tumor cell entry. In particular, o-HSVs, genetically modified to interact with specific receptors 
overexpressed on tumor surfaces, behave like the wild-type HSV during infection whereas their 
tropism factor structure is totally unrestricted3. For example, it is possible to introduce in position 61–
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218 of gD a heterologous ligand for oncolytic purpose with comparable dimensions to that of the same 
gD. Other examples carry a single-chain Antibody (ScFv) between position 24 and 25 or inside the 
deletion 1–32 or 6–38, which allows detargeting from natural receptors.165 These chimeric 
glycoproteins retain activities in spread and infection that are comparable to that of the wild type HSV, 
while this result strikingly contrasts the structural data so far available. In particular, insertion in the 
structure of gD should interfere with gD auto-inhibition mechanism, as gD C-terminal domain might 
constitutively fail to find its auto-inhibiting grove on gD.165 This leads to the hypothesis that oncolytic 
mutant form of gD would be able to activate fusion independently from profusion domain dislocation. 
Thus, it seems as if the profusion domain continuously alternates interactions with gH/gL or gB, until 
the encounter with a gD receptor stimulates fusion. Fusion might occur as elucidated in measles fusion 
machinery (constituted by Hemoagglutinin-Neuroaminidase and Fusion glycoproteins), i.e., gD would 
be triggered by an artificial or natural receptor and thus become capable of signal transmission to gB, 
only if the receptor binds gD when gD profusion domain is transiently bound to gH/gL.165 The tropism 
factor function ascribed to gD will be then bring together all the entry components, continuously 
alternating interactions among them to maintain the glycoproteins ready to release their fusogenic 
potential upon receptor binding. Subsequent events triggered by gD might encompass stabilization or 
dissociation of a glycoprotein complex, or change in host interactors engagements.165 
 
1.5.4 HSV gH/gL 
 
All the herpesviruses so far identified made use of an evolutionarily conserved glycoproteins trio made 
of the trimer gB and the heterodimer gH/gL as fusion machinery. HSV gH has 838 residues and bears 7 
glycosylation sites, its single TMR is located at 804–824 positions. HSV gL is a soluble protein of 224 
residues, with only one glycosylation site. HSV-2 gH has seven cysteines, while HSV-1 has eight 
cysteines. The numbering scheme presented in the HSV-2 gH structure derives from that of HSV-1 gH, 
but lacks cystein 3 (C3). HSV-2 gH displays three disulfide bonds, in particular cysteines are paired as 
C2-C4, C5-C6 and C7-C8, which is in agreement with previous genetic studies.229 α-herpesvirus share 
conserved C2-C4 and C5-C6 disulfide bonds; mutations in these cysteines cause incorrect 
conformation of gH/gL.229 In general, in α-herpesviruses C8 is conserved while C7 has a different 
position in PrV gH. HSV-2 gH N-terminal appears to be less structured than that of EBV (a 
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gammaherpesvirus), because of its higher Pro/Gly content (18% in respect to 13%), as Pro/Gly 
contribute to the formation of disordered regions.178 
 
  
  
Figure F. Protein structures of HSV gH ectodomain and gL. Left: gH ectodomain (red) interacting with gL 
(blue) is depicted, forming the HSV gH/gL heterodimer. Right: HSV gH/gL heterodimer is depicted in rainbow 
colors, gH H3 domain (blue) forms membrane proximal domain. Crystal structures are from PDB (3M1C). 
Schematics provide an overview of ectopic domain arrangements.  
 
HSV gH and gL are found in virion or infected cells at 1:1 stoichiometry ratio and they elicit 
neutralizing antibodies.230 Both gH and gL have signal peptide, gL remains tethered to gH to facilitate 
folding and trafficking of gH in the secretory pathway and to decorate virion envelope.231 gL reaches 
the secretion pathway if expressed alone, partly retained and partly secreted from the cell.232 If gL is 
absent gH is retained in the endoplasmic reticulum with an improper conformation.233-235 gH interacts 
with gL through residues 259 – 323, while gL interacts with gH through residues 20-161, which 
represents almost the whole gL protein.188,236 
Unexpectedly, HSV-2 gH/gL crystal structure shows that this conserved heterodimer does not resemble 
any known structure (figure F).188 As gH neither resembles any known structure nor forms a trimer, it 
is not classifiable into any class of fusion proteins. Moreover, gH/gL has no structural homolog in any 
of the fusion domains described before.188,237 In particular, the refined model was provided for residues 
Arg49–Pro797 of gH and Thr24–Asn203 of gL, based on structure from Gly48 to Pro803 of gH in 
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complex with residues Gly20-Asn224 of gL. Positions His19–Thr47 of gH were ablated to obtain 
diffraction-quality crystals, these residues did not seem to be involved in viral entry or cell-cell 
fusion.238 Disordered loops in gH (Gly116–Pro136, Thr328–Asp331 and Arg720–Arg724) and in gL 
(Phe112–Ala114 and Leu166–Pro196) were missing from this structure. 
Crystal structure shows that HSV-2 gH/gL heterodimer is 8 nm height and 7 nm length and boot-
shaped; hence, the gH/gL heterodimer is larger than gD but smaller than the gB trimer. Cryo-electron 
tomography showed angled glycoprotein spikes emerging from virion surface, attributable to gH/gL.60  
In HSV gH three different structural domains were identified: H1, H2 and H3.188 These domains were 
divided into five distinct domains, considering their intrinsic properties; H1A: 19–120, H1B: 121–331, 
H2A: 332–441, H2B: 442–645, H3: 646–797.188 Sequence conservation among herpesviruses gH 
increases from domain H1 to domain H3, as only 30% of H1 residues display secondary structure. H2 
and H3 are made of hydrophobic sequences that seem to be folded independently from H1 and are well 
conserved across herpesviruses. These domains are speculated to give support in fusion.164 In 
particular, domain H3 is very sensitive to changes; most of the insertions or point mutations identified 
so far in this domain disrupt cell-cell fusion, interfering with gH structure.229,239 
Several anti-HSV neutralizing MAb target H1 domain, part of these also inhibit spreading; mutations in 
H1 domain often abolish cell-cell fusion.233,236,240 The N-terminal part of gH is clamped by gL with 
extensive interactions to gain proper stability of either the components of the heterodimer. N-terminus 
of gH lacks a stable folded core, in the absence of gL only a six-stranded β-sheet in gH may account for 
the improper residual folding of HSV gH N-terminus.235,238 
HSV gH residues Arg49–Leu115, from domain H1A, form a β-hairpin including a six-stranded mixed 
β-sheet plus three short α-helices (α1-α3). The mixed β-sheet is contributed by both gH with β2-1 
strands and gL with four strands (Lβ4-5-6-2). A linker made of residues Gly116–Pro136 in gH 
connects subdomains H1A and H1B. Residues Ala137–Pro327 belong to H1B domain, arranged into a 
six-stranded antiparallel β-sheet (β12-6-7-8-9-10), where strand β-12 belongs to domain H2. This β-
sheet climbs the central bundle of helices of domain H2 and acts as a diaphragm separating a bulk 
made by H2-H3 domains to the above domain H1 and gL. H1B C-terminus contains also two short α-
helices, α4 and α5 as well as both a two-stranded and a three-stranded antiparallel β-sheet (β4-11 and 
β3-5-6); this ensemble resembled a fence.241 Residues Arg176–Thr230 wrap around the bottom of gH–
gL to constrain domain H1 to domain H2 without contacting other residues in H1. H2 forms the central 
part of gH and is a globular domain, made of 13 α-helices (α6–α21), which also contribute with its 
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strand β-12 to β-sheets within H1B domain. H2A domain encloses a helical bundle subdomain 
consisting of three antiparallel helices displaying a Syntaxin-Like Bundle (SLB) folding. The helical 
disposition in domain H2B resembling that of HEAT repeats, a kind of helix-turn-helix folding.178,242 
The HSV-2 diaphragm is forced to assume a peculiar planar conformation instead of the typical β-
sheets right-handed twist by the SLB.178 The SLB includes helices α7–α9 in HSV-2 gH and α2–α4 in 
PrV gH, and both structures resembled the N-terminal domain of syntaxins 1 and 6. Syntaxin 1 
mediates intracellular fusion as part of the SNARE complex, its Habc domain is adjacent to a helical 
bundle which resembled the helical bundle inside gH, next to the SLB subdomain.178 Conversely to gH, 
upon triggering, Habc domain oligomerizes to exert SNARE mediated membrane fusion.  The fence 
and the SLB are separated in distinct domains in HSV-2 gH/gL structure.188 A helix termed α1 
impinges both on the SLB and the fence, and it is thought to impose specific angles to the whole gH 
molecules. α1 helix length might contribute to shape a toe-like gH/gL in HSV-2 or VZV. Interestingly, 
the SLB domain in HSV-2 gH contains an RGD integrin-interacting motif and it was speculated that 
integrin interaction might trigger a conformational modification in gH through the SLB, leading gH to 
the release of the energy needed for gB destabilization.178,243 In HSV-2, the long α11 helix forms the 
“heel” of gH/gL, again altering the overall packaging of gH domains towards a boot-shaped 
conformation, in contrast with PrV gH whose α11 helix is 20 residues shorter.178,188 
The C-terminal domain H3 forms the membrane proximal base of the ectodomain and is made of 5-
stranded β-sheets in a 10-stranded β-sandwich configuration in HSV-2. H3 domain represents the tip of 
the boot-shaped heterodimer and gH TMR originates from one loop, which protrudes from the margins 
of the β-sandwich configuration. One β-sheet interacts with domain H2 of HSV-2 gH/gL. The five β-
sheets in terminal H3 domain of HSV-2 gH/gL are not perpendicular to the membrane because of the 
toe-shape of HSV-2 gH/gL. H3 domain of HSV-2 gH exposes extended loops on its edges, two of them 
are connected by a disulfide bond (C7-C8). In PRV one loop was termed flap, as it masks a 
hydrophobic patch on the lower surface of gH.178 The flap connects the two β-sandwich edges of the 
PRV gH domain IV, leaning on a charged surface spanning from Asn542 to Cys573 between strands 
β9 and β10. In PrV, two conserved disulfide bonds constrain both the ends of the flap, giving structural 
contributions to domain IV, eventually supporting a change in PrV flap orientation through disulfide 
bond reshuffling. The surface created by the membrane proximal domain of α-herpesvirus gH is highly 
hydrophobic but shielded by the flap, which is an evolutionarily conserved element. Flap dislocation, 
due to conformational changes that ensue in PrV gH during its activation, was speculated to promote 
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fusion in PrV.178 A similar process might happen also in HSV-2 gH/gL, as it displays a similar 
surface.178 
The presence of the flap and the SLB as conserved elements of herpesviral gH leads to speculations 
based on analogies with synaptotagmins interaction with SNARE host fusion proteins.244-246 
Synaptotagmins contain a mobile element, “C2” domain, that upon Ca2+ triggering impinges on 
membranes. This event gives energy contribution to SNARE mediated fusion, providing the necessary 
membrane curvature, a role which might be exerted by the PrV flap. In particular, flap displacement 
might induce membrane destabilization, when the unmasked hydrophobic patch underneath the flap 
exerts repulsive interaction with the surroundings. Alternatively, the hydrophobic surface buried by the 
flap would interact directly with membranes when the flap dislocates. To this purpose, in VZV, 
increasing hydrophobic score of the surface underneath the flap rescued fusion impairment due to 
mutations in neighboring residues.129,247 
HSV gL is required for thecorrect folding of gH, its trafficking and surface expression.231,235,236 
Anyway, as it remains associated to gH and is necessary for gH to function, gL role resembles the one 
of a scaffolding protein.188,231,236 Structurally, gL does not have a stable core, as only 30% of residues 
have a secondary structure. gL is neither conserved among herpesviruses nor swappable among its 
members apart for HSV-1 and HSV-2.229,248 
HSV gL forms three α-helices (Lα1, Lα2 and Lα3) and two β-sheets on its own and contributes with 
four strands to a six-stranded antiparallel β-sheet in gH domain H1A, forming a V-shaped groove.188 
Together with gH, gL forms also a short three-stranded mixed β-sheet including Lβ3-Lβ1-Lβ7. Both 
HSV-1 and HSV-2 gL display two disulfide bonds, encompassing four cysteines termed LC1- LC4, 
implicated in correct folding and function of the heterodimer.229 Crystal structure of gH/gL is lacking 
gL residues Leu166–Asn224, a sequence  known to reduce HSV-2 or HSV-1 gH/gL surface expression 
but not cell-cell fusion.249 These residues are also absent from other α-herpesviruses as PrV and VZV. 
Crystal structure shows that whole gL interacts exclusively with gH domain H1, covering a 
hydrophobic surface area of 7,326.8 Å2.188,233,250 The interacting surfaces between gL and gH integrate 
seamlessly, such that they clearly need each other to co-fold. 
Once bound to gH, gL displays a chemokine fold typical of CC and CXC chemokines, formed by a 
three-stranded β-sheet and an α-helix, stabilized by a single disulfide bond.251 Similarities with 
chemokines and  gH/gL include the fact that chemokines dimerization is often achieved by formation 
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of an intermolecular β-sheet, i.e. as it happens with IL8 homodimer. Provided that mammalian cells 
secrete HSV gL in the absence of gH, it is possible that gL could function as a chemokine.232  
In fusion proteins, a lipophilic sequence of residue could take part in fusion peptide formation, but it 
may also constitute the hydrophobic core of the same protein. Before crystal structure of gH/gL became 
available, it was speculated that gH/gL carried an intrinsic fusion function.247,252-254  A fusion peptide 
could be a loop with hydrophobic residues located in its tip, capable of insertion into membranes. In 
HSV gH hypothetical fusion peptides were recognized to bind artificial membrane liposomes at low 
affinity, due to their intrinsic hydrophobicity.255-257 In gH/gL structure these putative peptides are 
buried helices (residues 377-397) or β-hairpins found in multistranded sheets. In gH crystal structure, 
peptides, which mimic putative gH heptad-repeat (residues 444–479 and 542–582, which inhibited cell 
fusion), form helical hairpins required for domain H2 stability.258 Coiled coils and helical bundles are 
often formed by helices bearing heptad repeats.259-262 In particular, residues 766–802 take part in 
formation of a five-strand β-sheet in domain H3, arguing against a possible excision and insertion into 
a target membrane. It was also demonstrated that a synthetic peptide mimicking gH regions 626-644 
inhibited cell-cell fusion. These peptides could have interfered with the interaction among fusion 
proteins. Nevertheless, postfusion trimeric hairpin bundle, characteristic of class I and III fusogens, or 
internal fusion loops, typical of class II and III, are absent from the gH–gL structure.263 
HSV gH/gL induces virus-neutralizing antibodies and its functional regions (FR) were defined by 
epitope mapping of neutralizing MAbs94. MAb LP11 and 52S to gH/gL are two potent neutralizing 
antibodies that identify FR1 and FR2 (H2-H3), respectively.192,264,265 . Other neutralizing antibodies 
which block cell-cell fusion and spreading are MAb CHL17 and CHL32 that identified FR3.236,266 
FR3 is situated in gH N-terminus at H1 domain, in position 19-38, and it also includes gL C-terminal 
residue as identified by MAb CHL18 and CHL39.236 Ablation of N-terminal region (FR3) of gH HSV-
2 at residues 19–47 or 19–28 induced a constitutive low level of cell-cell fusion by gB even when gD 
was absent.267 This was speculated to be due to the resemblance of an N-terminal truncated gH to an 
activated conformation assumed by gH/gL to trigger fusion by gB.267 
FR1 is identified by MAb LP11, a neutralizing MAb against gH which hampers cell-cell fusion and 
binds to the N-terminal half of gH; its epitope encompasses residues 86, 168, 300, 315-317, 
325.188,192,239 MAb LP11 recognizes a conformational epitope, which is present only in correctly folded 
gH/gL. Mutant HSV-1 with monoclonal antibody resistance (MAR) overwhelmed LP11 neutralization. 
Sequencing of gH from MAR HSV-1 mutants shows the following mutations: E86K, D168G, D168N, 
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R329W or R329Q192 The mutations provided surface charge exchange and impeded LP11 binding to 
gH/gL, while wild-type HSV-2 gH already has residue substitutions E86A and R329P. In HSV-2 
gH/gL structure, Asp168 is close to Pro329, but Ala86 is exposed on the opposite surface of gH. The 
insertion mutations hampering LP11 binding, partly map on the surface identified by residues Asp168 
and Pro329.239 Most probable positions eligible for LP11 binding are thus gH residues 168 and 329 
while position 86 must imply a long-range steric hindrance exerted by LP11.188 
MAb 52S, which identifies FR2, inhibits cell-cell fusion and neutralizes infection.188,192 MAR mutant 
HSV-1 S536L and A537V escape MAb 52S binding to gH/gL and consequent neutralization.192 On 
HSV-2 gH/gL, these residues are located on the opposite surface in respect to LP11 MAR residues, in 
agreement with data suggesting that epitopes for LP11 and 52S do not overlap.192 
In Bi-Molecular Complementation (BiMC) technique, a fluorescent reporter is splitted in two halves 
and cloned connected to cytoplasmic tails of investigated membrane interactors.186 Upon ectodomains 
binding between the investigated membrane proteins, the fluorescent reporter is reconstituted in a non-
reversible, manner testifying that a molecular interaction had happened. In particular, to reveal 
interactions among these tagged glycoproteins, combinations thereof are expressed on cell surface and 
challenged with soluble proteins or even antibodies. Modifying these parameters allows to display 
specific time-course of interactions besides highlighting the interactors themselves. 
gH/gL and gB were separately tagged with split halves of EYFP, if gD was omitted only background 
fluorescence was revealed and no syncytia formation (resulted from HSV fusion) was reported. When 
gD was expressed, EYFP was reconstituted and emitted fluorescence as gB and gH/gL had 
interacted.186,189 Neither the non-neutralizing antibody 53S to gH/gL, nor neutralizing antibody 52S 
hampered EYFP reconstitution, while neutralizing antibody LP11 did.188 As expected, only 
neutralizing LP11 and 52S MAb inhibited cell fusion, decreasing the amount of induced syncytia, 
while MAb 53S did not.188 
These observations suggest that neutralizing MAb LP11 blocks gB interaction with gH/gL and cell-cell 
fusion, while 52S only inhibits fusion. Thus, events in FR1 that lead to gH activation and gB 
interaction must take place before the ones involving FR2 that promote cell-cell fusion in the HSV 
glycoprotein's interaction cascade.189 Since mutants in gB fusion loops hampered both interaction with 
gH/gL and fusion, it was speculated that gB should insert its fusion loops before interacting with 
gH/gL.180,189 Bimolecular complementation showed also association between gD and gH/gL.186,187 It 
was speculated that gH/gL serves as a positive regulator for gB to exert fusion, as gH/gL is subjected to 
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co-activation by a receptor-bound gD.180 gB–gH/gL complex formation should happen before cell-cell 
fusion.188 
The surface eligible for gB binding contains a large groove, which is highly conserved in HSV-1 and 
HSV-2 gH/gL.188 As both HSV-1 and HSV-2 gB were shown to be interchangeable in fusion assays, 
the gB binding site on gH/gL might be conserved in other herpesviruses.177,248 Mutations engineered in 
VZV gH/gL to destabilize interactions among helices were proven to hamper cell-cell fusion.129 Fusion 
inhibition exerted by MAb 52S could be explained if upon gB binding to gH/gL, gB displaces a series 
of aligned α-helices in gH domains H2A-H2B changing configuration of the gH α-helix carrying 52S 
epitope.177 Structural flexibility typical of gH/gL might provide response to gB interaction with another 
similar conformational change in gH/gL that could consequently activate gB for fusion. After gB 
interaction with gH/gL, neutralizing MAb 52S may act on gH/gL preventing the delivering of a 
response signal to gB, i.e. a conformational modification in gH/gL. These speculated molecular 
mechanisms imply strong structural flexibility inside gH/gL. Internal mobility of gH/gL structural 
elements is in accordance with viable mutants accommodating insertion in buried regions of H2A and 
H2B domains.239 
It was recently demonstrated by sequentially exchanging HSV glycoproteins serotype that HSV gH/gL 
defines fusion kinetics. Taking advantage of an improved cell-cell fusion assay, it was shown that gH 
of HSV-2 (gH2) leads to an increased level of fusion than gH of HSV-1(gH1).
180 This was not due to a 
different expression of gH glycoproteins on cell surface, but was an intrinsic HSV-2 gH property.180 
gH/gL from HSV-2 could have a higher affinity for gB than gH/gL from HSV-1; hence gH/gL from 
HSV-2 might activate a greater number of gB trimers, thereby enhancing the fusion levels. In fact, 
mutant gB that could interact with gH/gL, induced enhanced fusion by gH2/gL2 as compared to 
gH1/gL1, regardless of the phenotype imposed by the gB mutation.
180 The maximum fusion activities of 
all the mutant forms of gB tested were dictated only by changes in its structure, while the fusogenic 
capacity of any gB molecule was finally regulated by gH/gL. 
Other portions of gH/gL which are essential to perform standard fusion, are located both in the 
cytoplasmic tail and between the non-solved membrane proximal domain and the TMR of the protein. 
Insertions in position 791-799 impair gH/gL function, while fusion is performed at low efficiency with 
a truncated gH mutant.239,268,269 
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1.5.5 HSV gB  
 
 
Figure G. Protein structure of HSV gB. Post-Fusion gB (POgB) trimer is depicted in rainbow colors, the 
crown (lighter blue) forms membrane distal domain. Crystal structure is from PDB (2GUM). 
 
gB of HSV is a trimer, and belongs to class III fusion protein, together with VSV G and baculovirus 
gp64, as it accounts for more than class I and class II features.175 In particular HSV gB has three long 
central α-helices, typical of class I fusion protein, and bears a bipartite fusion peptide per protomer, 
typical of class II fusion protein.175,263  
N-terminal residues 30 – 773 of a gB protomer represent the gB ectodomain, while TMR encompasses 
residues 774 – 794; a soluble form of gB, gB730t, was used for crystalization (figure G). The 
cytoplasmic tail spans residues 795 – 903 and contains Golgi targeting sequence at 848 – 851 and an 
internalization motif at 888 – 891. gB has 6 N-glycosilation sites and its structure shows 5 disulfide 
bonds. gB membrane trafficking is dependent on its cytoplasmic domain, gB reaches host membrane 
surface where it is subsequently internalized in the Golgi apparatus for envelopment of HSV virions.175 
Electron density for Pre-fusion form of HSV gB (referred as PRgB) and crystal structure for stable 
Post-fusion form of HSV gB (referred as POgB) are available.175,270 
POgB trimer forms rod-like structures perpendicular to the membrane of 8 nm radius and 16nm 
height.175,270,271 The crystal structure shows that the POgB homotrimer is the HSV fusion glycoprotein; 
syncytial mutations causing hyperfusogenic phenotype are found in gB.175,272 Nonetheless, gB executes 
fusion only if the gH/gL heterodimer is present, a feature typical of all herpesviruses.188 
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gB protomer structure consists of five domains, differently distributed between PRgB and POgB. 
POgB residues 730-773 constitute the essential, but not yet resolved, hydrophobic membrane proximal 
region.175 
HSV gB domain I corresponds to the fusion domain, it contains fusion loops characterized by 
lipophilic residue near charged hydrophilic ones.175 Mutations in gB domain I cause altered virus entry, 
in addition to hampered cell-cell fusion.190 Domain I would be found juxtaposed or inserted into the 
membrane in POgB structure, while in full-length PRgB electron density map (EM) it stands apart, 
pointing away from the membrane (figure H).270 Conformation of PRgB, with domain I in the most 
distal part, could aid interaction via fusion loops with a target membrane. This is in accordance with the 
mapping of gH/gL binding site on gB, that identifies domain I or domain II as likely interacting sites.189 
 
Figure H. Cartoon of metastable conformation transition in HSV gB trimer. From left to right: in Pre-
Fusion gB (PRgB) trimer, the crown (orange) stands delocalized at the equator of the trimer while the Fusion 
Loops (blue) occupy membrane distal domain; in Post-Fusion gB (POgB) trimer, the crown (orange) forms 
membrane distal domain and fusion loops are located at membrane proximal domain. Pictures adapted from ref. 
270. 
 
Four different FRs were identified in gB by function blocking analysis with MAbs. FR1 is targeted by 
MAbs SS55/SS106/SS144 and correspond to gB fusion domain I containing the bipartite fusion loop. 
In POgB, the fusion domain is located at the bottom of ectodomain, proximal to the membrane.190,194 
FR2 was defined by C226/H1838/H1781 MAbs and it is the interaction domain with gH/gL. Adaptors 
involved in protein-lipid interactions, Pleckstrin-homology domains (PH), were identified in both FR1 
and FR2. FR3 carries epitopes for MAbs SS10/SS67-69 and was mapped on the distal part of POgB, 
the "crown".175 A linear epitope in FR4 is recognized by MAb H1817 and resides in the not resolved 
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flexible N-terminus. FR4 binds heparan sulfate moieties and other surface molecules, identified as gB 
receptors, as paired immunoglobulin-like type 2 receptor-α (PILR-α) (figure I).273,274 
 
 
Figure I. Protein structure of Paired immunoglobulin-like type 2 receptor-α (PILR-α). PILR-α is depicted 
in in full color. Crystal structure is from PDB (4NFB). 
 
PILR-α modulate host immune system and is recruited by gB to perform fusion together with gH/gL 
and gD, at least in several cell lines, i.e. human retinal pigment epithelial cells.273,274 PILR-α promotes 
HSV infection in Chinese Hamster Ovary (CHO) cells which bear no gD receptor. PILR-α behaves 
also as a routing factor, in that it promotes HSV entry at the plasma membrane in CHO, while HVEM 
or nectin1 expressed in CHO lead to an entry pathway which is dependent on acidic endosomes. In 
addition to providing initial binding to heparan sulphate together with gC, gB also interacts with 
CD209, a molecular marker typical of the dendritic cell surface, promoting tethering and 
infection.164,275 Myosin 9 or non-muscle myosin heavy chain IIA (NMMHCIIA) is another cellular 
receptor which seems to interact directly with gB to drive HSV fusion.164 The role of these receptors in 
HSV entry remains elusive. 
Wild-type HSV gB has an innate fusogenic capacity that can be influenced by structural restrictions 
imposed by various mutations; specific mutations in the fusion loops of gB which prevented the 
interaction between gB and gH/gL, were not enhanced by gH/gL serotype swapping, which was shown 
to improve cell-cell fusion in an HSV-1 glycoprotein context. This indicates that these single-amino-
acid changes truly destroyed the ability of gB to function in cell-cell fusion.180 
Mutations in gB FR3, the crown of gB or domain 4, (F641Y, Y649A, and Q584A) are functional but 
exhibit slow initiation time and diminished overall extent of fusion.180 Conversely another mutation in 
the crown (H657R) lead to an hyperfusogenic gB phenotype (gB fast mutant). Non related mutation in 
cytoplasmic tail dileucine loop (LL871AA) which enhances gB membrane retention, showed the 
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highest levels of fusion.180 gB fast mutants were postulated to represent unlocked forms of gB (further 
along in the transition path from pre to post fusion conformation) that were inherently in a higher 
energy state than wild-type (wt) gB.180 
To provide data on pre-fusion states, full-length gB was expressed to gain proper membrane anchoring 
and native topology. gB trimer was then analyzed on extracellular cell-derived vesicles, by electron 
cryotomography (cryoET).276 Membrane inserted gB trimer conformation was inferred by fitting with 
restraints POgB domains inside the PRgB volume identified by EM. This approach leads investigators 
to capture a transitional/metastable state of gB, conformationally foregoing to POgB (figure J).175,263 
Expressing soluble herpesvirus gB ectodomain lets gB to stabilize in its postfusion conformation 
(POgB).175,277-280 A gB pre-fusion conformation exists as gB is synthetized with an intrinsic instability 
and the tendency, if triggered, to adopt a more stable configuration while merging membranes. In 
particular, PRgB releases its own structural energy upon conformation modifications to allow the 
energetically unfavorable  process of fusing lipid bilayers.  
3D reconstruction of gB showed two kinds of spikes with threefold symmetry, whose axis was 
perpendicular to the membrane.270 Spikes of 16 nm height, corresponding to POgB, were found only on 
small vesicles, since POgB prefers high membrane curvature.281 Roughly globular spikes with a height 
of 10 nm and 8 nm in width were also found and represented PRgB, which was thus two-thirds of 
POgB in height, a condition that might aid in interfacing with the other fusion glycoproteins. 
 
 
Figure J. Cryo Electron Microscopy (Cryo EM) volume of HSV gB trimer. Left, Pre-Fusion gB (PRgB): the 
crown domain (orange) stands delocalized at the equator of the trimer while the fusion loop domain (blue) 
occupies membrane distal domain; Right, Post-Fusion gB (POgB): POgB trimer is depicted in rainbow colors 
encased in its Cryo EM Volume, the crown (orange) forms membrane distal domain and fusion loops are located 
at membran proximal domain. Pictures adapted from ref. 270. 
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Remarkable structural rearrangements were expected for PRgB, as in POgB structure TMR would be 
next to the fusion domain in the protomers, with a “hairpin” conformation.282 PRgB expands on its 
equator at 4 nm height from membrane surface, allowing neighboring gB trimers to form a net or 
contact interactors, via glycosylation site N398. In respect to POgB, PRgB shows a central cavity 
circumscribed by globular domain IV (the crown of POgB) and domain II; these domains are in part 
delocalized at the equator together with the flexible domain III. Contrariwise, POgB domain III 
structures the core of the gB trimer, forming the trimeric coiled coil; in POgB domain V, stalks run 
conversely and adherent to domain III until reaching the membrane proximal region.270,282 
PRgB trimer is membrane-anchored by a tripod made by protomer domain V C-terminal arms, the 
highly hydrophobic membrane proximal region and TMRs. TMRs stand 6 nm apart from each other 
and converge on the opposite side of the membrane (the cytoplasmic face), forming a central density of 
1,5 nm x 3 nm. Fusion loops in the PRgB trimer are 5 nm apart among protomers and different surfaces 
of domains I and II are exposed in respect to POgB (figure K) .270 
  
Figure K. HSV Pre-Fusion gB (PRgB) structure. PRgB trimer is depicted in rainbow colors, in native and 
membrane anchored conformation (full length gB). PRgB crown (orange) stands at the equator of the trimer 
while the Fusion Loops (blue) occupy membrane distal domain. Structure is from PDB (5FZ2). 
 
It was speculated that upon triggering, the rotation of domain I brings the fusion loops of the three 
protomers together, causing formation of a "hydrophobic fusion patch". Subsequent coiled coil 
formation let the "hydrophobic fusion patch" to puncture the facing membrane, which is being 
juxtaposed by other glycoproteins tethering to their receptors. Target and virion membrane are then 
crushed along gB axis when gB opposed ends are joined by an intrinsic energy release, with domains of 
gB acting like a spring. The result is the rearrangement of gB domains with the formation of the crown 
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(domain IV) and the localization of gB fusion loops (domain I) next to TMRs, meaning inside the 
membrane.175,270 
Neutralizing MAbs, random linker-insertion mutagenesis and fluorescence protein insertion 
mutagenesis revealed unexpected exposure of some buried surface in POgB structure.194,283-285 For 
example, both MAb H1781 (residues 454–473) and H1838 (residues 390–410), are neutralizing 
antibodies, but their epitopes could not be fitted on POgB surface. Conversely, MAb H1781 and H1838 
epitopes are exposed on the surface of PRgB domain II. 
 
1.6.1 VZV fusion/entry 
 
The highly cell-associated nature of Varicella Zoster Virus (VZV) and its human-restricted tropism 
delayed research on its entry mechanism as compared to other herpesviruses, for which a cell-free high-
titer virion could be harvested in culture.126,286,287 VZV fusion, with a peculiar syncytia formation, is 
presumed to be different from that of other α-herpesviruses because of the absence of established 
tropism factors, as i.e. HSV gD.288 Deeply investigated examples of cellular receptors could be found, 
both for VZV gB or gE.289 Recently, integrin implication in VZV entry and cell-cell fusion was proven 
without discerning a glycoprotein candidate between gB and gH/gL.290 As already seen for other 
herpesviruses, thanks to its evolutive plasticity and multifunctionality, gH/gL might encase also the 
elusive tropism factor function needed for VZV cell entry. MAb 206 to VZV gH/gL hampers in vitro 
virion entry, while it inhibits virion egress or syncytia formation when it is internalized by infected 
cells. gH N-terminus is also involved in VZV in vivo replication and might be involved in receptor 
recognition. Further investigation in this direction might fill the gap among VZV and other 
herpesviruses in cell-entry knowledge. 
It was earlier proposed that cation-independent mannose 6-phosphate (M6P) receptor [MPRci] was 
involved in cell-free VZV infection.291-293 This was supported by finding that M6P inhibits VZV 
infection and that VZV glycoproteins contain M6P groups in phosphorylated N-linked complex 
oligosaccharides. MPRci is a membrane protein that functions as a molecular chaperone and is 
expressed ubiquitously.  MPRci transports modified proteins with N-linked oligosaccharides from the 
trans-Golgi network (TGN) to the early endosomes.294 The MPRci model for VZV entry should have 
explained the high VZV virion-cell-association as follows: in culture, as well as in vivo, newly 
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produced VZV virions emerging from the TGN remain linked through the M6P on their glycoproteins 
to the membrane MPRci, whose recycling is continuative in the cell.291 Moreover, as also lysosomal 
enzymes are equipped with M6P, both VZV virion tethered with its glycoproteins and lysosomal 
enzymes eventually shared the same pathway ending, with constitutive negative outcomes for VZV 
progeny.295 
This mechanism apparently self-limited VZV virulence; but the purpose of VZV should be that of 
conquering and not killing an individual, leaving the possibility for subsequent spreading in the 
population over many years. Similar mechanisms might be exploited by herpesviruses in general, 
whose establishment of a life-long latency is due to an extremely fine control of their own virulence.296  
Access to population ought to be granted to VZV only at skin level, where suprabasal epidermis cells 
downmodulate MPRci throughout their maturation, allowing dispersion of virions via desquamation 
even in the air.293 Nevertheless, as association with MPRci on cell surface is already described for other 
proteins, it is also possible that the role of MPRci is only that of enhancing adsorption of VZV virion to 
the membrane.294 In fact, though MPRci is required for cell-free VZV infection of MeWo cells, cells 
knockdown for MPRci are susceptible to cell-associated VZV infection, with syncytia formation.293 
Furthermore, cell surface expression of MPRci does not induce cell-cell fusion by VZV glycoproteins, 
whose physical interaction with MPRci was never demonstrated.291 It was thus suggested that MPRci 
and heparin compete in cell-free VZV infection, whereas the insulin-degrading enzyme (IDE) is 
exploited by VZV gE to spread among cells while mantaining its cell-associated status.297-300 
 
gE/gI 
 
VZV gE is the most represented VZV glycoprotein and it was thought to replace HSV-gD function in 
VZV cell-entry, since gE is essential for VZV infection and in vivo replication, as demonstrated by 
using gE mutant viruses.301 VZV gE ectodomain mutation D150N, retrievable in the VZV-MSP natural 
variant, leads to an increase in cell-cell in vivo and in vitro spread, while S31A substitution leads to 
decreased in vivo infection. gE residues 51–187 constitute an ectodomain region which is not 
conserved but essential for both skin and T cell in vivo tropism. gE is required to form the gE/gI 
heterodimer which is needed for viral replication and VZV virion maturation through TGN in 
vitro.127,302-304. gE should participate in fusion and was shown to drive cell-cell fusion if paired with gB, 
as reported for VZV-gH alone.127,302-304 However, these latter results were affected by the use of a 
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recombinant vaccinia virus system to express VZV glycoproteins leading to expression of also 
interfering vaccinia membrane proteins.289 
In cells infected with VZV, gE was also proven to interact with Insulin Degrading Enzyme (IDE).299,300 
IDE is ubiquitously expressed and IDE-expressing non-human cells became susceptible to an increased 
VZV infection, which is instead down modulated by IDE inhibition.299 Nonetheless, IDE seemed to 
bind to an immature form of gE in the cytosol and it was also reported that gE was not required for 
VZV membrane fusion.127,305 In fact, preventing IDE binding by ablating gE from VZV virion led to 
infection both in melanoma cells or fibroblasts in vitro.128 Furthermore, when the same mutant was 
used in vivo, it infected both neuronal cells and T cells, even if these latter are cell-cell fusion 
recalcitrant and do not form syncytia.306 Flow cytofluorimetry revealed that a gE-Ig fusion protein do 
not bind to cells expressing a surface form of IDE, and these latter cells are neither infected by VZV. 
Nevertheless, as cell-cell fusion had slightly increased in presence of IDE, its role in VZV fusion 
remained elusive.289 
VZV gE was also shown to bind myelin-associated glycoprotein (MAG) expressed on cell surfaces by 
flow cytometry and immunoprecipitation.289,307 MAG expression is restricted to the neuronal tissue and 
probably represents a VZV receptor only during the neurotropic pathway.290,308 VZV gE interaction 
with MAG did not result in membrane fusion and the efficiency of cell-cell fusion driven by MAG and 
VZV glycoproteins was even enhanced in the absence of VZV-gE. These results were not due to an 
interference by gE on surface expression of the other VZV glycoprotein, and cell-cell fusion was not 
induced by a combination of gE, gH, and gL or gE and gB.289 Moreover, cell-cell fusion efficiency is 
not altered by the formation of the heterodimer gE/gI.303 However, VZV gE and gI carry at least one 
Lys-Gly-Asp (KGD) integrin binding domain, while MAG has an Arg-Gly-Asp (RGD) integrin 
binding domain.309-311 Their role in VZV fusion need to be further addressed. 
 
VZV gB 
 
VZV gB is 931 amino acids in lenght and it is the only -herpesvirus gB cleaved by host furins, it is 
essential for VZV infection and shares 48% sequence homology with its HSV-1 homolog.312 Furin are 
protein convertases that recognize and cleave the motif [R]-X-[KR]-R-"CLEAVAGE"-X, which is 
conserved in the gB of all herpesviruses, except for HSV-1. The ablation of this motif leads to an 
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aberrant in vitro phenotype in PrV, while in VZV, the deletion or substitution of gB 491RSRR494 to 
491GSGG494 leads to the same gB distribution in transfected melanoma cells, as documented by 
conformation-dependent anti-gB MAb SG2.312 Disruption of the furin motif leads to decreased VZV in 
vivo infectivity in skin xenographts. VZV gB cytoplasmic tail carries an immunoreceptor tyrosine-
based inhibition motif (ITIM), whose tyrosine 881 phosphorylation was demonstrated to limit VZV 
fusion and syncytia formation.313 When Y881 phosphorylation is prevented, the consequent 
hyperfusogenic phenotype leads to a limited VZV virion production in vivo and in vitro. It was 
demonstrated that HSV-1 gB interacts with paired inhibitory and activating receptor-α (PILR-α), 
enhancing HSV-1 entry into promyelocytes and monocytes even if the interaction alone is not 
sufficient to mediate membrane fusion.273 As PILR family of receptors modulate host-pathogen 
interaction, PILR-α might also interact with VZV gB.314 PILR-α -Ig fusion protein did not bind cell 
surfaces expressing VZV glycoproteins. Inside the Sialic-acid-binding Ig-like lectin (Siglec) family of 
receptors, PILR- showed a 5 to 12% homology to Siglec-1, 4, 5.315 In particular cells expressing 
Siglec-4, termed also Myelin Associated Glycoprotein (MAG), were stained by VZV-gB-Ig on their 
surfaces, and their association was documented also by immunoprecipitation of lysates of VZV 
infected cells by means of a MAG-Ig.289 
MAG is expressed exclusively on the surface of myelin sheath of neural tissues, in particular it is 
retrievable on glial cells as oligodendrocytes or Schwann cells in vivo.307 MAG is involved in neural 
development and exerts regulation of axonal growth interacting with factors as Nogo-66 receptor or 
paired Ig-like receptor B.308,316-318 It mediates sialic-acid dependent cell-cell interactions to favor 
myelinating process on neuron cells, but MAG expression in glial primary culture cells was not 
detectable.289 No human cell line expresses endogenous MAG in vitro and this might account for in 
vitro restriction of infection by cell-free VZV, as in vivo both VZV and HSV-1 infect glial cells during 
the acute phase of infection.40,319,320 
MAG was showed to drive fusion in 293T cells with formation of polykaryons when two populations 
were mixed: one carried VZV-gB, gE, gH, gL and the other MAG on their membrane. This result was 
replicated with a quantitative luciferase reporter system, showing that VZV gB and gH/gL expression 
represents the minimal requirement for fusion mediated by VZV glycoproteins of MAG expressing 
cells.289 In human oligodendroglial (OL) cells, only the stable expression of MAG allows VZV 
infection, which was prevented by anti-MAG MAb administration.  
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1.6.1 VZV gH/gL 
 
Further investigations revealed syncytia formation even in absence of MAG, when effector cells 
bearing VZV gB and gH/gL were co-cultured with melanoma target cells.288,290 In susceptible cells, 
VZV gB and gH/gL trio expression is sufficient to induce cell-cell fusion, which should represent the 
essential fusion machinery mediating VZV entry.129,289,321 In fact, mutant VZV virion bearing 
recombinant gH/gL or gB were showed to have impairments in viral replication and cell-cell fusion in 
vitro and in an in vivo models.129,288,313 
It was demonstrated that administering high-titer of Ig directed to VZV envelope glycoproteins in 
human subjects just exposed to VZV decreases the incidence of varicella, preventing cell-to-cell spread 
and even the infection from starting.322 MAb206 directed against VZV gH/gL was proven effective in 
hampering viral entry and spread in an in vitro and in an in vivo model.321,323,324 Recombinant MAb 
were obtained also from humans, in independent studies, with neutralizing activity against the whole 
gH/gL heterodimer.325,326 IgG-24 and IgG-94 derived from a library of pooled B cells coming from 
naturally immune individuals, while rec-RC IgG was isolated from plasma blasts recovered after a 
zoster vaccine immunization.327 
Fragment of antigen-binding (Fab) from these MAbs were used in structural studies to restrict gH/gL 
conformational flexibility as to gain diffraction quality crystals. Nevertheless, either VZV gH/gL/Fab-
RC or gH/gL/Fab-94 complexes display flexible N-terminal residues, thus modeled structures started 
from amino acid A36 (figure L).327 
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Figure L. Protein Sturucture of VZV gH/gL, in complex with Fab-RC.  VZV gH (red) complexed with gL 
(yellow) was co-crystallized with Fab-RC heavy and light chains (blue and light blue). Crystal structure is from 
PDB (4XHJ). Schematics provide an overview of ectopic domain arrangements. 
 
VZV gH/gL is boot shaped and closely resembles the structure of HSV-2 gH/gL, also in that gH and 
gL are clearly dependent on each other to fold.178,188,241,327 VZV gL contains a chemokine fold, which is 
composed of two α-helices (α2-α3) and a three-stranded β-sheet (β4-β5-β6).328 Chemokine fold is 
structured by the conserved disulfide bond between Cys49 and Cys80.328 
VZV gH/gL domains are divided as in HSV gH/gL; the gH H1 domain is the most divergent domain. 
In particular, H1A domain in VZV gH/gL has more β-strands than that of  HSV; an eight-stranded 
antiparallel β-sheet is formed by an equal strand contribution by VZV gL and gH. In contrast to HSV 
gH, whose N-terminus is coiled, in VZV gH the N-terminal strands β1 (aa 36–45) and β2 contributed to 
the mixed antiparallel β-sheet.327 
In contrast to HSV gH/gL, the crystal structure of VZV gH/gL shows extended interactions between α-
helices Lα2/Lα3 of gL and multiple loops, that belong the gH H1 domain. In details, loop A (with the 
structural resemblance of a "thumb") of gH H1B domain (aa 285–298) is located on the surface created 
by gL α-helices Lα2/Lα3. Among gH loops positioned beneath, there is loop B (aa 154–161) which 
was designated as "the palm", because it gives structural support to the ensemble, including gH loop A 
and gL Lα2/Lα3 helices.327 
The first four α-helices of H2 domain contribute to the formation of the syntaxin-like helical bundle 
(SLB); these helices display extensive interactions with the eight stranded β-sheet in H1B 
domain.178,241,327 As expected, gH domains H2 and H3 are conserved in structure in α-herpesviruses, 
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thus these domains are supposed to perform conserved functions.327 In VZV gH, the α-helix at position 
aa 600–609 replaces a disordered loop present in gH homologs.  
The location of IG-RC and IG-94 epitope seems to represent a critical target for MAbs in general, since 
it overlaps with that of LP11, as shown by comparing VZV and HSV-2 structures.188,192,239,327 The 
LP11 epitope on HSV-2 gH/gL spans an area that in VZV gH/gL matches loop A and loop B regions 
that clamp VZV gL α2-α3 helices. By homology, it was suggested that the gB activating site on VZV 
gH probably resides near IG-RC and IG-94 epitopes.327 
Fab-24, Fab-94 and Fab-RC interfere by 50–75% with cell-cell fusion; this result highlights the 
contributions of different gH subdomains to fusion blockade (exerted by different Fabs). An increased 
fusion inhibition, driven by IgG instead of corresponding Fab-94 and Fab-RC, might be explained by 
cross-linking gH to gL. Surface plasmon resonance (SPR) evidenced that Fab-RC and Fab-94 
competed with each other for gH/gL binding, with IgG-RC having the highest affinity. VZV gH/gL 
structure shows that Fab-RC and Fab-94 bind a common epitope on VZV gH/gL, with different 
orientations, and Fab-RC covers a larger surface in respect to Fab-94 (1036 Å2 and 822 Å2, 
respectively).327 
Both Fab-RC and Fab-94 interact with a surface groove delimited by loop A 294LNPP297 and loop B 
156PLVW159. Fab-94 contacts E114 in a loop between gL Lα2-Lα3 helices and R121 at the end of 
Lα3 helix of gL. Fab-RC interacts with D122 and D126 of gL Lα3 helix. VZV gH mutated in loop A 
behaves in fusion assay as the wild-type, arguing that residues side chains interactions are not 
determinant.327 Loop A residues mutations 288DTTWFQL294 to 288AGGAAQD294 hampered both 
Fab-RC and Fab-94 binding of gH, while in the same condition gH retained its ability to 
heterodimerize with gL and to interact with Fab-24. Indeed, Fab-24 binds both gH domains H1 and H2; 
Fab-24 epitope seems to exert long range interactions with loop A and loop B.327 
VZV and PrV share a conserved Protein Disulfide Isomerase (PDI) domain (CXXC) in their gH, 
whereas this domain is not conserved in HSV-2 gH/gL.178 CXXC PDI domain in gH might contribute 
to proper gH folding in the endoplasmic reticulum.129 However, provided that the CXXC PDI domain 
is not at the core of gH but near the "flap" conserved structure, it was speculated that the PDI domain 
would contribute to fusion.178  In particular, an exchange in disulfide bridge asset, insisting on the flap 
C-terminal end, might unveil the underlying hydrophobic surface and stimulate fusion.178 
Residues 18–45 in VZV gH are targeted by the murine neutralizing MAb 206; mutation of 38LREY41 
to 38GRGG41 reduced the affinity of MAb 206 for VZV gH . Indeed, a recombinant VZV carrying 
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38GRGG41 mutation was not neutralized by MAb 206; the same mutant displayed weakened 
replication in human skin.129 Mutation in the sequence 38LREY41 in gH may destabilize the first two 
β-strands of gH (in the mixed antiparallel β-sheet) with a straight impact on overall stability of 
gH/gL.327 These data support a role for these species-specific gH β-sheet in receptor binding and skin 
tropism.129 The structure of HSV-2 gH/gL was stabilized to gain diffraction quality crystal exactly 
ablating residues 19–38.188 This way, HSV-2 gH/gL might have suffered of an irreversible 
conformational change, such that the HSV-2 gH/gL structure displayed one of gH/gL metastable states 
instead of the native gH/gL conformation.  
 
1.7.1 Integrins and Human α-Herpes Viruses 
 
Integrins serve as adhesion molecules and are heterodimeric membrane integral proteins.329 Integrin 
heterodimers are formed by the combination of 18 α-subunits and 8 β-subunits, specifically found in 
different anatomic districts.330 Integrins connect the cytoskeleton to the extracellular matrix and are 
capable of both inside-out and outside-in signal transmission.331 Integrins are ubiquitous surface 
molecules, that activate various cellular functions.332-335 Different viruses evolved entry strategies 
taking advantage of integrin widespread distribution.336 Examples include DNA viruses as 
Adenoviruses (which are not enveloped viruses) or Herpesviruses. Integrin β3 is found on various types 
of tumors and endothelial tissues, while β6 is typical of proliferating epithelia and melanoma. Integrin 
β8 is retrievable in fibroblasts, keratinocytes and neural tissues. αVβ3, αVβ6 and αVβ8 integrins are 
present in epithelial and endotelial tissues and all have similar cellular and tissue distribution due to 
their shared α-subunit (figures M and N).329-331,334 
Herpesviruses might take advantage of integrin signaling in order to deliver their capsid to the nucleus, 
through modification of cytoskeleton or actin filaments. Activated αVβ3 integrin might induce Ca2+ 
release from intracellular stores and activate focal adhesion kinase (FAK). The silencing of αV or β3 
integrin subunits or the adsorption of an HSV-2 gH-/- HSV prevented FAK activation or Ca2+ release.337 
Downstream events triggered by FAK activation are also hampered by β3 integrin silencing, i.e., 
phosphorylation of c-Src and Akt kinases (also involved in cytoskeleton modification).338 Integrin-
dependent rearrangements of actin filaments are mediated also by Rho GTPases as Cdc42, Rac1, and 
RhoA. These small GTPases alter stress fibers, lamellipodia and filopodia formation. These GTPases 
could contribute to HSV entry by loosening actin physical barrier to virion endocytosis, disassembling 
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cortical actin.339,340 HSV drives another mechanism, termed surfing, that facilitates its own entry, 
namely it induces filopodia formation on cell surface by enhancing Cdc42 activation; dominant 
negative forms of Cdc42 and Rac1 block virus entry.341 
 
 
Figure M. Protein structure of αV(red) and β3 (blue) integrin. Integrin αV back folds towards membrane. 
Integrin modular Ig folding is noticeable. Crystal structure is from PDB (4G1M). 
 
Integrins are capable of activating various host signaling pathways, that could be activated also in 
association with other receptors as epidermal growth factor receptor (EGFR) and Toll-like receptors 
(TLRs). In particular, integrin αVβ3 is implicated in innate immunity response, as it may trigger 
nuclear factor κB (NF-κB) pathway, while αvβ6 and αvβ8 integrins do not participate.342,343 αVβ3 
integrin, in association with TLR2 receptor, contributes to sensing pathogen by binding to HSV gH/gL 
or bacterial lipopolysaccharide (LPS).338,344 In different cell types, integrin and TLR interaction elicits 
an innate response via NF-κB activation, inducing inflammatory cytokines including IL-2 and IL-10 or 
interferon (IFN) induction.342,345,346 Nevertheless, HSV has evolved molecular strategies to evade the 
innate response triggered by αVβ3. HSV exploits its immediate early proteins ICP0 and ICP27 to 
counteract NF-κB response or virion host shutoff RNAse (VHS) that degrades host mRNAs in the 
cytoplasm.347-350 In particular, ICP0 protein readily promotes degradation of the myeloid differentiation 
factor 88 (MYD88) in the cytosol and interferes with the activity of IFN regulatory factor 3 (IRF3) and 
IRF7.338,342,351 It is reported that vβ3 integrin cooperates with TLR2 pathway: the silencing of β3 
integrin blocks recruitment of MYD 88 to TLR2. HSV ICP0-/- mutant, whose entry is hampered at low 
multiplicity of infection (MOI), behaves as the wild type virion in cells deprived of αvβ3 integrin and 
TLR2.342 
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1.7.2 HSV and αVβ6 and αVβ8 integrins 
 
αVβ3 integrin on host membrane acts as a routing factor for HSV-1, relocating HSV receptor nectin1 
to lipid rafts and thus defining the HSV-1 pathway of entry. In particular αVβ3 enables an HSV-1 entry 
pathway which starts at lipid rafts and is dependent on acidic endosomes and dynamin2 and 
independent of caveolin1.171,352,353 αVβ3 binds to a soluble form of HSV-1 gH/gL.176,243,354 αVβ3 is not 
an entry receptor or coreceptor for HSV-1 as αVβ3 silencing does not impair HSV-1 entry but modifies 
HSV-1 entry pathway.352 Furthermore, a soluble form of gH/gL binds different types of cells in an 
αVβ3 independent manner. HSV in vitro infection was prevented by the expression of full lenght gH 
sequestering host interactors for HSV-1 glycoproteins.354 Moreover, it was shown that the soluble form 
of HSV gH/gL is capable of aggregating cells expressing various integrins, including αVβ3.243 
 
 
Figure N. Protein structure of integrin αvβ6 heterodimer ectodomain. αV(gray) β6 (blue) integrin structure 
is depicted. Crystal structure is from PDB (4UM8). 
 
HSV further exploits available host integrins to maximize its spread, using integrins as entry receptors. 
In fact, αvβ6 and αvβ8 integrins serve as receptors for HSV gH/gL, and mediate endocytosis. HSV gH 
carries a non-conserved integrin interacting motif in domain H1B, positions 176-178 RGD but 
mutation D178E does not affect entry of HSV.239,243 Hence, integrins implication in HSV entry was 
excluded239. It was afterwards demonstrated that HSV infection required gH RGD motif only when 
integrin αvβ6 was used for entry, but not αvβ8. Recently, αVβ6 and αVβ8 integrins were shown to bind 
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a soluble form of gH/gL (gHt/gL) at high affinity (10
−8 M). Conversely, αVβ5 did not bind gHt/gL.176 
Function-blocking antibodies against αVβ6 and αVβ8 heterodimers, MAb 2077 and 37E1 respectively, 
hampered HSV infection. The silencing of αVβ6 and αVβ8 integrins reduced HSV infection in either 
cases, but maximum effect occurred when both integrins were silenced. Depletion of both αVβ6 and 
αVβ8 integrins reduced HSV infection to a lower level than a single integrin heterodimer depletion did, 
thus αVβ6 and αVβ8 were interchangeable.176 
A gain-of-function experiment was performed in K562vβ6 myelocytic cell line, that expressed only 
αVβ6 integrin and a lower amount of α5β1 integrin.176 α5β1 is supposed not to interfere with αV 
integrin subunit.355 Even if K562 are recalcitrant to HSV infection, K562vβ6 showed an increase in 
HSV infection, in respect to the parental K562.356 J cells are baby hamster kidney derivatives, 
artifically deprived of HSV gD receptors, expressing low level of endogenous hamster integrins. 
Expression of high level of αVβ6 and αVβ8 human integrins together with low level of the entry 
receptor nectin1 allowed an increased HSV infection in respect to J cells expressing only nectin1 at the 
same level. However, the expression of αVβ6 or αVβ8 integrin alone does not allow HSV to infect 
cells, hence integrins do not substitute for an HSV receptor.176 It is known that mutations in RGD 
domain should prevent interactions with αV integrin. To this purpose, a gH/gL with substitution of 
RGD domain in ADA (gHADA/gL) was used in both cell-cell fusion and virus entry assays. An HSV 
gH-/- (ScgHZ) was grown in a complementing cell line, expressing gHADA/gL, and was used to infect J 
cells overexpressing human integrin αVβ6 or αVβ8.354,357  This pseudotyped HSV failed to infect J 
cells expressing αVβ6 integrin plus an entry receptor, while the RGD domain was dispensable for 
infection of J cell expressing an entry receptor and αVβ8 or no integrin. Thus, the RGD domain in HSV 
gH is exploited for interaction with αVβ6 integrin only, while αVβ8 interaction with HSV gH/gL relies 
on a different mechanism. Moreover, cell-cell fusion was inhibited by RGD to ADA substitution in gH 
only when J cells expressed αVβ6 human integrin.176 J cell expressing nectin1 and αVβ6 or αVβ8 
human integrins allowed a deep analysis of HSV infection with entry inhibitors. These cells, upon 
expression of an HSV entry receptor, enable an entry pathway independent of lipid raft and acidic 
endosomes.171  As well as for vβ3 integrin, also vβ6 and vβ8 integrins are involved in the choice of 
HSV entry pathway. αVβ6 or αVβ8 integrins allowed an entry pathway dependent on acid endosomes, 
but only entry mediated by αVβ8 depended on lipid rafts and Dynamin 2.176 These various entry 
pathways exploited by HSV allow infection to proceed through alternative routes in different cells, 
facilitating HSV infection and spread, in accordance with HSV broad tropism.164 
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1.7.3 VZV and αV integrins 
 
Human melanoma cells (Mel) are permissive to VZV infection, and actually lead to the same peculiar 
syncytia formations retrieved in infected skin.288 Mel cells are expected to express cellular components 
needed for VZV fusion via gB and gH/gL. Since almost five of the eight human herpesviruses exploit 
integrins as entry receptors or coreceptors, the role of integrins in VZV infection was recently 
investigated.176,337,290,358,359 Trascriptome analysis revealed that Mel cells potentially express twelve 
integrin combinations among the possible twentyfour found in human cell lines.  
To gain reproducibility, a new kind of cell-cell fusion assay was engineered, leading to lower 
background level and higher sensibility, in contrast with a conventional transfection approach. 
Lentiviruses were used to generate target reporter cell lines, allowing an absolute quantification of 
fusion, without the experimental variability proper of T7polimerase-T7luciferase systems, where the 
expression of the reporter gene is typically heterogeneous among target cells.289,290 In particular, 
recently described dual split proteins (DSP) were implemented in the so called stable reporter fusion 
assay (SRFA).360 SRFA system employs single lentiviral vectors to express both DSP and a shRNA to 
respectively detect the amount of fusion and to interfere with the expression of cellular proteins 
relevant for fusion of target cells. Relevant proteins were inferred by transcriptome data. Splitted GFP 
and Renilla luciferase are constitutively expressed in the cytosol of different cell populations. The 
whole reporter reconstitution, and thus signal, is immediately revealed upon a cell-cell fusion event 
involving cytoplasms of different cell populations.290 
Knocking down αV integrin, α6 integrin and β1 integrin suffice to recapitulate all the possible integrin 
combinations in Mel cells. shRNA to αV integrin reduced fusion mediated by gB and gH/gL to 60%, 
implicating integrins in VZV tropism for the first time, namely as receptors for VZV. In accordance, 
integrin αV is retrievable on surfaces of T cell membrane, epithelial cells, keratinocytes, and dermal 
fibroblasts, which all are VZV permissive cells.41, 361-366 
Knocking down exerted by other integrin shRNA instead resulted in 30% fusion increase, due to an 
enhanced expression of αV integrin, which was documented with WB and depended onto intrinsic 
balancing mechanisms proper of integrins. shRNAs against β3 integrin, β5 integrin or β8 integrin were 
tested to discriminate the paired β-subunits further involved in VZV fusion. Only cells knocked down 
for β3 integrin showed 15% reduction in gB and gH/gL mediated fusion, which, however, was not 
statistically significant.290 
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Furthermore, administering a MAb anti αV integrin to fusing cocultures of CHO cells, that express gB 
and gH/gL, and to Mel cells results in a 63% fusion inhibition. The addition of an anti-gI MAb, used as 
a negative control, did not decrease fusion while the neutralizing anti-gH MAb 206, used as a positive 
control, did.290,321,323 
Cell-associated VZV pOka was used to infect Mel cells silenced for αV integrin, β1 integrin, and β3 
integrin. VZV spread was measured by averaging respective plaque size displayed after 72 h.290 Cell-
associated infection was reduced to 60% in αV integrin  silenced cells as compared to control or other 
integrin silenced cells.290 αV Integrin shRNA even causes a statistically significant reduction of virus 
propagation between 24 h to 72 h post infection, decreasing the viral titer up to ten times in respect to 
control or other integrins shRNA.290 Integrins contribution at 96 h post infection was lower, as cell-
associated VZV pOka infection of the other integrin-silenced cells led to similar viral titers147. In 
contrast, in cell-free VZV infection, both αV integrin and β3 integrin led to a statistically significant 
reduction in the mean number of plaque at 96 h post infection, while β1 integrin or non-correlated 
control shRNAs did not.290 
Therefore, in VZV entry, all the trascriptionally represented integrin β subunits may act as 
interchangeable partners for the essential αV integrin subunit, as also occurred for other 
herpesviruses176,367 VZV might take advantage for its infection of the membrane modifications driven 
by an interaction with integrin αV, since αV integrins affect cell adhesion migration and 
proliferation.368,369 Another point is that integrins usually recognize in their ligand the RGD integrin 
interacting motif, which has already been found other herpesviruses entry glycoproteins.243,370 
However, neither RGD domains nor disintegrin-like domains (DLD) were found in VZV gB and 
gH/gL, leaving the questions open on the VZV glycoprotein involved in integrin binding, and on the 
kind of integrin interaction exploited by these VZV glycoproteins.290,370,371 It was speculated that, as for 
HSV-1 (even if VZV has no gD homolog), integrins could relocalize VZV entry receptor to lipid rafts, 
were integrin resides.353 This should facilitate VZV entry process and might account for the recovery in 
VZV titers seen at 4 days post infection.290 
Finally, while it was demonstrated that VZV gE and gI were not essential for VZV in vitro infection, 
together they carry three KGD integrin interacting motifs and may play a role in VZV-integrin 
interactions awaiting to be further investigated.289,290 
 
 
63 
 
2 PUBLICATION 
Results reported about HSV were published in:  
Gianni T, Massaro R, Campadelli-Fiume G. 2015. Dissociation 
of HSV gL from gH by αvβ6- or αvβ8-integrin promotes gH 
activation and virus entry. Proc Natl Acad Sci U S A 
112(29):E3901-10 
Results presented about VZV are unpublished and are should be 
considered as confidential communication  
 
 
 
 
 
 
 
 
 
 
64 
 
3.1 HSV RESULTS  
 
3.1.1 The extracellular domain of integrin β6 increases HSV entry 
 
J cells are baby hamster kidney (BHK) derivatives, deprived of HSV entry receptors: they allow HSV 
infection only if they express an HSV receptor.204 J cells surface has a low amount of hamster integrins, 
which might originate only low interference with human integrin overexpression.176 Earlier, this 
laboratory reported that integrin αvβ6 and αvβ8 serve as receptors for HSV, and they also allow an 
entry pathway depending on acidic endosomes.176 To discriminate which part of the integrin exerts 
integrin double role on HSV entry, the mutant integrin β6N1 chimera was engineered. β6N1 chimera 
contains the extracellular domain of β6 integrin, whereas the transmembrane and cytoplasmic tail 
belong to nectin1. The integrin β subunit was chosen as it is the signaling part of the integrin 
heterodimer and nectin1 is a non-signaling receptor. Expression of β6N1 chimera in J cells, together 
with v integrin subunit and nectin1, allowed an increased entry upon HSV infection, similar to the 
one seen with wild type β6 integrin (figure 1).176 The increase in HSV infection upon αvβ6 or αvβ6N1 
integrin expression implies a specific molecular interaction at high affinity among αvβ6 ectodomains 
and HSV gH/gL.176 This interaction enhances the tethering between HSV and the target cell surface via 
gH/gL, interacting with integrin heterodimers, increasing HSV infection.176 
 
 
Figure 1. The graphic shows a similar increase in HSV infection due to overexpression of integrin αvβ6 or 
αvβ6N1 chimera in J cells already expressing nectin1. The extracellular domain of β6 integrin determinates HSV 
increase in infection upon encounter of both αvβ6 and nectin1.176 
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These results indicate that integrins are critical for HSV infection. 
 
3.1.2 Integrin αvβ6 cytoplasmic tail determinates the HSV entry pathway 
 
The HSV virion endocytosis in acid endosomes driven by integrins does not seem to be essential as it 
was also documented HSV entry at neutral endosome compartment or at cell surface.170,171,174 Two 
inhibitors were used to interfere with integrin endocytosis mechanism: Bafilomycin A and 
Wortmannin. Bafilomycin A (BFLA) inhibits specifically vacuolar ATPase and prevents acidification 
of endosomes, whereas Wortmannin (WM) inhibits phosphoinositide-3-Kinase (PI3K), which is 
generally involved in endocytosis. BFLA and WM hampered infection in J cells, expressing αvβ6 
integrin: once present, this integrin drives HSV to enter through the acidic endosome pathway of entry 
(figure 2). Endocytosis function essentially maps in the cytoplasmic tail of the integrin β subunit, as 
HSV entry was not inhibited by BFLA or WM in cells expressing the wt integrin but not the αvβ6N1 
chimera. 
 
  
   
Figure 2. The graphics show the dependence of HSV infection to Bafilomycin A (BFLA) (inhibitor of 
endosome acidification) and Wortmannin (PI-3K inhibitor) when J cells expressing nectin1 and integrin αvβ6 or 
αvβ6N1 chimera are infected. Replacing the cytoplasmic tail of β6 integrin rendered the HSV entry not 
dependent on endocytosis. 
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3.1.3 HSV gL is dissociated from gH in HSV glycoprotein complex harvested on 
STREP-tagged αv β6 or β6N1 or β8 integrins, but only if nectin1 gD, gH/gL and gB 
were also present in cis. 
 
An immunoprecipitation (IP) assay followed by western blot (WB) was used to investigate changes in 
the glycoproteins constituting the HSV complexes which mediate entry.179 At first, the overexpression 
of HSV glycoproteins, together with their receptors and coreceptors on the same cell membrane (in 
cis), was chosen to provide evidence of conformational modification triggered by the interplay between 
integrin αvβ6 or αvb8 and HSV glycoproteins. In particular, combinations of stable complexes were 
harvested from protein extracts by pull-down experiments from STREP tagged αv integrin, nectin1 and 
HSV gD (respectively αvSTREP, nectin1STREP and gDSTREP) .αvSTREP integrin was paired with non-tagged 
β6 or β8.338 Results show that gL of HSV was dissociated from gH/gL heterodimer upon binding to 
αvβ6 or αvβ8 integrins, and only in the presence of all the HSV glycoproteins and the HSV receptor 
nectin1 (figure 3, lane 1).  
 
Figure 3. Western blot analysis of glycoprotein complexes assembled on STREP tagged αv, nectin1 or gD. Pull-
downs were assayed from extracts of J cells expressing various in cis combinations of nectin1, integrin αvβ6, 
αvβ8 or αvβ6N1 chimera and HSV glycoproteins. gL dissociation is indicated with red arrows. 
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All the combinations including or not integrins were probed, combining all the HSV essential entry 
glycoproteins and nectin1, using different STREP tagged interactors. Accordingly, gD, gH/gL, gB were 
expressed in suitable combinations, together with or without nectin1 and/or integrins αvβ6 or αvβ8. 
The only in cis combination in which gL dissociation is detected is the one which better mimicks the 
composition of the complex that forms upon host HSV infection, or the one which comprises all the 
essential in vivo molecular interactors. If αvSTREPβ6 or αvSTREPβ8 integrins were independently 
expressed with wild type nectin1, the complex assembled onto integrin contained nectin1 and gD, gH 
and gB. gL was absent (red arrow, figure 3). When nectin1 was omitted, the combination set on 
αvSTREPβ6 or αvSTREPb8 integrins contained again gH/gL and gD or gB (blue arrow, figure 3).  To 
match all the possible cases, an extended comparison was made among complex gathered from 
nectin1STREP or HSV gDSTREP. From nectin1STREP all the glycoproteins were collected together, 
irrespective of the presence of integrins, and only when gD was present. Integrin was not detected in 
this kind of complex. gDSTREP was able to precipitate nectin1 and all the other HSV glycoproteins when 
present, while it was not capable of pulling down integrins, as expected. αvSTREPβ6 integrin interacted 
with HSV gH/gL in the absence of nectin1, as demonstrated by surface plasmon resonance.176 If β6 
integrin was replaced with β8 or β6N1 chimera subunits, and assayed in the presence of the complete 
range of interactors, this condition led to similar results as αvβ6, namely gL dissociation (red arrow, 
figure 3). Hence, β8 behaves similarly to β6 in promoting gL dissociation from the HSV entry 
glycoprotein complex in an assay which mimicks HSV entry. Moreover, only the extracellular domain 
of β6 is involved in gL release from gH/gL. Lysates were analyzed by WB to verify the presence of all 
the HSV glycoproteins and their host interactors, and of gL also in condition of gL dissociation (figure 
4).  
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Figure 4. Western Blot analysis of lysates from extracts of J cells expressing in cis various combinations of 
nectin1, integrin αvβ6, αvβ8 or αvβ6N1 chimera and HSV glycoproteins, showing glycoprotein complexes and 
host interactors assayed in figure 3.   
 
3.1.4 gL dissociation is not a consequence of gH degradation 
 
Integrin αvβ6 might act in combination with nectin1 to degrade HSV gH N-terminus and thus freeing 
gL from the gH/gL heterodimer. Therefore, gL dissociation might only be the outcome of a mechanism 
eventually induced by integrin or an aspecific effect. To rule out this possibility, an aliquot of the same 
pull-down protein extracts described before probed with H12 MAb, which specifically recognizes gH 
(figure 5). 
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Figure 5. Western Blot analysis of three lysates from the extracts assayed in figure 3 showing all the same 
molecular weight, as detected by Mab H12 to gH. gL dissociation upon gH degradation is excluded. 
 
If gH had been degraded, its apparent molecular weight would have been decreased, in those samples 
which exibited gL dissociation. Another possibility is that, if gH had been degraded, the whole amount 
of gH would have been smaller in the sample  where gL dissociation took place. The results show that 
neither is the case. 
 
3.1.5 HSV gL is dissociated from gH in HSV glycoprotein complex harvested on 
STREP-tagged αv plus β6, β6N1 or β8 integrins, but only if nectin1 gD, gH/gL and 
gB were also present in trans. 
 
After HSV virion attaches to heparan sulphate on the host cell and interacts via its glycoproteins, 
specifically with host receptors, integrins and nectin1 are vis-a-vis or in trans to HSV glycoproteins. 
This situation could be easily mimicked by co-culturing two cell populations, one called “target”, 
which expresses HSV receptors, while the other population, termed “donor”, expresses cognate HSV 
glycoproteins or combination thereof. Target J cells population expressed combination of αvβ6 integrin 
and nectin1, while donor J cells expressed combinations of HSV gD, gH/gL and gB. A pull-down from 
αvSTREPβ6 or nectin1STREP was performed when integrin and nectin1 were present both together and 
individually as control. All the HSV glycoproteins were pulled down on nectin1STREP irrespective of the 
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simultaneous presence of αvβ6 integrin (figure 6, blue arrow). In contrast, yet accordingly with 
previous co-transfection data, the glycoproteins’ complex assembled onto αvSTREPβ6 integrin, lacked 
gL when nectin1 was present (figure 6, red arrow). 
 
 
Figure 6. Western Blot analysis of glycoprotein complexes assembled in trans on αvSTREPβ6 or nectin1STREP. 
Pull-downs assayed from extracts of J cells expressing various combinations of nectin1 and integrin αvβ6 
(target) and HSV glycoproteins (donor). gL dissociation is indicated with a red arrow. 
 
Again, the glycoproteins’ complex assembled onto αvSTREPβ6 integrin contained gL when nectin1 was 
absent (figure 6, lane 5). Interestingly, if gD was omitted, αvSTREPβ6 integrin was still capable of 
collecting gB and gH/gL, confirming that these HSV glycoproteins interact in their steady-state, as 
already demonstrated (figure 6, lane 6).179 Moreover, even when gB was not included, αvSTREPβ6 
integrin precipitated gH/gL together with gD, arguing in favor of the presence of HSV glycoproteins’ 
pre-assembled complexes in resting conditions (figure 6, lanes 8 and 9).179 The amount of gD 
precipitated by nectin1STREP was higher than the one precipitated in the same conditions by αvSTREPβ6 
integrin (figure 6, lane 5), while the whole lysate quantification confirmed homogeneous expression of 
the different glycoproteins and receptors (figure 7). Lysates were analyzed by WB in order to verify the 
presence of HSV glycoproteins and their host interactors (as described for every combination), also in 
conditions that led to gL dissociation (figure 7). 
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Figure 7. Western Blot analysis of lysates from extracts of J cells expressing in trans various combination of 
nectin1 and integrin αvβ6 and HSV glycoproteins, showing glycoprotein complexes and host interactors assayed 
in figure 6.   
 
3.1.6 The RGD domain of HSV gH is essential for gL dissociation 
 
HSV gH 176RGD178 domain is an integrin interacting motif located at the beginning of the H1B 
domain. HSV gH mutant 176ADA178 (gHADA) is capable of infecting susceptible cells via an αvβ6 
integrin dependent entry, although at a low level of infection.176 This suggests that RGD domain is 
exploited by HSV, but it might not represent the only domain interacting with integrins. Figure 8 shows 
that the HSV glycoprotein complex assembled onto integrin αvβ6 contained gL when gHADA mutant 
was used instead of the wild type gH and nectin1 was present (blue arrow, figure 8) . Since gL did not 
dissociate from gHADA mutant, the conclusion is thatthe RGD domain in wild type gH is essential for 
gL dissociation.  
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Figure 8. Western Blot analysis of glycoprotein complexes assembled in trans on αvSTREPβ6 integrin. Pull-
downs assayed from extracts of J cells expressing nectin1 and αvβ6 integrin (target cells) and HSV glycoproteins 
(donor cells) with or without gH mutated in its RGD domain (gHADA). gL dissociation is indicated with a red 
arrow. Reference lysates of wild type HSV glycoproteins are shown on the right.  
 
3.1.7 HSV gH mutant RGD to ADA is still precipitated by αvSTREPβ6 integrin 
 
The absence of gL dissociation from gHADA was not due to the lack of gHADA/gL heterodimer 
formation. Since αvSTREPβ6 integrin was able to pull-down HSV gH/gL on its own, as previously 
demonstrated here and in ref.176, this feature was used to investigate whether also gHADA/gL could 
have been pulled down by αvSTREPβ6 integrin, implying that mutant gHADA is folded correctly. Pull-
downs from αvSTREPβ6 integrin analyzed by WB revealed that gHADA/gL were precipitated in a similar 
fashion to gH/gL wild type, but at a lower level (figure 9). Again, as HSV gHADA still interacts with 
αvSTREPβ6 integrin, HSV gH RGD domain contribution might depend on nearby residues or 
domains.176  
 
73 
 
 
Figure 9. Western Blot analysis of HSV gH/gL assembled on αvSTREPβ6. Pull-downs assayed from extracts of J 
cells expressing only integrin αvβ6 and HSV gL plus wild type or gH mutated in its RGD domain (gHADA). A 
lower amount of gH/gL heterodimer is pulled down by integrin αvβ6 alone if gHADA is used instead of wild type 
HSV gH. 
 
3.1.8 gL dissociates from gH of immobilized HSV virions (VIR ELISA) 
 
To detect gL release directly in HSV virions, the properties of two different MAbs to HSV gH, Mab 
52S and MAb 53S were exploited. MAb 52S is a neutralizing MAb while MAb 53S is non-
neutralizing.265 MAb 52S binds a gL independent epitope on gH and allowed the detection of the total 
amount of gH present on HSV virions, either bound or not bound to gL. MAb 53S allows the detection 
of the gH, which is in complex with gL, as MAb 53S binds a gH epitope, which is gL dependent. gL 
dissociation should correlate with a decreased reactivity of MAb 53S on HSV virions which had 
interacted with cells bearing αvβ6 and nectin1. No decrease in MAb 53S reactivity should be detected 
if only nectin1 is present on the cells. MAb 52S reactivity should remain constant during HSV virions 
interaction with susceptible cells, irrespective of the receptors they express. A comparison was made 
between MAbs reactivity during HSV virions absorption of susceptible cells bearing αvβ6 plus nectin1 
or nectin1 only. In the VIR-ELISA approach, HSV virions were immobilized on the multiwells surface, 
a suspension of J cells expressing nectin1 or nectin1 plus αvβ6 integrin was overlaid. J cells were 
removed and MAb 53S reactivity of the tethered HSV virions was probed, resulting in a 76% reduction 
in HSV virions which had interacted with J cells carrying αvβ6-integrin plus nectin1, as compared to 
HSV virions which had interacted with J cells carrying only nectin1 (figure 10). Since MAb 52S 
reactivity was instead at least the same between J cells expressing nectin1 plus or minus αvβ6 integrin, 
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the decrease in MAb 53S detected in gL dissociation conditions implied no HSV virion degradation or 
detachment from the plate. MAb 52S reactivity level was even higher in HSV virions subjected to J 
cells bearing αvβ6 integrin and nectin1; this could be due to unknown structural modifications in gH 
during αvβ6 integrin interaction, which further increases epitope reactivity. The fast kinetics of VIR-
ELISA test implies that gL dissociation, detected via MAbs, is likely to take place during HSV virion 
absorption or entry. 
 
 
Figure 10. VIR-ELISA: MAb 52S recognizes an epitope in gH that is gL independent, while 53S epitope in gH 
is gL dependent. HSV virion reactivity to MAb 52S and 53S was measured after absorption and removal of J 
cells expressing nectin1 plus or minus αvβ6 integrin to tethered HSV virion. gL release corresponded to the 
decrease in 53S reactivity detected when HSV virions absorbed to J cells expressing nectin1 plus αvβ6 integrin. 
Increase in Mab 52S reactivity to HSV gH might be due to an unknown conformational modification ensued in 
gH upon gL dissociation. 
 
3.1.9 gL dissociates from gH of HSV virion only when virions encounter nectin1 
together with αvβ6 integrin  
 
To further investigate gL dissociation from HSV virions, an opposite layout between HSV and target J 
cells was adopted. The reactivity of MAb 52S and MAb 53S to HSV virions absorbed to J cells was 
assayed by means of flow cytofluorimetry. HSV virions were absorbed for 1h at 37°C to J cell 
monolayers, and then removed and immediately analyzed by flow cytofluorimetry for MAb 52S and 
MAb 53S reactivity. As mentioned above, MAb 52S reactivity reflects the total amount of HSV 
virions. Again, the decrease in MAb 53S reactivity reflected the gL dissociation from gH/gL, 
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happening in HSV virions absorbed to J cells expressing nectin1 plus αvβ6 integrin but not nectin1 
only (figure 11). In particular, MAb 52S reactivity of absorbed HSV virions was comparable among J 
cells expressing nectin1 plus αvβ6 integrin (62.5%) and nectin1 alone (56%). MAb 52S reactivity of 
HSV virions absorbed to J cells expressing only αvβ6 integrin without nectin1 was 40% (figure 11, 
quantification). MAb 53S reactivity was 58% when HSV virions absorbed to J cells bearing nectin1 
only, whilst it was diminished to 13% upon absorption to J cells expressing αvβ6 integrin together with 
nectin1. MAb 53S reactivity decrease implies that, upon interaction with J cells carrying integrin αvβ6 
and nectin1, gH/gL heterodimer changes its conformation as the gL dependent epitope identified on gH 
by MAb 53S disappears (gL dissociation). Decrease in both MAbs reactivity when HSV virions 
absorbed to J cells expressing αvβ6 integrin might only be due to decreased HSV virions absorption. 
 
  
 
Figure 11. Quantification and flow cytofluorimetry analysis of HSV virions absorbed to J cells. MAb 52S 
recognizes an epitope in gH, while 53S epitope in gH is gL dependent. HSV virion reactivity to MAb 52S and 
53S was measured after absorption to immobilized J cells expressing nectin1 plus or minus αvβ6 integrin or 
αvβ6 integrin only. gL was dissociated as documented by the decrease in MAb 53S reactivity when HSV virions 
absorbed to J cells expressing nectin1 plus αvβ6 integrin.  
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3.1.10 HSV virion, virion deleted in gB or HSV virion neutralized with PAb to gD 
prevent gL dissociation from gH upon binding of virions to J cell expressing 
nectin1 and integrin αvβ6. 
 
Here, the question was if gL dissociation took place under conditions preventing virus entry, 
exemplified by non-infectious virions or virions preincubated with neutralizing Mabs. In particular, as 
it happened for the pull-down experiments, here it was tempting again to investigate gL detachment 
requirements eliminating once at a time one or the other essential glycoprotein, but acting directly on 
the infective particle. Notably, as gL detached only if all the actors of the entry apparatus were present, 
the condition tested would have nonetheless resulted in HSV entry blockade, either due to the 
interference in gD-nectin1 interaction mediated by the neutralizing PAb R8, or to the lack of gB 
fusogen as for the entry defective HSV mutant gB-/-. HSV in presence of PAb R8 or mutant gB-/- was 
used to infect J cells carrying various combinations of αvβ6 integrin and nectin1. A lack in required 
glycoproteins or receptors mediating entry may hamper the conformational changes to the gH/gL 
heterodimer, in addition to the obvious neutralization effect on virus infectivity.  Infection performed 
with both virion pre-incubated with PAb R8 and gB-/- virion, led to the retention of gL, as no decrease 
on MAb 53S reactivity was detected compared to MAb 52S reactivity (figure 12, quantification for gB-
/-, plots for PAb R8 pre-incubation). Thus, virion gL dissociation took place when gD, gH/gL and gB 
were present on the HSV virion and the host cell expresses together receptors nectin1 and αvβ6 
integrin. 
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Figure 12. Quantification and flow cytofluorimetry analysis of HSV virions preincubated with Neutralizing PAb 
to gD (R8) absorbed to J cells and quantification of gB-/- HSV virions absorbed to J cells. Mab 52S recognizes an 
epitope in gH, while 53S epitope in gH is gL dependent. HSV virion reactivity to MAb 52S and 53S was 
measured after absorption to immobilized J cells expressing nectin1 plus or minus αvβ6 integrin or αvβ6 integrin 
only. gL was never dissociated as documented by MAb 52S and 53S reactivity when HSV virions absorbed to J 
cells expressing nectin1 plus αvβ6 integrin.  
 
3.1.11 gL dissociation is not affected by presence of BFLA  
 
αvβ6 integrin dependent decrease in MAb 53S reactivity (up to 12%) upon infection of J cells bearing 
both integrin and nectin1 took place irrespective of the presence of the endocytosis inhibitor BFLA 
(figure 13). Thus, virion gL dissociation took place when gD, gH/gL and gB were present on the HSV 
virion, and the host cell expresses receptors nectin1 and αvβ6 integrin together. gL dissociation was 
either not dependent on, or took place before, endocytosis of the HSV virion. 
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Figure 13. Quantification and flow cytofluorimetry analysis of HSV virions absorbed to J cells. MAb 52S 
recognizes an epitope in gH, while 53S epitope in gH is gL dependent. HSV virion reactivity to MAb 52S and 
53S was measured after absorption to immobilized J cells expressing nectin1 or nectin1 plus αvβ6 integrin in 
absence or presence of the endocytosis inhibitor BFLA. gL was dissociated irrespective of the presence of 
BFLA, as documented by the decrease in MAb 53S reactivity when HSV virions absorbed to J cells expressing 
nectin1 plus αvβ6 integrin.  
 
3.1.12 gL dissociation coincides with its release in the media of HSV virion and host 
cell mixture 
 
When gL is detached from the gH heterodimer, it should be found in the medium of virions absorbed to 
J cells expressing nectin1 and vβ6 integrin. Media from the experiments described above (figure 11-
13) were harvested after virion absorption to J cells, and assayed by WB. gL was detected in the media 
of virion-cell mixtures only if nectin1, αvβ6 integrin and gD, gH/gL, gB were present, and 
irrespectively of the presence of the endocytosis inhibitor BFLA (figure 14, red arrows). Neither J cells 
expressing only nectin1 (figure 14, blue arrow) nor integrin αvβ6 alone caused dissociation of gL 
during HSV infection and its detection in the media. Moreover, the pre-incubation with neutralizing 
PAb R8 to gD or the use of gB-/- virions hampered gL dissociation and its presence in the media. 
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Importantly, only gL was found in the media of virions-J cells mixtures, as WB showed no gB, gH or 
gD release or shedding in the media (figure 14). 
 
 
Figure 14. Western Blot analysis of culture media harvested from HSV virion- J cell mixtures. J cells expressed 
nectin1 plus or minus integrin αvβ6 or integrin αvβ6 alone. Red arrows indicate gL release in the media due to 
its dissociation from gH/gL upon virion binding to J cells expressing nectin1 together with αvβ6. Reference 
lysates of wild type HSV glycoproteins are shown on the left, while reference lysates of HSV gB-/- virions 
glycoproteins are shown on the right. BFLA was added only in the sample indicated. 
 
3.1.13 gL dissociation and its release in the media of HSV virion - J cells mixtures is 
not induced by gH degradation 
 
As for the pull-down in the J cell transfection system, it is necessary to exclude that gL detected in the 
media, where gL dissociation took place, was instead the result of an αvβ6 integrin dependent 
degradation of gH. To this end WB analysis of virion- J cell mixtures showed that, in every case 
examined, gH molecular mass had not changed (figure 15). The decrease in gH reactivity seen after 
HSV virion absorption to J cells expressing only integrin αvβ6 and no nectin1 might be due to a less 
efficient absorption of HSV virions mediated by integrin αvβ6 in the absence of nectin1. 
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Figure 15. Western Blot analysis with MAb H12 to gH of three cell lysates from of HSV virion - J cells 
mixtures showing all the same molecular weight. gL dissociation upon gH degradation is excluded. MAb H12 
reactivity to a reference lysate of wild type HSV is shown on the left. 
 
3.1.14 αvβ8 integrin promotes gL dissociation, similarly to αvβ6 integrin 
 
To ascertain if the results obtained with HSV virions and αvβ6 integrin extended also to integrin αvβ8, 
an experiment was performed, where HSV virions were absorbed to J cells expressing nectin1 and 
integrin αvβ8 or nectin1 alone or integrin αvβ8 alone. Apart from a lower expression on J cells of 
integrin αvβ8 (33%) as compared to integrin αvβ6 (60%), results showed again a consistent decrease in 
MAb 53S reactivity compared to MAb 52S reactivity only upon HSV virions absorption to J cells 
expressing both nectin1 and integrin αvβ8. Hence, also integrin αvβ8 mediated gL release from gH/gL 
heterodimer upon entry of HSV virion in susceptible J cells (transiently expressing nectin1). Moreover, 
in the case gL was dissociated and MAb 53S reactivity was decreased as compared to that of MAb 52S, 
gL was also detected in the media. In those cases where gL was not dissociated, it was not detected in 
the media (figure 16, western blot).  
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Figure 16. From left to right: Quantification of flow cytofluorimetry analysis (left panel), western blot culture 
media analysis (A) and flow cytofluorimetry analysis (panel d, e, f below) of HSV virions absorbed to J cells 
expressing combination of αvβ8 integrin and nectin1. MAb 52S recognize an epitope in gH while 53S epitope in 
gH is gL dependent. HSV virion reactivity to MAb 52S and 53S was measured after absorption to immobilized J 
cells expressing nectin1 or nectin1 plus αvβ8 integrin or αvβ8 integrin alone. gL was dissociated in the same 
conditions as for αvβ6 integrin. gL dissociation was documented by the decrease in MAb 53S reactivity when 
HSV virions absorbed to J cells expressing nectin1 plus αvβ8 integrin. The extent of gL dissociation is lower 
with αvβ8 integrin as compared to αvβ6 integrin due to a lower expression of αvβ8 integrin. WB analysis of 
culture media harvested from HSV virion-cell mixtures. Only in J cells expressing nectin1 plus integrin αvβ8 gL 
was released in the culture media of HSV virion J cells mixture. Reference lysates of wild type HSV 
glycoproteins are shown on the left. 
 
3.1.15 gL dissociation detected by means of immunofluoresce 
 
To provide direct evidence of gL dissociation, fluorescent HSV virions (K26GFP) were employed to 
infect J cells expressing combinations of αvβ6 integrin and nectin1. The release of gL was monitored 
by fluorescence microscope. In particular, K26GFP HSV virions encase GFP fused with VP26, which 
is a viral protein contributing to HSV capsid formation; hence, K26GFP HSV virions emit 
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fluorescence. Fluorescence microscopy revealed that, upon 30’ absorption, HSV virions lost a part of 
their reactivity to MAb 53S, or to a MAb directed against gL, only when encountered J cells expressing 
nectin1 together with integrin αvβ6, once again implying gL dissociation to happen. In particular, 
K26GFP HSV virions and J cells mixtures were fixed and incubated with MAb 52S, MAb 53S and 
MAb VIII-62 to gL; the latter two showed decreased secondary Ab reactivity only if J cells expressed 
nectin1 and integrin αvβ6. In contrast, no change in MAbs reactivity was shown if host J cells 
expressed only nectin1 or when MAb 52S was used for immunofluorescence (figure 17).  
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Figure 17. Immunofluorescence microscopical analysis of K26GFP HSV virions absorbed to J cells expressing 
nectin1 or nectin1 plus αvβ6 integrin. MAb 52S to gH (which monitors the whole amount of gH, both 
complexed or not with gL), MAb 53S to gH (which recognizes a gL dependent gH epitope and thus its decrease 
correlates with gL dissociation from gH/gL) and Mab VIII-62 to gL were used to screen J cell populations. 
Representative images are shown. GFP green channel, proportional to the amount of absorbed HSV virions, was 
used to normalize the output from the red channel, relative to the MAb selected. It is noticeable the lower red 
fluorescence in J,K panel (VII-62 and 53S, corresponding to nectin1 plus αvβ6 integrin expressing J cells, with 
gL dissociation) in respect to D,E (VIII-62 and 53S, corresponding to nectin1 only expressing J cells). 52S 
reactivity is supposed not to decrease, even if gL is released. 
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Fluorescence data acquired were elaborated so as to provide an indirect quantification of gL 
dissociation. 30-40 cells per case were scored both for GFP and secondary MAb red fluorescence 
intensities; mean ratio between red and GFP fluorescence was calculated to get normalization for every 
case scored. Reactivity of either the MAb to gL or MAb 53S decreased in HSV virions absorbed to J 
cells expressing both nectin1 and integrin αvβ6 to 50% of HSV virions absorbed to J cells expressing 
only nectin1, whereas reactivity of MAb 52S did not change (figure 18). 
 
 
Figure 18. Quantification of the dataset exemplified in figure 17 obtained by immunofluorescence microscopical 
analysis. K26GFP HSV virions absorbed to J cells expressing nectin1 or nectin1 plus αvβ6 integrin. A statistical 
sample of 30-40 J cell was screened to investigate mean reactivity to MAb 52S to gH, MAb 53S to gH (which 
recognizes the gL dependent gH epitope) and MAb VIII-62 to gL. GFP green channel, proportional to the 
amount of absorbed HSV virions, was used as a normalizer (100%). 52S reactivity had not changed in the 
population considered. Mean gL MAb reactivity (as of panel D) decreased (as of panel J) and mean 53S Mab 
reactivity (as of panel E) decreased (as of panel K), both documenting gL dissociation from HSV virion gH/gL. 
3.1.16 Silencing of β6 and β8 integrin subunit in SW480 human cell line prevented 
gL dissociation upon HSV absorption  
 
Colon carcinoma cell line SW480 expressed a high level of integrin αvβ6 and αvβ8 and thus 
represented a suitable human epithelial cell model to extend results obtained in J cells.176 HSV virion 
gL dissociation during HSV entry was detected again by means of MAb 52S and MAb 53S reactivity, 
while combinations of integrins were provided by selective subunits depletion with siRNAs against β6 
and β8 integrin subunit. Knocking down specific integrin subunits in SW480 should prevent gL 
dissociation, as seen when HSV virions encountered J cells bearing only nectin1. Integrins depletion in 
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silenced cells was monitored by qRTPCR and by assaying reactivity to MAb 2077 to αvβ6 integrin and 
MAb 37E1 to αvβ8 integrin with a flow cytofluorimeter. β6 and β8 integrin subunits were both 
silenced at about 60-80% and the same extent of silencing was achieved when both β6 and β8 integrin 
subunits were silenced together. Control siRNA exerted no effect (figure 19, panel A). As detected by 
means of MAb 2077 to αvβ6 integrin, αvβ6 integrin expression was reduced to about 15% when β6 
integrin subunit was silenced in SW480 cells, while silencing of both β6 and β8 integrin subunits lead 
to a decrease of about 20% in MAb 2077 reactivity to αvβ6 integrin (figure 19, panel B and C). Both 
the depletion of β8 integrin or the double depletion (β6 and β8) affected MAb 37E1 reactivity to αvβ8 
integrin to about 30% (figure 19, panel B and C). 
 
 A   
 
Figure 19. qRTPCR quantification of β6 and β8 integrin subunit expression and flow cytofluorimeter analysis of 
αvβ6 and αvβ8 integrin expression after β6 and β8 integrin subunits silencing with siRNA in SW480 human cell 
line. (A) Integrin reactivity was monitored after silencing with MAb 2077 to αvβ6 and MAb 37E1 to αvβ8 
integrin. Integrin depletion reached 60-80% degree for either β6 or β8 integrin subunits, both for singly silenced 
subunit or doubly silenced subunit. Control siRNA exerted no effect. (B,C) αvβ6 integrins expression was 
reduced by about 15% and 20% respectively when β6 integrin subunit was singly or doubly (together with β8) 
silenced in SW480 cells, as detected by MAb 2077 reactivity decrease to αvβ6 integrin. Both β8 single integrin 
subunit or double silencing (both β6 and β8 integrin subunit) affected MAb 37E1 reactivity to αvβ8 integrin by 
about 30%. 
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Silencing of integrin subunits in SW480 cells reduced both the decrease in MAb 53S reactivity and the 
detection of gL in the media after HSV virion absorption. In particular, the reactivity to MAb 52S was 
different among control silenced cells (91%), the cells silenced for one or the other of the two integrin 
β subunits (61%) and the cells silenced for both β6 and β8 integrin subunits. As integrin αvβ6 and αvβ8 
are involved in HSV virion tethering as receptors, depletion of one of them would have directly 
decreased HSV virion attachment and thus the total amount of HSV absorbed.176 Simultaneous 
depletion of both β6 and β8 integrin subunits decreased HSV virion absorption, as estimated by MAb 
52S reactivity compared to the single silencing. In fact, β6 and β8 integrin subunits are 
interchangeable, but both contribute to HSV virion tethering, a process which depends also on αv 
integrin subunit.176 On the other hand, MAb 53S reactivity of absorbed HSV virions increased from 
control cells (22%) to cells silenced for one of the two integrin subunits (40%); but apparently 
decreased in doubly silenced cells (26%), probably because the absence of the two integrins reduced 
the level of HSV virion absorbed on cell membrane (figure 20). Nevertheless, when MAb 53S 
reactivities were normalized onto MAb 52S ones, it emerged that corrected reactivities for MAb 53S 
increased from 20% (control cells) to 73% (double silenced cells), implying that silencing integrin β6 
and β8 subunits effectively prevented the dissociation of gL also in human SW480 (figure 20). 
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Figure 20. Flow cytofluorimetry analysis and corrected quantification of HSV virions absorbed to SW480 
human cell line silenced for either β6 or β8 integrin subunits or both. Mab 52S recognizes an epitope in gH, 
while 53S epitope in gH is gL dependent. HSV virion reactivity to MAb 52S and 53S was measured after 
absorption to immobilized SW480 human cell line silenced with siRNA for either β6 or β8 integrin subunits or 
both (figure 19). In the cells that received control siRNA, gL was dissociated as documented by the decrease in 
MAb 53S reactivity. In double silenced SW480 cells, the cytofluorimeter analysis result of MAb 53S reactivity 
apparently argues for gL dissociation (26,7%, panel G). After normalization for MAb 52S reactivity (as integrin 
subunits are important for HSV virion tethering, and their deprivation might have influenced total HSV virion 
binding) also double integrin subunit silencing exerted inhibition effect on gL dissociation (detected as the 
increase in MAb 53S reactivity to 73%). 
 
As described above, the decrease of MAb 53S reactivity during absorption of HSV virions reflected gL 
release in the media from HSV virion. MAb 53S reactivity was low in control cells, and gL is detected 
in the medium, whereas it increased in cells silenced for one of the two integrins or for both integrin β-
subunits (where no gL was detected in the media) (figure 21). 
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Figure 21. Western Blot analysis of culture media harvested from mixtures of absorbed HSV virion to 
immobilized SW480 human cell line silenced with siRNA for either β6 or β8 integrin subunits or both. In cells 
that received control siRNA, gL was released and detected in the culture media. The extent of gL release is 
lower when only either β6 or β8 integrin subunit is silenced, as the other integrin β subunit might promote a 
residual extent of gL release. In double silenced cells, no gL release was detected. Reference lysates of HSV 
virion glycoproteins are shown on the left. 
 
3.1.17 gH-/- HSV virion infectivity is rescued to a higher degree when soluble 
gHt/gL is added to J cells expressing nectin1 and integrin αvβ6, as compared to J 
cells expressing nectin1 alone 
 
The purpose of subsequent experiments was providing a further line of evidence that gH underwent a 
conformational change during virus entry. The rationale was as follows. If the interaction of gH/gL 
with integrins promotes a conformational change to gH/gL, critical for the cascade of glycoproteins 
activation, then virion bound gH/gL should be replaced with a soluble form of the heterodimer, 
gHt/gL.
354,357 It was reported that a soluble form of gD (gDt) allowed infection of susceptible cells by 
gD−/− HSV virion. Moreover, gDt rescue of gD
−/− HSV virions implied that soluble gDt had changed its 
conformation to allow infection of susceptible cells.219 Soluble form of HSV gH/gL allowed fusion of 
cell transfected with plasmid for nectin1 and gB, when gD was either encoded by a plasmid or 
administered as a soluble protein. J cells expressing nectin1 plus or minus αvβ6 integrin were exposed 
to gH−/− HSV virions in presence or absence of gHt/gL plus or minus gDt or control BSA. gH
−/− HSV 
virion infectivity rescue was monitored by detecting β-galactosidase activity, proper of this HSV 
mutant. gH−/− HSV virions were rescued by gHt/gL, and even better by combination of gHt/gL with 
gDt, while no rescue was detected when BSA was added (figure 22). Endogenous hamster integrin 
contribution was lower than that exerted by over-expression of human αvβ6 integrin, as documented by 
the higher gH-/- HSV virion rescue upon binding J cells expressing both nectin1 and αvβ6 integrin. The 
results argue in favor of a conformational change to gH/gL which drives infectivity rescue of gH−/− 
HSV virions, leading to entry in J cells. gH−/− HSV virion rescue was dependent on J cells expression 
of the gH/gL receptor αvβ6 integrin, as the extent of gH−/− rescue increased when J cells expressed 
nectin1 plus integrin αvβ6 in respect to nectin1 alone (figure 22). 
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Figure 22. Quantification of infectivity rescue of HSV virions deprived of gH/gL upon addition of soluble form 
of gH/gL or gD and gH/gL. gH−/− HSV virion infection was monitored by β-galactosidase activity proper of this 
HSV mutant. J cells expressed nectin1 plus or minus integrin αvβ6. The extent of gH−/− HSV virions rescue was 
higher when both gHt/gL and gDt were present, both in nectin1 only or nectin1 plus integrin αvβ6 expressing J 
cells. The extent of gH−/− HSV virions rescue was higher when soluble glycoproteins were added to assay 
infectivity on J cells expressing nectin1 plus αvβ6 integrin, as compared to J cells expressing nectin1 alone. 
 
 
3.1.18 Infectivity of gH-/- HSV virion is not rescued by soluble gHt/gL in SW480 
human cell line depleted of integrin β6 or β8 or both by silencing. 
 
gH-/- HSV virion infectivity rescue with soluble gHt/gL (plus soluble gDt) was assayed also in SW480 
human cell line, after the silencing of human β6 and/or β8 integrin subunits. gHt/gL plus soluble gDt 
rescued infectivity of gH-/- HSV virion only when control siRNA was used; when one or both integrin 
β subunits were silenced, no rescue was observed (figure 23).  
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Figure 23. Quantification of infectivity rescue of gH-/- HSV virion upon addition of soluble form of gD and 
gH/gL. gH−/− HSV virions infectivity rescue was monitored by β-galactosidase activity proper of this HSV 
mutant. SW480 human cell line was control silenced or silenced for one or both integrin β6 and β8 subunits. 
gH−/− HSV virion rescue takes place only if control siRNA SW480 cells are used to test gH−/− HSV virion 
infectivity rescue with soluble gHt/gL and gDt. 
 
Media from this experiment were collected and analyzed by WB. gL was present in the media of gH−/− 
HSV virions absorbed on cells transfected with control siRNA (figure 24). In this sample, the total 
amount of gL is the sum of the gL contained in the soluble gHt/gL used for the rescue and the gL 
dissociated from gH. When SW480 cells were silenced for one of the integrin β subunits investigated, 
the total amount of gL in the media of virion cell mixtures appeared less and corresponded to the input 
of soluble gHt/gL used; thus, no gL dissociation was detected (figure 24). Hence, the rescue of gH
−/− 
HSV virion infectivity by soluble gHt/gL relied on the presence of αvβ6 and αvβ8 integrins, leading to 
gL dissociation. 
 
91 
 
 
Figure 24. Western Blot analysis of culture media harvested from mixtures of absorbed gH−/− HSV virion to 
immobilized SW480 human cell line silenced with siRNA for either β6 or β8 integrin subunits or both. After 
soluble forms of gD and gH/gL were added, gL was detected in higher amount in the culture media of cells that 
received control siRNA, as compared to that of cells silenced with siRNA for either β6 or β8 integrin subunits or 
both. Soluble gDt elettrophoretic mobility is shown on the right. 
 
3.1.19 Neutralizing MAb LP11 to gH prevents gL dissociation upon HSV virion 
binding to J cells expressing nectin1 plus αvβ6 integrin 
 
gL dissociation and its release in the medium took place only in the typical conditions that lead to HSV 
infection of susceptible cells; in particular, only when gD, gH/gL, gB, nectin1 and integrin αvβ6 or 
αvβ8 are present together. As demonstrated, the absence of the entry receptor or of the host 
components led to conditions where no gL dissociation had been detected. Accordingly, MAbs to 
gH/gL which prevented gL dissociation without being neutralizing, could not be found. In fact, gL 
dissociation may represent an essential step for HSV entry. The different properties of known MAbs to 
gH/gL were exploited to hinder gL dissociation from gH/gL during HSV entry. In effect, it remained 
possible that some neutralizing MAbs to gH/gL exert their negative effect on HSV entry impeding gL 
dissociation from HSV gH/gL and thus inhibiting gH/gL activation. MAb LP11 to HSV gH epitope 
resides on the opposite surface in respect to the one recognized by MAb 52S and both these MAbs are 
neutralizing for HSV. MAb 53S recognizes a gL dependent epitope on gH and it is not 
neutralizing.193,265,267 HSV virions were incubated with control Ig or the specified MAbs and then used 
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to infect J cells expressing nectin1 plus or minus integrin αvβ6; after 30’, media was analyzed by WB. 
Pre-incubation of HSV virion with control Ig, MAb 52S or MAb 53S allowed the dissociation of gL 
from gH/gL and its release in the media when J cells expressed nectin1 together with αvβ6 integrin 
(figure 25). Contrariwise, pre-incubation with MAb LP11 prevented gL dissociation from gH/gL and 
its release in the media when J cells expressed nectin1 together with αvβ6 integrin. Therefore, 
neutralizing MAb LP11 could exert its strong HSV entry blockade effect by blocking gL to gH, finally 
joining HSV entry to gL dissociation and eventually disclosing a negative regulation function of gL on 
gH, which is αvβ6 or αvβ8 integrin dependent. 
 
 
Figure 25. Western Blot analysis of culture media harvested from mixtures of absorbed pretreated HSV virion to 
immobilized J cell expressing nectin1 plus or minus αvβ6 integrin. When HSV virions were preincubated with 
control Ig, MAb 52S or MAb 53S and were used to infect J cells expressing nectin1 together with αvβ6 integrin, 
gL dissociation from gH/gL and its release in the media was allowed. If J cells expressing nectin1 together with 
αvβ6 integrin were infected with HSV virion preincubated with MAb LP11, gL dissociation from gH/gL and its 
release in the media were blocked. Elettrophoretic mobility of HSV virion essential glycoprotein is shown on the 
left. 
 
 
 
 
3.2 HSV DISCUSSION  
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3.2.1 HSV entry summary 
 
Entry of Herpesviruses is a highly controlled process.164,165,222,372 gH/gL and gB are conserved across 
herpesviruses. Available gH/gL stuctures showed that gH/gL does not resemble other fusion 
glycoproteins, arguing at a regulator role gH/gL.178,188,241 gL binds gH in its H1 N-terminal domain and 
gH/gL heterodimerization function is conserved in the majority of herpesviruses. Tropism of HSV is 
dictated mainly by gD, while gB structure features revealed that gB is the HSV fusogen.175,279 HSV 
fusion begins with the encounter of gD with host receptors: nectin1 or HVEM. Upon binding, gD 
changes its conformation, displaying its profusion domain. gH/gL gathers fusion promoting signals 
from its own receptors, αvβ6 and αvβ8 integrins, and from activated gD, in order to trigger gB to 
execute fusion.176 αvβ6 and αvβ8 integrins are HSV receptors for gH, but they do not allow HSV entry 
when present alone; integrins need one of the HSV gD receptors to exert their role. The stepwise 
activation model for HSV entry suggests that host nectin1 or HVEM and virion gD, gH/gL and gB are 
sequentially recluted to gain fusion of virion and host membrane. In contrast, in the HSV resting 
membrane, different preassembled complexes of  glycoproteins are already interacting with each other 
at the equilibrium, without reaching the gB activation end point.179 In fact, preassembled complexes of 
HSV virions glycoproteins were detected, i.e., gD interacting with gB, arguing against the sequential 
engagement proper of the stepwise activation model.179,181 Hence, HSV glycoproteins might contact 
each other even when not triggered by their receptors, but the binding of glycoproteins to receptors 
promotes the conformational changes that favor the fusion process.179 
 
3.2.2 αvβ6 and αvβ8 integrins 
 
αvβ6 and αvβ8 integrins enable HSV virion entry, as depletion of these integrins with MAb or siRNA 
against αvβ6 and αvβ8 integrins reduced HSV infection.176 Integrin antibodies might mimick ligand 
and induce integrin to proceed in endocytic pathway with consequent disappearance from the 
membrane. Antibodies against integrins may also act to stabilize an integrin conformation, or to mask 
the gH/gL docking site used to deliver triggering signal to the HSV entry machinery. αvβ6 and αvβ8 
integrins promote an HSV entry pathway in host cells, which is dependent on endocytosis. Apart from 
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this entry mechanism, HSV could use other ways to infect cells: cells in which HSV entry takes place 
at plasma membrane or neutral compartment were described.170,171,174,176 Through surface plasmon 
resonance, it was demonstrated that αvβ6 integrin interacts at high affinity with soluble gHt/gL.176 This 
argues for a direct binding between the ectodomain of gH/gL and host integrin heterodimers 
ectodomains, with a potential increase in absorption efficiency.176 Apart from an enhancement in 
absorption, the increase in infection seen in presence of integrins might imply a further mechanism: 
integrins could improve HSV entry. In particular, αvβ6 or αvβ8 integrins might promote gH/gL 
transition to its active form, which prompts gB to execute fusion. Interaction between integrins and 
gH/gL might affect the interactions among HSV entry glycoproteins. Moreover, as αvβ6 and αvβ8 
integrins are HSV receptors, it is plausible that they could trigger conformational modification to the 
glycoproteins they bind, namely gH/gL, during HSV entry. 
 
3.2.3 HSV gL dissociation 
 
αvβ6 or αvβ8 integrin interaction with gH/gL promoted the dissociation of gL from gH/gL and its 
release in culture media, but only when nectin1, gD and gB were also present. gL dissociates during 
HSV virion absorption or entry. gL dissociation is specifically inhibited by neutralizing MAb LP11 to 
gH, but not by neutralizing MAb 52S to gH, implying that a conformational modification takes place to 
gH when HSV enters cells expressing αvβ6 or αvβ8 integrins. gL dissociation might allow gH to reach 
its active conformation, which is necessary to trigger gB to fuse. It is possible that gL might act as an 
inhibitor that must be dissociated from gH to promote HSV entry and fusion.  
gL dissociation upon gH/gL binding to αvβ6 or αvβ8 integrin was assayed by means of cotransfection, 
coculture and during HSV virion absorption and entry. In cotransfection, combinations of molecular 
interactors are expressed on the same cellular surface, while in coculture, a distinction is made between 
target cells, expressing combinations of receptors, and donor cells, expressing combinations of viral 
glycoproteins, in order to respectively mimick host cell membrane and virion envelope . In 
cotransfections, all actors are espressed in cis. One limit of this approach is that interactions eventually 
detected might take placein the secretory pathway and not on cell membrane, leading to false positive 
interactions in virus entry investigations. Also, the in cis approach is the least likely representation of 
the HSV entry phenomenon. A co-culture assay was established to bypass the limit of co-transfection 
system. The same assay conduced in trans is a better representation of the interactions between viral 
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envelope and cell membranes, as it follows the correct in vivo topology. In absence of nectin1, gD or 
gB no gL dissociation was detected upon gH/gL interaction with αvβ6 integrin, while gL dissociation 
was detected when endocytosis was hindered by BFLA, implying that endocytosis is not required for 
gL dissociation. 
Co-seeding is a very clear and easy system to mimick molecular interactions among virus glycoproteins 
and their cellular receptors, but the better way to study HSV entry mechanism is to use directly HSV 
virions. Also during HSV entry the requirements for gL dissociation mediated by αvβ6 or αvβ8 integrin 
are the same as for HSV infection, namely that nectin1, gD, gH/gL and gB should be present together. 
In particular, gL dissociation required not only all the essential HSV virion glycoproteins, but also the 
host cellular receptors nectin1 and αvβ6 or αvβ8 integrins. 
3.2.4 Molecular mechanism of HSV gL dissociation  
 
The mechanism which dissociates gL from the gH/gL heterodimer depends on a conformational 
modification that ensues in gH/gL upon appropriate condition, and it is hampered by MAb LP11. MAb 
LP11 to gH might hamper a structural rearrangement of gH N-terminus, thus blocking gL in its original 
position, finally inhibiting the possibility for gH to activate gB for fusion. RGD integrin interactin 
motif resides at position 176-178 of gH; gL binds gH in positions 259-323 and LP11 contacts residues 
86, 168, 300, 315-317 and 325 in gH as detected by MAb Resistance Mutants.188,192,239 Instead of a 
direct competition of gL with αvβ6 integrin for a common binding site on gH surface, gL dissociation 
should depend on a gH/gL conformational change induced by integrin binding to gH/gL. It is possible 
that binding of MAb LP11 to residue 168 imposes steric hindrance to gH, thus preventing αvβ6 
integrin binding to gH RGD (176-178) domain. To confirm this hypothesis, figure 8 shows that no gL 
dissociation was detected upon gH RGD to ADA mutation. Hence, gL dissociation from gH/gL 
depends on gH RGD domain, the same domain mediating HSV entry by αvβ6 integrin, while gH/gL 
binding to integrin αvβ8 does not depend on gH RGD.176  Figure 9 demonstrates that a detectable 
amount of gH/gL heterodimer is pulled down by αvβ6 integrin, even when gHADA is used instead of 
wild type HSV gH, implicating that integrin binding site on gH/gL extends over the gH RGD domain. 
gL dissociation ensues during gH/gL activation by host receptor αvβ6 or αvβ8 integrin; gH 
conformational modification triggered by αvβ6 or αvβ8 integrin could be ultimately part of HSV entry 
mechanism. In particular, MAb LP11 to gH N-terminus (FR1) both neutralizes HSV and hampered gL 
dissociation, while other neutralizing MAb to gH (52S, which instead bind H2-H3 domain of gH, FR2) 
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or non-neutralizing MAb to gH (53S), do not, indicating that LP11 exerts a kind of specific inhibition 
to gH/gL conformational change and to HSV entry. Thus, the LP11 neutralizing effect on HSV might 
be exerted by preventing gL dissociation. 
gH conformational modification takes place during HSV virion entry and might represent a metastable 
state of the glycoprotein induced during αvβ6 integrin dependent HSV infection. In fact, gH-/- HSV 
virions were rescued in their infectivity by adding a soluble form of gH/gL plus soluble gD, in an αvβ6 
integrin dependent fashion. gL might act as a negative regulator of gH that, once dissociated, enables 
αvβ6 integrin dependent HSV entry, preventing premature exhaustion of gH fusogenic potential by 
introducing an additional rate limiting step control.  Cross-linking the soluble gHt/gL chemically with 
formaldehyde or engineering intermolecular disulphide bonds to costrain the heterodimer might 
prevent only the subordinate process of gL dissociation from gH/gL without exerting neutralization 
capabilities, namely without inhibiting the upper process of HSV entry. However, if integrin dependent 
HSV entry depends on gL dissociation it might not be possible to separate these events. 
An established example of protein activation through inhibitor dissociation is the cytokine activator 
Nuclear factor κB (NFκB) which, upon triggering by cytosolic signals, undergoes a conformational 
change that dissociates its IκBα inhibitor subunit.373 However, gL would represent more than an 
inhibitor for gH. Providing that gH did not resemble any known structure, its folding might require 
more than the host protein folding machinery (exemplified by chaperones), and gL is properly thought 
to accomplish this role. In fact, HSV gH needs gL both to gain proper folding, i.e. all of its standard 
epitopes, and to be correctly processed during secretion pathway.231,235 Yet, gL is not a chaperone for 
gH because chaperones catalyze the folding of newly-synthetized proteins but do not remain tethered or 
cofold with the protein they facilitate, as gL does. It is possible that gL serves to prevent gH activation 
until the HSV multipartite apparatus is ready to encounter its receptors; hence, its dissociation would 
establish a no return point towards gB activation upon correct triggering by host receptors. 
Thus, integrin interaction would play a similar role of the other HSV receptors, i.e. to induce 
conformational modifications to the entry glycoproteins. Once these modifications start, they should 
trigger an inter-molecular signaling cascade that breaks the existing equilibrium among preassembled 
glycoprotein complexes and culminates in fusion of HSV envelope with host membrane. These striking 
results emerged from J cells coexpressing on membrane surface arrangements of HSV glycoproteins, 
integrins and cognate HSV receptors. Conformational modifications triggered by αvβ6 integrin 
consisted in gH/gL heterodimer disassebly. This latter modification might allow synchronization of 
membrane fusion, a process exerted by HSV entry glycoprotein apparatus and host receptors, with 
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endocytosis, which is contributed by integrins. gL release during HSV entry was not inhibited by 
BFLA and was prevented by R8 PAb to gD or by the absence of gB, i.e. conditions that hamper HSV 
infection. Hence, gL dissociation might represent a necessary step for gH to gain its active 
conformation, with gL possibly working as an inhibitor of gH.  
 
3.2.5 Refinement of HSV entry model 
 
The first step in HSV entry is the gD interaction with one of its receptors, nectin1 or HVEM, called 
triggering step.  
The second step involves gH/gL, which collects an activation signal from receptor bound gD and 
directly reacts to αvβ6 and αvβ8 integrins; this step is called activation step. αvβ6 or αvβ8 integrin-
dependent HSV entry proceed through the activation step only if both signals are present. The outcome 
of the second step is gH/gL activation by gL dissociation (inhibitor release). This step might break the 
existing equilibrium among preassembled glycoprotein complexes delivering a different signal to gB, 
which is then allowed to mediate fusion between viral and host membranes. During HSV entry process, 
gH/gL still function as an upregolator of gB fusogenic properties. The heterodimer is self-inhibited by 
gL. The role gH/gL in HSV entry is thus to integrate signals from multiple sources and to deliver the 
fusogenic signal to gB. Since αvβ6 integrin, once bound to HSV gH/gL, promotes virion endocytosis 
by its signaling C-tail (β6 subunit), gL dissociation might provide correct timing necessary for fusion in 
the endosome compartment. 
The third step is fusion and, in most herpesviruses, it is a gB driven process. In the case of HSV, gB 
might integrate signals from its receptor PILRα or other candidate gB receptors (figure 26). 
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Figure 26. Schematic of αvβ6 integrin dependent HSV entry. Sequential steps that result in αvβ6 integrin 
dependent HSV entry proceed through the following events: Triggering (gD and host receptors), Activation (gH 
and αvβ6 integrin) and Fusion (gB). See full text for details. Adapted from ref. 374. 
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4.1 VZV RESULTS  
 
4.1.1 Integrins mediate VZV fusion, especially when coexpressed with MAG 
 
To investigate whether integrins of the αv family have a role in VZV fusion, the well-established 
luciferase-based assay was performed. In particular, donor cells mimic VZV virion and express 
combinations of VZV entry glycoproteins: gH/gL and gB plus or minus gE/gI. Target cells mimic host 
cell membranes, expressing combinations of integrins of the αv family plus or minus the VZV 
established receptor Myelin Associated Glycoprotein (MAG).289  
The two COS cell populations were coseeded for 24 h and relative units of luciferase were measured. 
Figure 27 shows that: 
1. The highest level of cell-cell fusion was observed when all of the available actors, viral 
glycoproteins and cellular receptors, were contemporarily present. In particular, the highest 
level of fusion resulted from coculture of donor cells expressing combination of gH/gL, gB and 
gE/gI while target cells expressed MAG plus integrin αv and one of the β3, β5, β6 or β8 
integrin subunits. This situation reflects what happens during VZV entry process.  
2. A lower but still consistent extent of fusion was detected when gH/gL and gB were expressed 
on donor cells and co-seeded with target cells expressing MAG together with one of the αv 
integrin heterodimers investigated. This condition may represent the minimum set required for 
cell-cell fusion, where viral glycoproteins and their cellular counterpart are present.  
3. When cells expressing gH/gL, gB and gE/gI were co-cultured with cells expressing integrins 
alone, the fusion level was comparable, or slightly higher, than that obtained when donor cells 
expressed gH/gL and gB and target cells expressed only MAG; a situation reported to induce 
the highest fusion level by others.289  When donor cells expressed the five VZV glycoproteins 
and target cells expressed MAG, the level of fusion was higher than that observed when only 
integrins were expressed on target cells. This result suggests a primary role for MAG, when all 
VZV glycoproteins are present. 
4. When cells expressing MAG alone or integrins alone were assayed with donor cells expressing 
only the three VZV glycoproteins, a very low level of fusion was detected. In particular there 
was no increase in fusion level as compared to fusion of donor cells with cells expressing 
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integrins or cells which expressed no receptors. The fusion level, was doubled when MAG was 
present.  
 
 
 
 
Figure 27. Luciferase assay. See full text for detailed results. Cell-to-cell fusion between donor COS cells 
expressing VZV gH and gL plus gB or VZV gH and gL plus the trio of gB, gE and gI, and target COS cells 
expressing MAG alone, or MAG plus αvβ- integrin heterodimers or integrins alone, or no receptors. Fusion was 
quantified by means of a T7 promoter-driven reporter luciferase gene transfected in target cells, and expressed as 
relative luciferase units (R.L.U.). Each point represents the average of triplicates. Bars show SD. Each value, 
proper of the specific combination tested, was normalized onto HLB MAG combination, the condition where 
VZV fusion was reported to reach its maximum extent.289 
 
4.1.2 VZV pull-down assay 
 
To investigate if VZV gH/gL and gB physically interact with integrins of the αv family, 
immunoprecipitation assay and western blot were performed in a coculture system, so as to mimick 
VZV Virion interaction with host membrane. In particular, 293T donor cells were tranfected with 
amounts of VZV gH/gL and gB that ensured similar expression. Target 293T cells were transfected 
101 
 
with STREP tagged integrin αv (αvSTREP) alone, αvSTREPβ3, αvSTREPβ6 or control STREP tagged HSV 
gD (gDSTREP). VZV glycoproteins transfection was delayed by 12 h relative to integrins transfection, so 
as to prevent costitutive exhaustion of glycoprotein fusogenic potential before co-seeding. 16 h after 
integrins transfection target and donor cells were cocultured for 6 h or 10 h. 
Figure 28 shows that αvSTREP integrin subunit pulled down increasing amounts of VZV gH in a time 
dependent manner, only when β3 subunit was present. In particular, αvSTREPβ3 integrin interacts with 
VZV gH already at 6 h after co-seeding (lane 2). The amount of pulled down gH increased at 10 h (lane 
6). αvSTREP integrin alone (lanes 4 and 8), or αvSTREPβ6 (lanes 3 and 7), were capable to pull down 
modest amounts of gH.  αvSTREP integrin over-expressed alone might have formed integrin heterodimer 
with a 293T resident human β3 integrin subunit, thus αvβ6 integrin might have been not involved in 
VZV gH interaction. There was no increase in gH retention by αvSTREP after β6 integrin over-
expression, when compared to the amount pulled down by integrin αvSTREP alone (compare lanes 3 and 
7 with lanes 4 and 8). The uncleaved form of VZV gB was pulled down aspecifically, as it was 
detected also when only HSV gDSTREP was expressed. VZV gH was pulled down alone. In all tested 
conditions gL was absent, while gL was detected in the total cell lysates. gH was never pulled down by 
HSV gDSTREP, providing evidence for specificity (lanes 1 and 5). These observations are in accordance 
with recent findings that VZV enter human cells via integrins of the αv family.290 Presently, the pull-
down results are not in contrast with fusion assays findings, as the role of gE/gI heterodimer in pull-
down assay has not been investigated yet. 
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Figure 28. Western Blot analysis of VZV glycoprotein complexes assembled in trans on STREP tagged αv 
integrin. Tagged VZV gH, gL and gB were detected with MAbs raised against FLAG tag. αvSTREP and gD STREP 
were detected by specific antibody against STREP tag epitopes. Target 293T cells were transfected with αvSTREP 
alone, lanes 4 and 8, αvSTREPβ3, lanes 2 and 6 or αvSTREPβ6 lanes 3 and 7 or HSV gDSTREP as negative control, 
lanes 1 and 5. 8 h later donor cells were transfected with FLAG tagged VZV gB, and gH/gL. 16 h later donor 
and target cells were coseeded. 6 h (lanes 1to 4) or 10 h (lanes 5 to 8) later cells were harvested for lysis and 
STREP pull-down. Green arrows indicate that VZV gH was pulled down by integrin αvSTREPβ3 at high amount at 
10 h post coculture (lane 6) and in lower amount at 6 h post coculture (lane 2). The yellow arrow indicates that 
VZV gH was pulled down by integrin αvSTREPβ6 or αvSTREP at low level both at 6 h and 10 h post coculture (lanes 
3, 4 and lanes 7, 8 respectively). HSV gDSTREP pulled down no VZV gH FLAG. No VZV gL was detected, while 
uncleaved gB seems to be pulled down aspecifically. Elettophoretic mobility of reference proteins expressed in 
293T cells is shown to the right. 
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4.2 VZV DISCUSSION  
 
Most human herpesviruses use integrins as components of their entry machinery.176,337,290,358,359  It was 
reported that HSV gH/gL interacts with αvβ6 and αvβ8 integrins.176 HSV-1 gH/gL binds αvβ6 integrin, 
but not αvβ8 integrin, through its RGD domain. This interaction promotes HSV entry and modified 
HSV entry pathway. Epstein-Barr Virus (EBV) uses αvβ5, αvβ6 and αvβ8 integrins as receptors for 
epithelial cells. These integrins interact with EBV gH/gL at amino acid position 188KGD190. In 
Kaposi's sarcoma-associated herpesvirus (KSHV), it is gB that interacts with an αv integrin. This 
interaction is able to induce virus entry through an endocidic pathway. In addition, HCMV interacts 
with integrins in a very complex manner. It seems that integrin binding depends on the origin of the 
virus, such that clinical isolates bind different integrins as compared to laboratory strains. Presently, it 
remains elusive which viral glycoprotein, between gH/gL heterodimer and gB, is involved. However, it 
is clear that herperviruses have evolved to use integrins as cellular receptors. It is evident that integrin 
binding capacity resides in the conserved viral glycoproteins gH/gL or gB.  
It was recently reported that, as for VZV,  there is an involvement of αv integrins during virus 
infection, but it remains unclear which β subunit and expecially which viral glycoprotein is involved in 
integrin binding.290 Here, for the first time, a physical interation between the VZV entry glycoproteins 
and integrins of the αv family was reported. In particular, it seems that αvSTREPβ3 integrin interacts 
specifically with VZV gH, this result is in accordance with the recent finding that VZV enters human 
cells via integrin of the αv family.290 αvβ3 integrin did not interact with gL. Integrins are also involved 
in VZV fusion, as expression of integrins together with MAG induces fusion mediated by gH/gL and 
gB, especially when also gE and gI are expressed, a condition mimicking the VZV infection. VZV gE 
and gI were considered for a long time essential in VZV entry, due to the lack of a tropism factor, as 
HSV-1 gD. 
The entry machinery of herpesviruses accomodates various functions. During viral species evolution, 
the entry functions were unevenly distributed among glycoproteins. Thus, it is conceivable that gH/gL 
includes the tropism factor function and directly interacts with integrins in a RGD or KGD independent 
way, as these domains are not present in gH/gL. However, three KGD are present in VZV gE and gI. It 
is possible that VZV use ancillary proteins to increase or better define tropism determined by gH/gL, 
i.e. via gE/gI KGD mediated integrin interaction (a condition that has similarities with HCMV 
pentameric complex375). To this purpose, the interaction among gE/gI with integrins remains to be 
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elucidated, especially because well established examples of in vivo infection models revealed that part 
of gE/gI ectodomains are involved in VZV infection. It is known that MAG is a receptor for VZV gB, 
and that MAG over-expression allows VZV entry. MAG carries an RGD integrin binding domain and 
interacts with both VZV gB and gE.289,309-311 It is conceivable that through its RGD domain MAG 
could relocalize integrins in specific sites of the cell membrane, favoring gH/gL interaction and VZV 
entry,  as already reported for nectin1 in HSV-1 model.353 
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6 MATERIALS and METHOD 
 
Cells, viruses, soluble proteins and antibodies 
 
J cells were derived from baby hamster kidney (BHK-TK-). J cells and do not express HSV entry 
receptors. J cells were grown in Dulbecco modified Eagle’s medium (DMEM) containing 5% fetal 
bovine serum (FBS), as previously described.204 SW480 human cell line was derived from colon 
carcinoma and was grown in Lebovitz L-15 10% FBS. 293T and COS cells were grown in DMEM 5% 
FBS.  
Wild type HSV strain F was previously described.204,376 K26GFP, an HSV recombinant, expressed a 
green fluorescent protein (GFP) in frame with VP26 capsid protein, was previously described.376 The 
gB deletion mutant ΔgBKΔT was grown and titrated in complementing cells and previously 
described.377  In the gH deletion mutant ΔgH SCgHZ, gH was substituted with LacZ gene and virions 
were grown F6 complementing cells, as previously described.357 R8102 is an HSV recombinant which 
carries a LacZ reporter gene controlled by the α27 promoter.204 
Soluble gDΔ290t-299t was from Cohen G. H. and  Eisenberg R.378 gHt/gL,  a soluble form of gH/gL 
containing a One-Strep-Tag epitope for affinity purification, was previously described.354  
R8 polyclonal antibody (PAb) to gD, MAb CK6 to Nectin1 and H12 monoclonal antibody (MAb) to 
gH were from Cohen G. H. and Eisenberg R. MAb VIII-62 to gL was from Spear P. G. Western Blot 
(WB) positive MAb  H1817 to gB and WB positive MAb H170 to gD were from Goodwin Institute. 
PAb to gH/gL heterodimer, obtained against soluble gHt/gL, was previously described.
354  Neutralizing 
MAb 52S to gH, recognizes a conformational epitope in gH; both not neutralizing MAb 53S to gH and 
neutralizing MAb LP11 to gH recognize conformational epitopes in gH, which are gL-dependent.193,265 
MAb 2077 to αvβ6 integrin heterodimer was from Chemicon. Antibody to Strep-Tag, conjugated with 
horseradish peroxidase was from IBA, Solutions for Life Sciences. MAb R1.302 to Nectin1 was from 
Lopez M.204 MAb to FLAG epitope was from Sigma-Aldrich. 
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Plasmids 
 
HSV gH, gL and gB genes were cloned in MTS vector; gD gene was cloned in pcDNA3.1. All genes 
were expressed under cytomegalovirus promoter, as previously described.379 Plasmids encoding for 
Nectin1 and for epithelial growth factor receptor 2 Δ (EGFR2NΔ, which codified for a non-signaling 
EGF receptor termed Erb2Δ32), were previously described.354,380 gHADA carries the following 
substitutions in the RGD domain,  gH176RGD178 to gH176ADA178, gHADA was previously 
described.354 Plasmid encoding for αvSTREP tagged integrin was previously described.338 Plasmid 
encoding for β8 was from Nishimura S. L.381 Plasmids encoding for αv, β3, β5, β6 were from Blystone 
S.355  Plasmid pCAGT7 containing the T7 RNA polymerase gene and plasmid pT7EMCVLuc 
expressing the firefly luciferase under the control of the T7 promoter were described.382  
Plasmids encoding for FLAG tagged VZV gH, gL and gB, and plasmids encoding for VZV gE, gI and 
for Myelin Associated Glycoprotein (MAG) were from Suenaga T.  
 
Constructs 
 
 
To generate gDSTREP, the gDN plasmid was digested with BglII-HindIII restriction enzymes to eliminate 
GFP N-terminus.187 The following annealing oligonucleotides was used to amplify  the Strep Tag 
epitope: 5′-GGA AGA TCT CTG GCT GGA GCC ACC CGC AGT TCG AGA AAG GTG GAG GTT 
CCG GAT CGG GAG GTG GAT CG-3′ and 5′-CCC AAG CTT CCC GGA TCC TCA TTT TTC 
GAA CTG CGG GTG GCT CCA CGA TCC ACC TCC CGA TCC GGA ACC T- 3′.  The PCR 
product was digested with the same enzymes used before and ligated in frame with gD gene.  
To generate Nectin1STREP encoding plasmid, was used a similar strategy applied for generation of 
plasmid encoding for gDSTREP. In particular, Nectin1STREP was generated thorough digestion with BglII-
XhoI restriction enzymes of NectC plasmid in a way to eliminate GFP C-terminus.
187 The following 
annealing oligonucleotides were used to amplify Strep Tag epitope:  5′- GGA AGA TCT AGC GGA 
GGT GGA CAT CAT CAC CAT CA CAT AGC GGA GGT GGA AGC GCT TGG AGC CAC CCG 
CAG TTC GAG AAA GGT GGA GGT TCC GAG GGT- 3′ and 5′- CCG CTC GAG TCA TTT TTC 
GAA CTG CGG GTG GCT CCA CGA TCC ACC TCC CGA TCC ACC TCC GGA ACC TCC ACC 
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TTT CTC GAA CTG CGG GTG GCT CCA AGC G-3′. The fragment obtained from PCR was 
digested with the same enzymes and cloned in frame with Nectin1.  
To generate β6N1 chimera, pCF18HNK was digested with BamHI-HpaI restriction enzymes in a way 
to eliminate only the ectodomain of Nectin1.171 pCF18HNK encoded for full length Nectin1 but had 
three silent mutations for the insertion of the HNK (HpaI, NheI and KpnI) sites before the 
transmembrane domain of Nectin1.171  The ectodomain of β6-integrin was PCR amplified from β6-
integrin plasmid with the following oligonucleotides 5′- GAA CTG GGA TCC ATG GGG ATT GAA 
CTG CTT TGC C- 3′ and 5′- CAT GGG GTT AAC TGG AGG CTT CGG ACA ATC- 3′. The PCR 
product was digested with the same enzymes and ligated in frame to Nectin1 TMR and C-tail. 
 
Effect of pharmacological inhibitors and role of β6 integrin C-tail in virus entry  
 
J cells transfection was carried out with Lipofectamine 2000, as previously described.345 Each time that 
J cells were transfected with Nectin1 plus integrins cells received a threefold dose of integrin αvβ6 
plasmid in respect to Nectin1, while J cells expressing only Nectin1 received threefold dose of 
Erb2Δ32 control plasmid. 48 h after transfection, J cells expressing Nectin1 or Nectin1 plus a 
combination of integrin αVβ6 or β6N1, were pre-incubated for 1 h at 37 °C with bafilomycin A 
(BFLA) or wortmannin (WM), all from Sigma Aldrich. Cells were infected with R8012 in presence of 
inhibitors at 3 MOI (Multiplicity of infection = 3 Plaque Forming Unit (PFU) / 1 host cell) for 1.5 h at 
37°C. Viral inoculum was removed and cells were left in culture media containing inhibitors for other 8 
h. Alternatively, 48 h after transfection, J cells expressing Nectin1 or Nectin1 plus a combination of 
integrin αVβ6 or β6N, were infected with R8012 at increasing MOI. R8102 inoculum was removed and 
cells were left in culture media for other 18 h. Quantitation of infection was carried out with O-
nitrophenyl–β-galactopyranoside (ONPG), a colorimetric substrate that allow measure of β-
galactosidase activity proportional to R8102 infection, and read at 405 nm.  
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Strep-Tag Pull downs 
 
In cis pull down experiments, J cells were co-transfected with appropriate combination of plasmids 
encoding HSV glycoprotein gD (gDSTREP or wild type), gH (gHADA or wild type), gL and gB. The same 
J cell population, was transfected with Nectin1 (Nectin1STREP or wild type), Nectin1 plus integrins 
αvSTREP, β6 (β6N1 chimera or wild type) and β8 or αSTREP β6 integrin alone in appropriated 
combinations. In pull down trans experiments, donor J cells were transfected with a combination of 
HSV glycoproteins, target J cells were transfected with a combination of receptors.  24 h after 
transfection the two populations were co seeded for other 24 h. Cells were harvested and cell lysates 
subjected to Strep-Tag pulldown, as previously described.181 Expression plasmid for Erb2Δ32, was 
added when required, to ensure equal amount of total transfected DNA. Proteins collected by means of 
Strep-Tactin resin were separated by Sodium Dodecyl Sulphate polyacrylamide gel electrophoresis 
(SDS/PAGE) and analyzed by WB with appropriate antibodies using a ChemiDoc XRS+ and Image 
Lab Software (Biorad). 
For VZV pull down experiments target 293T cells were transfected by means of Lipofectamine 2000 
with αVSTREP plus β3 or β6 integrins (150ng /24 well) or  with HSV gDSTREP alone (50ng / 24 well) as 
negative control. 8 hours later 293T donor cells were transfected with VZV gBFLAG (150ng/24well) 
plus gHFLAG (100ng/24well) and gLFLAG (75ng/24well).  The day after donor and target cells were co-
seeded in equal amount in DMEM 5%FBS and 6 h or 10 h later cells were harvested.  Lysates were 
pulled down by means of Strep-Tag as already described for HSV.  
 
Silencing and qRTPCR 
 
Integrins were silenced in SW480 human cell line by means of tranfection with Dharmafect One Target 
plus siRNAβ6-integrin, or  siRNAβ8-integrin, or both (Dharmacon, ON-TARGET plus), as previously 
described.345 siRNA to E.coli-polA_0054 (IBA, Solutions for Life Sciences ) was used as control. 
Extent of silencing was assayed by qRT-PCR by means of TaqMan gene expression assay (Applied 
Biosystems), as previously described.176 
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Immunofluorescence assay, flow cytometry and culture media analysis 
 
HSV virions were preincubated or not with PAb R8 to gD for 1 h at 37°C. These virions, or ΔgBKΔT 
virions, were absorbed to J cells expressing a combination of integrin αVβ6 alone or Nectin1 alone or 
both Nectin1 and αvβ6 integrin for 1.5 h at 4°C at 1 MOI, or equivalent MOI for ΔgBKΔT. Then J 
cells where shifted at 37°C for 30 min. Alternatively, when BFLA effect was investigated, J cells 
expressing Nectin1 plus αvβ6 integrin were incubated with 30 nM BFLA from 1 h before infection and 
during infection. Cells were then fixed with 4% paraformaldehyde and reacted with MAb 52S or MAb 
53S to gH, followed by anti- mouse secondary antibody conjugated with fluorescein isothiocyanate 
(FITC).  Cytofluorimetric analyses was performed using an AccuriC6 (Becton Dickinson) 
cytofluorimeter. Control cells received only secondary antibody.  In a similar manner SW480 human 
cells, transfected with siRNA against integrin β6 or β8 or both or mock transfected, were infected with 
HSV as described above. Cells were than staining with MAb 52S and MAb 53S to gH and analyzed by 
cytofluorimetric assay.  
Culture media was harvested from virions-cells mixture and subjected to fivefold concentration, 
deprived of serum Ig by absorption to protein A Sepharose and then analyzed through SDS/PAGE and 
WB as already described. 
For immunofluorescence assay (IFA) J cells were transfected with Nectin1 or Nectin1 plus αvβ6 
integrin. After 24 h J cells were magnetically sorted for Nectin1 expression by means of MAb R1.302 
to Nectin1 followed by anti-mouse IgG Micro Beads (Miltenyi Biotec). 48 h later, J cells were infected 
with K26GFP at 10 MOI for 0.5 h at 37°C and fixed with 4% paraformaldehyde. HSV glycoproteins 
were detected by MAbs 52S or 53S to gH, or by MAb VIII-62 to gL and stained with anti-mouse 
DyLight 549 secondary Ab (Jackson). Microphotographs were taken in a Nikon Eclipse Ni microscope 
and red and green fluorescence were analyzed with NIS Elements AR image analysis software. Red-to- 
green florescence ratio was determined for 30-40 J cells for each group. Briefly, membranes areas were 
circumscribed, pixels present in the green channel were analyzed and the green mean fluorescence 
intensity in each sample was made equal to 100. Same analysis was done for red fluorescence, but this 
was expressed as a percentage of green fluorescence in the same sample.  
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Rescue of gH−/− HSV virion by soluble gHt/gL 
 
gH−/− HSV virons were absorbed to J cells, expressing Nectin1 or Nectin1 plus αvβ6 integrins or to 
SW480 human cell line silenced for β6 or β8 integrins, or both, or mock silenced. 30 (equivalent) MOI 
of gH−/− virions were used. Virions were mixed together with BSA, used as negative control, or soluble 
gHt/gL, or soluble gHt/gL plus soluble gDΔ290t-299t at 300 nM final concentration for each soluble 
protein in phosphate saline buffer (PBS).354,378 After absorption for 2.5 h at 37°C the mixtures of gH−/− 
virons and soluble proteins were removed and J cells or SW480 cells were incubated in DMEM 1% 
FBS or L-15 1% FBS respectively. Rescue of  gH−/− virons by soluble proteins was detected 24 h after 
infection analyzing  β-galactosidase expression by means of ONPG quantification, as already 
described. When SW480 cells were used, the medium contained gH−/− virons plus soluble proteins 
were collected after cells absorption  and subject to SDS PAGE and WB as already described.  
 
VIRUS ELISA (VIR-ELISA)  
 
1 X 108 HSV virions per well were immobilized onto a 96 well plate by 18 h incubation using 
bicarbonate buffer pH 8, at 4 °C. J cells expressing Nectin1 or Nectin1 together with integrin αvβ6 
were overlaid to wells containing immobilized virions for 1 h at 37 °C. Cell suspension was removed 
and HSV gH expressed on virion surface was reacted with MAbs 52S or 53S followed by anti-mouse 
peroxidase-conjugated secondary antibody.  Quantification was done by reading the optical density of 
O-phenyilendiamine substrate at 490 nm . 
 
VZV fusion assay 
 
The luciferase-based cell-cell fusion assay was performed as described.257,383  
Donor COS cells were transfected with the indicated glycoprotein mixtures: gB, gH and gL or gB, gH, 
gL gE and gI together with pCAGT7 plasmid. Targeted COS cells were transfected with 
pT7EMCVLuc plasmid in presence of integrins heterodimers plus or minus MAG or without receptors. 
24 h after transfection donor and target cells were co seeded for other 24 h. Cell-cell fusion was 
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detected by means of a luciferase assay system (Promega) The total amount of transfected plasmid 
DNA was made equal by the addition of EGFR2Δ 2 plasmid. Each value represents the average of 
triplicate samples. 
 
Statistical Analyses 
 
When mean ± SD is presented, data included at least three independent experiments. Statistical 
significance was calculated by Student’s t test and intervals were as follows: *P < 0.05, ** P < 0.01, 
***P < 0.001. 
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